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Abstract 
Leptospirosis is an important but neglected zoonotic disease that is often overlooked in 
Africa. Although comprehensive data on the incidence of human disease are lacking, 
robust evidence of infection has been demonstrated in people and animals from all regions 
of the continent. However, to date, there are few examples of direct epidemiological 
linkages between human disease and animal infection. In East Africa, awareness of the 
importance of human leptospirosis as a cause of non-malarial febrile illness is growing. In 
northern Tanzania, acute leptospirosis has been diagnosed in 9% of patients with severe 
febrile illness compared to only 2% with malaria. However, little is known about the 
relative importance of different potential animal hosts as sources of human infection in this 
area. This project was established to investigate the roles of rodents and ruminant 
livestock, important hosts of Leptospira in other settings, in the epidemiology of 
leptospirosis in northern Tanzania. A cross-sectional survey of rodents living in and around 
human settlements was performed alongside an abattoir survey of ruminant livestock. 
Unusual patterns of animal infection were detected by real-time PCR detection. Renal 
Leptospira infection was absent from rodents but was detected in cattle from several 
geographic areas. Infection was demonstrated for the first time in small ruminants sub-
Saharan Africa. Two major Leptospira species and a novel Leptospira genotype were 
detected in livestock. L. borgpetersenii was seen only in cattle but L. kirschneri infection 
was detected in multiple livestock species (cattle, sheep and goats), suggesting that at least 
two distinct patterns of Leptospira infection occur in livestock in northern Tanzania. 
Analysis of samples from acute leptospirosis in febrile human patients could not detect 
Leptospira DNA by real-time PCR but identified social and behavioural factors that may 
limit the utility of acute-phase diagnostic tests in this community. Analysis of serological 
data revealed considerable overlap between serogroups detected in cattle and human 
leptospirosis cases. Human disease was most commonly attributed to the serogroups Mini 
and Australis, which were also predominant reactive serogroups in cattle. Collectively, the 
results of this study led to the hypothesis that livestock are an important reservoir of 
Leptospira infection for people in northern Tanzania. These results also challenge our 
understanding of the relationship between Leptospira and common invasive rodent species, 
which do not appear to maintain infection in this setting. Livestock Leptospira infection 
has substantial potential to affect the well-being of people in East Africa, through direct 
transmission of infection or through indirect effects on food production and economic 
security. Further research is needed to quantify the impact of livestock leptospirosis in 
Africa and to develop effective interventions for the control of human and animal disease.   
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1 Leptospirosis in Tanzania: an introduction to a 
neglected and complicated disease 
 
1.1 The global impact of leptospirosis  
Leptospirosis is often described as the most common and pervasive zoonotic bacterial 
disease around the world, but it remains overlooked in global infectious disease priorities, 
(Abela-Ridder et al., 2010). Recent work however has estimated that approximately one 
million cases of leptospirosis occur each year (Costa et al., 2015a) with a resulting loss 
around 2.9 million Disability-Adjusted Life Years (DALYs) per annum (Torgerson et al., 
2015). Compared to the burden of other neglected tropical diseases, leptospirosis has a 
similar impact to several diseases included World Health Organisation‘s list of priority 
neglected tropical diseases but yet remains relatively under-resourced (Table ‎1.1) (Murray 
et al., 2012, Hotez et al., 2007, Hotez, 2009).  
 
Table  1.1: The global burden of leptospirosis measured in Disability 
Adjusted Life Years (DALYs) per 100,000 population compared to Global 
Burden of Disease (GBD) estimates for other tropical diseases (Torgerson et 
al., 2015, Murray et al., 2012) 
Disease DALYs per annum Confidence Interval 
Malaria 1200 921 - 1594 
Rabies 52 22 - 145 
Leishmaniasis 48 32-71 
Schistosomiasis 48 25-91 
Leptospirosis 42 18-66 
Lymphatic filariasis 40 26-58 
Dengue fever 12 15-20 
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Approximately three-quarters of leptospirosis cases occur in tropical or sub-tropical 
regions of the world (Costa et al., 2015a, Torgerson et al., 2015). In Southeast Asia, the 
importance of leptospirosis as a cause of febrile illness is well recognised. Leptospira is a 
leading aetiology of NMFI in the Greater Mekong region (Cambodia, Lao PDR, Viet Nam, 
Thailand and Yunnan province of China) (Acestor et al., 2012) and a major cause of 
undifferentiated febrile disease in several other countries including Sri Lanka (Agampodi 
et al., 2011), Bangladesh (Kendall et al., 2010) and Nepal (Blacksell et al., 2007). 
Leptospirosis is also a prominent health threat in island communities around the world 
including the Caribbean (Alleyne, 1987, Everard and Everard, 1993, Everard et al., 1992), 
a variety of pacific island nations (Lau et al., 2016, Dreyfus et al., 2014a, Berlioz-Arthaud 
et al., 2007) and the western Indian Ocean islands (Desvars et al., 2013a). However, 
relatively little is known about the incidence of disease in Africa. 
Recent reviews of leptospirosis have highlighted that leptospirosis research in Africa is 
hampered by a lack of good quality surveillance data (Costa et al., 2015a, de Vries et al., 
2014). Seroprevalence studies indicate that human Leptospira infection is geographically 
widespread in sub-Saharan Africa, although serological data are often out-dated 
particularly for countries in Central Africa (de Vries et al., 2014). Costa et al. (2015a) also 
highlighted the lack of data from Africa as a whole in their global review of the burden of 
leptospirosis. However, based on available data, the East African region was predicted to 
have a relatively high incidence of disease, compared to many other global regions (Costa 
et al., 2015a). Leptospirosis therefore may be an important, but under-diagnosed cause of 
undifferentiated fever in East Africa, a region where awareness of the burden of non-
malarial febrile illness (NMFI) is growing.  
 
1.2 The problem of non-malarial febrile illness (NMFI) in Africa 
Febrile disease is one of the most common reasons for patients to seek health-care in sub-
Saharan Africa (Feikin et al., 2011, Crump and Kirk, 2015). Malaria is the major infectious 
cause of fever in Africa but there is growing evidence that the burden of malaria is 
decreasing in many parts of the continent (O'Meara et al., 2010, D'Acremont et al., 2010). 
Declines in malaria incidence are particularly prominent in East Africa over the last decade 
where marked reductions of up to ~ 80% have been reported in Tanzania (Mmbando et al., 
2010, Bhattarai et al., 2007) and Kenya (Okiro et al., 2007, O'Meara et al., 2008).  
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However, there is no evidence that the reduction in malaria morbidity has been 
accompanied by an overall reduction in the prevalence of febrile disease in sub-Saharan 
Africa (D'Acremont et al., 2010). Over diagnosis of malaria is a serious problem in parts of 
sub-Saharan Africa (D'Acremont et al., 2010, Amexo et al., 2004). Malaria continues to be 
diagnosed clinically and treated in a high proportion of febrile patients with little 
recognition or treatment of alternative causes of febrile illness. For example, in one study 
performed in northern Tanzania, only 46% of more than 4000 patients who received a 
clinical diagnosis of severe malaria were positive for Plasmodium parasitaemia on blood-
smear examination (Reyburn et al., 2004). In this population, patient fatality was 
significantly higher in patients with NMFI (12.1%) than those with laboratory-confirmed 
malaria (6.9%; p < 0.001). Similar scenarios have been described in other parts of the 
continent including in Kenya (Ye et al., 2009) and Sudan (A-Elgayoum et al., 2009). As 
yet, relatively little is known about other causes of fever in this part of the world.   
 
1.3 Investigating the causes of NMFI in Tanzania 
In response to growing awareness of the problem of NMFI in East Africa, a cohort study of 
the aetiology of febrile illness was performed in two hospitals in northern Tanzania. In 
total, 870 patients with non-specific febrile illness were enrolled between 2007 and 2008, 
and tested for a range of infectious causes of fever known to occur in tropical areas 
(Crump et al., 2013). On admission, more than 60% of patients received a clinical 
diagnosis of malaria, but only 2% of study participants received an aetiological diagnosis 
of malaria after laboratory testing. In contrast, 8.8% of patients met international 
serological case definitions for acute leptospirosis (Crump et al., 2013, Biggs et al., 2011). 
This finding demonstrated the relative importance of leptospirosis in this area, but also 
highlighted many knowledge gaps critical to be able to detect and control the disease. 
Firstly, all diagnoses of human leptospirosis were made retrospectively with little 
opportunity to directly inform patient management. In addition, little was known about 
animal hosts of leptospirosis in the study catchment area limiting the potential to design 
and target effective disease control interventions. Consequently, work was initiated 
(including this PhD) to explore the epidemiology of leptospirosis in this area in greater 
detail.  
Leptospirosis, however, is a complicated infection to work with and to control. The disease 
is difficult to differentiate clinically from other causes of febrile illness and laboratory 
diagnosis of leptospirosis is challenging even in well-resourced, high-income settings 
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(Musso and La Scola, 2013, Haake and Levett, 2015). Infection can be caused by one of a 
wide variety of Leptospira organisms, and multiple animal hosts as well as environmental 
sources may be involved in the epidemiology of infection (Levett, 2001, Ko et al., 2009). 
However, control strategies rely on thorough understanding the types of circulating 
leptospires and animal maintenance hosts of infection, as well as thorough surveillance to 
monitor the outcome of any interventions (Hartskeerl et al., 2011). The next sections of 
this introductory literature review will briefly outline and discuss important pathogen 
characteristics, epidemiological features and limitations of available diagnostic tests that 
have to be taken into consideration when studying this overlooked but important disease.  
 
1.4 Leptospira bacteria: the causative agents of leptospirosis  
Leptospirosis is caused by infection with pathogenic Leptospira bacteria. Leptospira are 
spirochaete bacteria with a characteristic coiled or spiral appearance (Adler and de la Pena 
Moctezuma, 2010). The Leptospira genus is thought to have arisen from an early branch of 
eubacterial evolution and the taxonomy of this group is complex and continually being up-
dated (Levett, 2015). To date, genetic analysis has identified nine pathogenic and six 
saprophytic (non-pathogenic) Leptospira spp., in addition to five Leptospira species that 
exhibit intermediate pathogenic properties (Table ‎1.2) (Cerqueira and Picardeau, 2009, 
Levett, 2015).  
 
Table  1.2: Pathogenic, intermediate and saprophytic Leptospira species 
(adapted from Levett (2015)). 
Pathogenic Leptospira Intermediate Leptospira  Saprophytic Leptospira 
L. alexanderi L. broomii L. biflexa 
L. alstonii L. fainei L. meyeri 
L. borgpetersenii L. inadai L. terpstrae 
L. interrogans L. licerasiae L. vanthielii 
L. kirschneri L. wolfii L. wolbachii 
L. kmetyi  L. yanagawae 
L. noguchii   
L. santarosai   
L. weilii   
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Within each species, Leptospira are further sub-divided into serovars, which is the smallest 
taxonomic unit of Leptospira bacteria (Levett, 2015). To date, around 282 pathogenic 
serovars have been described, 88 of which belong to the best-characterised pathogenic 
species, L. interrogans (Ko et al., 2009, Cerqueira and Picardeau, 2009). 
The Leptospira genome ranges in size from 3.9 mega-bases (MB) for L. borgpetersenii and 
4.7 MB for L. noguchii (Fouts et al., 2016). The genome consists of a large circular 
chromosome (approximately 3.6 to 4.3 MB) and a smaller replicon roughly 350 kilo-bases 
(KB) in length (Picardeau, 2015). L. biflexa, the prototype saprophytic leptospire, also has 
a third extra-chromosomal genomic element P74 (74 KB) that has not been detected in any 
pathogenic Leptospira species (Picardeau et al., 2008). Essential housekeeping genes, 
including the secY and ribosomal RNA (rRNA) genes are used to classify the bacteria (rrs, 
rrl and rrf) and are located mainly on the large circular chromosome (cI). In contrast to 
most bacteria where the rRNA genes are clustered and co-transcribed, these genes are not 
linked to one another and are widely scattered along the cI chromosome (Picardeau, 2015). 
Most of the genes encoding virulence factors, such as lipL32 and ligB, are also located on 
chromosome cI (Picardeau et al., 2008). Overall however, there appears to be substantial 
amount of functional gene redundancy in Leptospira, particularly in pathogen-specific 
genes where up to 78% of genes have no known function (Adler et al., 2011). 
Leptospira bacteria also show unusual patterns of genetic organisation and mechanisms of 
gene regulation (Bulach et al., 2006, Saint Girons et al., 1992). Although a substantial 
proportion of the genome is shared between pathogenic species, there is relatively little 
synteny even for species with a short evolutionary distance between them (Picardeau et al., 
2008). Pseudogenes and insertion sequences (IS) are common features in the Leptospira 
genome (Picardeau, 2015). IS-mediated sequence disruption and genome reduction is 
thought to be an important mechanism in the evolution of Leptospira and the number of 
IS-elements varies between species and serovars (Bulach et al., 2006). In general however, 
the Leptospira genome is considered relatively stable as Leptospira serovar identity is 
maintained in in vitro culture for more than 80 years in the absence of selective pressure 
(Picardeau, 2015). Lateral gene transfer and homologous recombination events are 
considered to make a relatively minor contribution to the overall genetic diversity of 
Leptospira (Picardeau et al., 2008, Picardeau, 2015). 
As well as the gene-based taxonomic classification described above, serovars are clustered 
into 24 serogroups, based on similarities in their serological characteristics (Levett, 2001). 
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Serogroups do not have any taxonomic value per se but are important to understand the 
epidemiology of infection on a regional level and are used in serological diagnosis of 
infection (Levett, 2015). Furthermore, serogroups and genetic species show relatively poor 
concordance. A single serogroup for example may include serovars belonging to several 
different Leptospira species and vice versa (Cerqueira and Picardeau, 2009). However, 
serogroup classifications remain critical to serological diagnosis of leptospirosis and our 
understanding of the epidemiology of leptospirosis on a regional scale, and hence this unit 
continues to be an important part of Leptospira classification (Goris and Hartskeerl, 2013, 
Levett, 2001). 
 
1.5 The epidemiology of leptospirosis 
As a zoonotic bacteria (i.e. one that can transmit between animals and people (World 
Health Organization, 2006)), infection in both people and animals must be considered in 
the epidemiology of the disease. A large number of animal host species of Leptospira have 
been reported for the 250 or so recognised Leptospira serovars (Levett, 2015, Cerqueira 
and Picardeau, 2009). In a particular ecosystem, the specific role of each susceptible 
animal host broadly divides into either maintenance or non-maintenance hosts of infection 
(Ellis, 2015, Levett, 2001). 
In the disease ecology literature, a maintenance host is defined as a host that is able to 
maintain infection without re-introduction from other animal or environment sources of 
infection (Viana et al., 2014). Maintenance hosts of Leptospira generally appear to be 
well-adapted to infection with their associated serovars and are able to reach a state of 
equilibrium with the pathogen without major detrimental effects to the host (Bonilla-
Santiago and Nally, 2011, Bharti et al., 2003). Persistent renal or genital tract colonisation 
occurs following Leptospira infection in a maintenance host and infectious leptospires may 
transmitted through sexual contact or shed in the urine of these animals for several years 
(Levett, 2001, Ellis, 2015). Transmission of infection from maintenance hosts to non-
maintenance hosts usually occurs either through direct with infected urine or indirectly as a 
consequence of environmental contamination (Levett, 2001). 
A non-maintenance host of Leptospira is usually referred to as an incidental host in the 
leptospirosis literature, which is defined as a mammalian host that becomes incidentally 
infected with a Leptospira serovar that is not normally maintained by that particular 
species or population (Ko et al., 2009, Levett, 2001). Virtually any mammal, including 
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humans, may be an incidental Leptospira host (Levett, 2001). Renal colonisation occurs 
after an initial period of bacteraemia but typically is less well-tolerated than in a 
maintenance host and may be associated with clinical disease and more severe renal 
pathology (Zhang et al., 2012, da Silva et al., 2010). Urinary shedding also occurs in 
incidental hosts but the duration of shedding is generally thought to be short-lived (Levett, 
2001). However, the distinctions between maintenance and incidental hosts of Leptospira 
in a particular setting are not mutually exclusive or absolute. A mammal that is a 
maintenance host for one serovar may be incidentally infected with a different serovar for 
which it is a non-maintenance host, and the specific factors and mechanisms that define 
these roles remain poorly characterised (Ellis, 2015, Monahan et al., 2009). However, any 
infected host that is capable of shedding infectious leptospires in its urine has the potential 
to act as a source of infection for other people and animals and hence both maintenance 
and non-maintenance hosts may contribute to the overall reservoir of infection
*
 in a 
particular ecosystem (Haydon et al., 2002).  
Leptospira infection has been reported in many different animal species including 
domestic animals such as cattle, sheep, pigs, horses and dogs. A wide variety of wild 
animal hosts including numerous rodent species, bats, possums, deer, mongoose and small 
insectivores also been reported (Ellis, 2015, Bharti et al., 2003) However, two major 
groups of animal host are considered fundamental to the epidemiology of human infection; 
rodents and livestock (Figure ‎1.1) (Haake and Levett, 2015, Mwachui et al., 2015).  
                                                 
*
 A reservoir of infection is defined by Haydon et al as one or more epidemiologically connected populations 
or environments in which a pathogen can be permanently maintained and from which infection is transmitted 
to the target population.   
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Figure  1.1: Key features of the epidemiology of leptospirosis.  
Domestic and wild animals may maintain infection (curved arrows) and act as sources of 
infection for people (solid arrows). Transmission of infection occurs through direct contact 
between animals and people, or indirectly through contaminated soil or water. 
Transmission may also occur between domestic and wild animal species (dashed arrow).   
Rodents are considered by many sources to be the most important animal hosts for human 
Leptospira infection (Haake and Levett, 2015, Levett, 2001), and contact with rodents is a 
common risk factor for human infection around the world (Mwachui et al., 2015). Rodent-
associated leptospirosis is typically seen in environments that are favourable to rodent 
invasion such as rural areas with abundant food sources (Gratz and Arata, 1975) or urban 
slum settlements with low-quality housing and poor sanitation and waste management 
(Masi et al., 2010). As a consequence, rodent-associated leptospirosis is an emerging 
health problem in urban communities in low-income settings such as slum communities in 
Brazil (Reis et al., 2008) or rapidly-expanding urban areas of south-east Asia (Kendall et 
al., 2010, Sakundarno et al., 2014).  
Livestock-associated leptospirosis is described as an occupational health risk for 
professions that bring people into close contact with infected animals, such as dairy 
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(Dreyfus et al., 2014a, Levett, 2001). Livestock production, particularly of cattle and pigs, 
is a global risk factor for leptospirosis (Mwachui et al., 2015). Livestock contact is a 
typical part of daily life in subsistence farming communities around the world (Grace et 
al., 2012b), and hence livestock are potentially important sources of Leptospira infection 
for people living in rural communities, which carry a high burden of infection (Costa et al., 
2015a).  
Finally, environmentally-acquired leptospirosis can occur in any ecosystem where infected 
animal hosts live that provides the moist, warm conditions needed for pathogenic 
Leptospira bacteria to survive outside a mammalian host (Lau et al., 2010, Levett, 2001). 
Tropical areas are particularly well-suited to supporting environmental transmission of 
leptospirosis (Costa et al., 2015a). Initial contamination of water and soil with Leptospira 
must derive from an infected animal living in that ecosystem. Environmental survival is 
variable, but may be several weeks for some pathogenic Leptospira species (Levett, 2001). 
Outbreaks of disease may occur after heavy seasonal rainfall or flooding (Lau et al., 2010, 
Reis et al., 2008). Particular high-risk behaviours associated with environmental 
transmission including swimming, fishing and walking barefoot have been identified 
(Mwachui et al., 2015). Recreational exposure to contaminated water sources is also an 
important and growing source of leptospirosis, particularly in relation to competitive 
sporting events or adventure travel-related activities (Haake et al., 2002).  
 
1.6 Leptospirosis: the disease 
1.6.1 Human disease, presentation and treatment 
In people, leptospirosis may range from a mild, flu-like episode to a severe life-threatening 
disease (Levett, 2001, Haake and Levett, 2015). Asymptomatic infection has also been 
reported (Bharti et al., 2003). Fever is the most common presenting sign in the acute phase 
of infection and may be accompanied by other non-specific signs such as headaches, chills 
and myalgia(Levett, 2001). Conjunctival suffusion is described as a pathognomic sign of 
leptospirosis but often does not occur (Haake and Levett, 2015). Severe disease 
manifestations, characterised by multiple organ dysfunction, occur in the secondary phase 
of infection following tissue localisation of circulating leptospires. The classic disease 
manifestation is ‗Weil‘s disease‘, a combination of renal insufficiency and jaundice that is 
often accompanied by thrombocytopenia and haemorrhage (Cruz et al., 2009, Haake and 
Levett, 2015). Other life-threatening disease sequelae include meningitis and severe 
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pulmonary haemorrhagic syndrome (SPHS). SPHS in particular is associated with a high 
patient mortality rate in excess of 50% (McBride et al., 2005, Ruwanpura et al., 2012, 
Simpson et al., 1998). For other disease manifestations, the average mortality rate is 
reported as around 5-10% (Haake and Levett, 2015). 
In general, most mild cases of leptospirosis will self-resolve but treatment is indicated 
when infection is diagnosed to reduce the potential for and impact of secondary sequelae 
and to shorten the duration of clinical disease (Haake and Levett, 2015, McBride et al., 
2005). Pathogenic leptospires shows good in vitro susceptibility to a wide range of readily 
available antimicrobial agents (Wuthiekanun et al., 2015, Bharti et al., 2003) but there 
continues to be some debate on the most appropriate antibiotic treatment strategy for 
recognised cases (Suputtamongkol et al., 2004, Vinetz, 2003). Severe cases also require 
intensive care to support renal function, manage pulmonary complications and reduce 
mortality (Haake and Levett, 2015).  
Chronic health problems have been reported following Leptospira infection although data 
are limited to a single study in the Netherlands (Goris et al., 2013a) and anecdotal reports 
from New Zealand (Jackie Benschop, personal communication). Sequelae including 
persistent fatigue, myalgia and headaches have been reported for years following an acute 
infection. Although recent DALY calculations of leptospirosis gave little weighting to the 
chronic sequelae of disease in estimates of global morbidity (Torgerson et al., 2015), the 
issue of long term health problems following an acute episode of leptospirosis is a 
neglected area of clinical research, which could have consequences for the overall impact 
of the disease.   
 
1.6.2 Animal disease 
In livestock species including cattle, pigs and small ruminants, clinical leptospirosis is well 
described but varies with the infecting species or serovar (Tibary et al., 2006, Radostits et 
al., 2000). Acute systematic infection is most common in calves and lambs but is also 
reported in adult dairy cattle as a cause of acute onset agalactia (‗milk drop syndrome‘) 
(Ellis, 2015). Chronic infections with leptospirosis can result in abortions, stillbirths and 
reduced fertility in all the major livestock species. Abortion outbreaks are common in 
leptospirosis infections in pig herds, which can result in large-scale economic losses for 
commercial units (Gresham, 2003). Reduced weight gain was reported in deer with 
subclinical Leptospira infection (Ayanegui-Alcerreca et al., 2007, Subharat et al., 2012).   
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Overt clinical disease is frequently reported in dogs and horses. In dogs, four potentially 
fatal, clinical syndromes (icteric, haemorrhagic, uraemic and reproductive) are described 
(Faine, 1994, Radostits et al., 2000). Leptospirosis is an important cause of recurrent 
uveitis in equids (Faber et al., 2000).  
In wildlife, little is known about clinical disease. Rodents and other small mammals are 
common hosts of infection but are not known to suffer from disease following infection 
with rodent-adapted serovars (Levett, 2001, Reis et al., 2008, Lau et al., 2010, Belmain, 
2006). However, in the laboratory, rodent species show differing vulnerability to clinical 
disease following experimental infection with different serovar. Some species such as 
hamsters and guinea pigs are susceptible to severe clinical disease and high rates of 
mortality with typical rodent-associated Leptospira serovars (Zhang et al., 2012, Coutinho 
et al., 2014). Infection has also been demonstrated or induced in other taxonomic classes 
such as amphibians, reptiles and birds (Faine, 1994, Levett, 2001, Radostits et al., 2000). 
To date, there is no evidence that these animals shed leptospires or act as sources of 
infection for people or other animals but it remains a possibility that non-mammalian 
species may also contribute to the epidemiology of infection in some ecosystems. 
 
1.7 Diagnosis of leptospirosis and Leptospira infection 
Leptospirosis is notoriously difficult to diagnose due to the non-specific nature of clinical 
signs in acute cases. Multiple testing strategies are described but each method has 
limitations and the choice of diagnostic tool is highly dependent upon the goal of testing. 
Different diagnostic approaches may be taken to diagnose an acutely unwell patient for 
example than in an epidemiological study investigating evidence of previous exposure in 
an animal population. The phase of the disease must also be taken into account when 
selecting an appropriate diagnostic test and sample. Leptospirosis is a biphasic disease 
consisting of 1) the leptospiraemic phase, when Leptospira organisms are circulating in the 
blood; 2) the leptospiruric or immune phase, when Leptospira colonises tissues and 
antibody production starts shown in Figure ‎1.2. 
Diagnostic methods for Leptospira infection may be divided into two complementary 
groups; firstly those that directly detect the presence of the pathogen through direct 
visualisation, culture and isolation, or demonstration of the presence of the pathogen‘s 
DNA in normally sterile sites (e.g. blood, kidney, cerebrospinal fluid); or secondly, tests 
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that rely on demonstration of Leptospira-specific antibodies to infer the infection status of 




Figure  1.2: Biological phases of leptospirosis and implications for sampling 
and diagnostic testing (adapted from (Haake and Levett, 2015)).  
(i) Leptospirosis is often described as a biphasic disease characterised by a period 
of leptospiraemia in the acute phase and leptospiruria in the convalescent or 
immune phase, which coincides with rising antibody titres (ii). Antibody titres may 
remain elevated for several months to years following infection and decline at a 
variable rate. (iii) The choice of sample type and diagnostic test is informed by the 
phase of infection. Serum samples for paired serology should be taken early in the 
acute leptospiraemic phase and then again 2-4 weeks later in the convalescent 
phase of infection (shown by arrows). The period where there is a possibility of 
detection of Leptospira by Polymerase Chain Reaction (PCR) or culture in the 
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1.7.1 Diagnostic tests for direct detection of Leptospira infection 
Leptospira culture and isolation is the gold standard test to directly demonstrate Leptospira 
infection and offers the best option for fully characterising the infecting Leptospira 
serovar. This approach therefore is well suited to determining animal hosts of specific 
serovars, for identifying sources of human infection and for describing population level 
diversity of Leptospira. However, the process is time consuming and laborious as 
leptospires are slow growing, fastidious bacteria, which require specialist media and long 
incubation times (up to 6 months according to some sources). As a result, this approach is 
of limited utility to a clinician concerned with making a rapid diagnosis to inform patient 
care (Picardeau et al., 2014). Culture is highly specific for Leptospira but the sensitivity is 
relatively low in clinical settings due to issues with timing of sample collection, impacts of 
prior antibiotic treatment and low bacterial load in clinical samples (i.e. blood and urine) 
(Faine, 1994, Levett, 2001). Also, no single culture medium is capable of supporting the 
primary isolation of all known pathogenic leptospires. The potential for serovar selection 
bias to be introduced through culture and isolation approaches should therefore also be 
considered (Ellis, 2015).  
Direct visualisation of infecting leptospires is possible using histopathology, 
immunohistochemistry or immunofluorescence techniques to diagnose infection. However, 
these diagnostic techniques are particularly labour intensive, relatively insensitive and are 
not well suited to routine surveillance of large numbers of patients or animals. 
Over the last decade, the popularity of nucleic acid amplification approaches such as 
Polymerase Chain Reaction (PCR) to provide rapid diagnosis of human and animal 
Leptospira infection has been growing (Picardeau et al., 2014, Sykes et al., 2011). A 
positive diagnosis of infection can be made in a matter of hours with PCR rather than the 
weeks to months required for culture. In human disease, PCR is most useful in the early 
stages of infection when the diagnostic test can be used to detect bloodstream infection 
(Figure ‎1.2). In studies of animal hosts, PCR can be used to demonstrate infection and 
determine prevalence in different species and geographic settings, as well as to diagnose 
infection in clinical cases (Desvars et al., 2013c, Sykes et al., 2011). Genetic typing of 
Leptospira species can also be performed directly from PCR products (Morey et al., 2006, 
Perez and Goarant, 2010). In clinical settings PCR is still subject to some of the same 
limitations as culture, including issues with timing of sample collection, prior antibiotic 
use and low bacterial load. PCR assays may also be inhibited by a variety of biological 
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compounds such as urea in urine samples, which reduce the probability of detecting an 
infection (Schrader et al., 2012). Overall however, PCR may offer a more practical and 
sensitive approach to demonstrating infection in the acute phase of illness in people, or in 
field surveys of animals where conditions often constrain the ability to definitely 
demonstrate infection by other techniques.  
 
1.7.2 Serological diagnostic tests for Leptospira infection   
Serology by microscopic agglutination test (MAT) is considered the cornerstone of 
leptospirosis diagnosis (Goris and Hartskeerl, 2013, World Organisation for Animal Health 
(OIE), 2014). Definitive serological diagnosis of acute leptospirosis by MAT is reached by 
demonstrating seroconversion between paired acute and convalescent serum samples. 
Single sample MAT tests can be used to demonstrate prior Leptospira exposure in 
epidemiological surveillance studies, and a single high titre can also be used to infer 
current or recent infection. However, a number of important limitations exist for the use of 
MAT to diagnose acute disease. Optimal sensitivity of the MAT requires prior knowledge 
of locally prevalent serovars to select a representative test panel (Goris et al., 2012, Goris 
and Hartskeerl, 2013). Diagnostic sensitivity of a single serum sample is low (~ 6%) 
during the first 7-10 days of illness due to a delay in antibody response following infection 
(Figure ‎1.2) (Limmathurotsakul et al., 2012, Goris et al., 2012). Paired serology improves 
the sensitivity of testing (~ 82%) but means that infection can only be demonstrated 
retrospectively and cannot therefore be used to inform patient care (Goris and Hartskeerl, 
2013). While the diagnostic specificity of seroconversion in paired MAT titres is good (~ 
100%) (Goris and Hartskeerl, 2013), less is known about the specificity of a single acute-
phase MAT. For people living in areas where prior exposure may be common, high MAT 
titres may imply either current or previous infection. Local validation is recommended to 
test the appropriateness of single titre MAT case definitions (Goris et al., 2012). 
In animals, paired serology can also be used to demonstrate seroconversion in an animal, 
or animal population (Sykes et al., 2011). However, serological approaches have limited 
utility for identifying animal hosts of Leptospira as they cannot be used to detect persistent 
Leptospira infection or shedding. Chronically infected animal hosts may mount only a 
transient antibody response and hence test negative by serology in the later stages of 
infection (Bonilla-Santiago and Nally, 2011, Ellis, 2015). Therefore, direct methods of 
detection are required to definitively identify chronic carriers of Leptospira within a 
population (World Organisation for Animal Health (OIE), 2014).  
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Another limitation of the MAT is that data can only be used to gain a broad understanding 
of infecting Leptospira serogroups at the population level. The MAT is notoriously 
unreliable in predicting infecting serogroups early in the course of infection due to a high 
degree of non-specific or paradoxical reactivity in the early stages of the immune response 
(Levett, 2003, Smythe et al., 2009). Determining the infecting serovar using MAT data is 
not possible at any stage as the MAT only shows specificity to the serogroup level (Faine, 
1994). Serogroup patterns can be deduced from reaction patterns on convalescent or 
background population samples. However, cross-reactions are common and should be 
taken into consideration particularly where multiple serovars are present in a population 
(Goris et al., 2012, Smythe et al., 2009). 
As well as the MAT, a variety of other serology-based rapid tests have been described for 
the diagnosis of acute leptospirosis in people (Goris et al., 2013b). Most commonly used 
are enzyme-linked immunoassays (ELISA) targeting either IgM antibodies for acute 
infection or IgG antibodies for historic infection (Goris and Hartskeerl, 2013, Niloofa et 
al., 2015). The IgM ELISA for acute leptospirosis is reported shows higher diagnostic 
sensitivity than the MAT using acute phase serum samples, but typically also has lower 
diagnostic specificity for acute infections (Bajani et al., 2003, Goris et al., 2013b). 
Laboratory confirmation of a positive acute-phase ELISA test by either direct pathogen 
detection (PCR or culture) or evidence of seroconversion by MAT, is required to make a 
definitive diagnosis of infection or characterise the infecting Leptospira type (Picardeau et 
al., 2014). Finally, unlike the MAT, most ELISA tests are host species-specific (e.g. 
human or bovine) and therefore cannot be used to generate comparable information 
between people and animals.  
 
1.8 Control and prevention of leptospirosis 
Broadly, strategies to control and prevent Leptospira infection in people and animals fall 
into three categories: 1) directly protecting people or domestic animals from infection or 
illness; 2) using tactics to reduce transmission from sources of infection; or 3) reducing or 
eliminating infection from source populations or contaminated environments (Hartskeerl et 
al., 2011, Haydon et al., 2002). Direct strategies to protect people from disease have been 
used in some high-risk settings where infection cannot be controlled at source. 
Prophylactic doxycycline treatment is recommended for travellers or military personnel 
visiting a highly endemic area (Takafuji et al., 1984, Haake et al., 2002), and human 
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vaccination has been used as a strategy for some high-risk occupations (Haake and Levett, 
2015) or in areas with a high burden of human disease that is attributed to infection with a 
small number of serovars (e.g. Cuba (Bharti et al., 2003, Martinez Sanchez et al., 2000). 
However, leptospirosis vaccinations rely on whole-cell preparations that are typically 
associated with high rates of side effects and a short duration of serovar-specific immunity 
(Haake and Levett, 2015, Hartskeerl et al., 2011). Hence human vaccinations are not 
generally practical or an effective method of controlling disease in large populations where 
multiple serovars are circulating.  
More commonly, control measures for human Leptospira infection focus on reducing 
transmission to people by either minimising contact with sources of infection, or reducing 
the burden of infection in animal source populations (Haake and Levett, 2015). Animal 
vaccination is one strategy that may reduce infection in animal source populations 
(Hartskeerl et al., 2011). Vaccination acts to protect the animal from clinical disease and to 
reduce urinary shedding of infectious bacteria (Ellis, 2015, Bolin and Alt, 2001). As with 
people, animal vaccination is serovar-specific hence full characterisation of circulating 
Leptospira serovars is important for vaccine selection (Hartskeerl et al., 2011) and clinical 
disease may still be encountered if animals are exposed to other serovars (Goldstein, 2010, 
Ellis, 2010). Treatment in infected animal herds has also been described as a method for 
reducing both urinary shedding and the impact of infection on the animal host (e.g. in 
cattle in the Netherlands (Hartskeerl et al., 2011)). Both methods of control of infection in 
animal hosts requires a thorough knowledge of the epidemiology of Leptospira infection in 
local populations and are only really feasible for domestic animal populations (Hartskeerl 
et al., 2011). Where human disease results from contact with wild animals (e.g. rodents) or 
environmental sources (or from serovars that cannot be controlled by animal vaccination), 
the only feasible option for control is to reduce the amount of contact between people and 
the sources of disease. Examples of the wide variety of control strategies that may need to 
be considered include improving sanitation in informal urban settlements (Reis et al., 
2008), reducing rodent invasion into households (Gratz and Arata, 1975), providing 
personal protection for people engaged in high-risk occupations (Dreyfus et al., 2014b) or 
protecting people from risks associated with flooding or other environmental disasters (Lau 
et al., 2010, Watson et al., 2007). Monitoring the efficacy of leptospirosis control strategies 
such as these requires a multidisciplinary approach as well as decent public health 
infrastructure and effective diagnostic testing for accurate surveillance (Hartskeerl et al., 
2011). Many of these attributes continue to be lacking from potentially high incidence 
areas such as sub-Saharan Africa.  
  37 
 
1.9 From theory to the field: an overview of study aims, objectives 
and the outline of this thesis 
Leptospirosis is a challenging disease to understand and to work on. The complicated 
classification system and complex multi-host epidemiology of the pathogen mean that no 
single approach can be applied to help us understand disease patterns around the world 
(Hartskeerl et al., 2011). Diagnostic limitations have resulted in limited surveillance, which 
has contributed to the continued neglect of this disease (Abela-Ridder et al., 2010). Even in 
the leptospirosis community, Africa still retains a low profile on a global scale (Allan et 
al., 2015b, Pappas et al., 2008). However, recent evidence demonstrates that leptospirosis 
is an important cause of NMFI in Tanzania (Crump et al., 2013), and that the incidence of 
infection is relatively high in East Africa (Costa et al., 2015a). More work is needed to 
understand the scale of the problem and the epidemiology of infection on this neglected 
continent.  
This study used a multifaceted approach to address some of the gaps in our knowledge of 
leptospirosis, both on the local level in Tanzania and at the continental level. An outline of 
the different components of this study is shown in Figure ‎1.3.  
Firstly, a systematic review of available literature on human and animal Leptospira 
infection was performed to assess the geographic distribution and prevalence of Leptospira 
infection in Africa. This study aimed to compile data on human and animal infection from 
across the continent, taking a ‗One Health‘ approach to compile and synthesise the 
available data on the epidemiology of leptospirosis in Africa in more depth (Chapter ‎2).  
Secondly, field studies were established to explore the epidemiology of animal populations 
in northern Tanzania. Rodents and ruminant livestock have been implicated as important 
sources of human infection in other settings and therefore were selected as the major 
animal hosts for investigation in this thesis (Chapter ‎5 and Chapter ‎6). qPCR assays were 
used to diagnose infection in these animal hosts and to diagnose human Leptospira 
infection (Chapter ‎6.4‎7). The selection of diagnostic assays for use was based on validation 
data presented in Chapter ‎4. Infecting Leptospira species in people and animal hosts was 
explored using both serological and genetic typing approaches and serological exposure 
patterns in people and cattle were also analysed. Finally data from all study elements were 
assimilated to identify potential sources of Leptospira for people in northern Tanzania and 
to inform evidence-based recommendations for leptospirosis surveillance, control and 
future research priorities in the region (Chapter ‎8).  
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Figure  1.3: Overview of thesis structure showing chapter outlines, key methodologies and outputs
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2 A systematic review of acute human leptospirosis and 
animal Leptospira infection in Africa 
 
2.1 Introduction 
Endemic zoonotic diseases affect impoverished and developing communities around the world 
but are typically overshadowed in public and clinician awareness by higher profile infections 
such as malaria and HIV/AIDS (World Health Organization, 2006, Maudlin et al., 2009). In 
Africa, zoonotic infections are directly affect human health through human morbidity and 
mortality but may also indirectly impact human well-being as a result of reduced livestock 
productivity and food security (Schelling et al., 2007, Perry and Grace, 2009, Halliday et al., 
2012). However, bacterial zoonoses such as leptospirosis are under-diagnosed and therefore 
under-reported in Africa. As a result, endemic zoonotic diseases are neglected on the continent 
(Molyneux et al., 2011, World Health Organization, 2006, Maudlin et al., 2009).  
Leptospirosis is thought to be one of the most common and widespread zoonotic infections 
worldwide. Disease is caused by infection with a pathogenic serovar of Leptospira spp. 
bacteria (Hartskeerl et al., 2011, Adler and de la Pena Moctezuma, 2010). More than 250 
pathogenic Leptospira serovars are known to exist that are classified into 24 serogroups based 
on their serological phenotype (Chapter ‎1.4) (Cerqueira and Picardeau, 2009, Levett, 2001). 
Nine pathogenic species have been described (Cerqueira and Picardeau, 2009, Evangelista and 
Coburn, 2010), which may be carried by a wide range of mammals that act as a source of 
infection for people and other animals (Levett, 2001, Hartskeerl et al., 2011). Mammalian 
hosts of Leptospira may be asymptomatic carriers of infection or develop clinical disease 
following infection (Levett, 2001, Faine, 1994). Infectious leptospires are shed in the urine of 
infected animals for months to years following infection. Leptospira serovars often 
demonstrate a degree of animal host preference and some common relationships between 
serovars and their hosts are reported (Bharti et al., 2003). Knowledge of the serovars 
circulating in local animal populations is necessary to determine sources and transmission 
routes for human infection (Hartskeerl et al., 2011). 
In people, infection with Leptospira occurs through direct or indirect contact with infected 
urine from an animal host (Adler and de la Pena Moctezuma, 2010, Hartskeerl et al., 2011, 
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Bharti et al., 2003). However, recognising leptospirosis in the early stages of disease is 
challenging. Most commonly, human leptospirosis presents as a non-specific ‗flu-like disease 
that is difficult to distinguish from other causes of febrile illness in tropical areas (Levett, 
2001, Cruz et al., 2009, McBride et al., 2005). However, infection can lead to severe 
secondary sequelae including renal failure, jaundice, meningitis and severe pulmonary 
haemorrhagic syndrome (SPHS). A mortality rate of 50% has been reported in complicated 
cases (Bharti et al., 2003, McBride et al., 2005).  
Leptospirosis is thought to be widespread in tropical areas where people and animals live in 
close contact, and warm and humid conditions favour environmental survival of the pathogen 
(Hartskeerl et al., 2011, Adler and de la Pena Moctezuma, 2010). In other tropical and sub-
tropical regions such as South-East Asia and South America, leptospirosis is recognised as an 
important cause of renal failure and febrile disease (Cruz et al., 2009, McBride et al., 2005, 
Crump et al., 2013, Acestor et al., 2012). However, despite its global importance, substantial 
gaps persist in our understanding of the burden and epidemiology of leptospirosis in Africa. 
Reports and a recent review from the WHO Leptospirosis Epidemiology Reference Group 
(LERG) indicate that leptospirosis incidence may be high in Africa, but also highlight the lack 
of available data (World Health Organization, 2011, Abela-Ridder et al., 2010, Costa et al., 
2015a). Seroprevalence studies demonstrate that Leptospira exposure is widespread in people 
and animals in Africa (de Vries et al., 2014, Benkirane et al., 2014). Yet, little is known about 
the distribution or prevalence of human disease or the epidemiology of infection in different 
animal hosts in Africa.  
 
2.1.1 Aims and objectives 
This chapter describes a systematic literature review performed to tackle gaps in our 
understanding and awareness of the epidemiology of acute human leptospirosis and animal 
Leptospira infection in Africa. The objectives for this study component were:  
Objective 1: Summarise current knowledge of the geographic distribution, prevalence and 
incidence of acute human leptospirosis in Africa;  
Objective 2: Summarise the geographic distribution, host range and prevalence of Leptospira 
infection in animal hosts in Africa; 
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Objective 3: Describe the species and serogroups of infecting Leptospira serovars involved in 
acute human leptospirosis and animal infection in Africa. 
A version of the work presented in this chapter has been previously published and is freely 
available at http://dx.doi.org/10.1371/journal.pntd.0003899 (Allan et al., 2015a) 
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2.2 Systematic review methodology 
2.2.1 Search strategy  
This systematic review following the Preferred Reporting Items for Systematic Reviews and 
Meta-analyses (PRISMA) guidelines (Moher et al., 2009). References for this review were 
identified through searches of eight international and regional databases. Database searches 
were performed in PubMed, Web of Science, Biosis, CABI abstracts, Zoological Record, 
Africa-Wide NiPAD, and Africa Index Medicus for resources published between 1
st
 January 
1930 – 31st May 2013, and Embase (Ovid) for resourced published between 1947 -2013. An 
additional search was performed on 24
th
 November 2014 to identify additional articles 
published in print or online between 1
st
 June 2013 and 31
st
 October 2014. Search terms for 
each database were developed with guidance from two library scientists (Megan Von Isenberg 
and Alastair Allan) (Table ‎2.1). Additional articles for inclusion were identified by 
bibliography hand searches of relevant articles (Hopewell et al., 2007). Results were exported 
into Microsoft Excel (Microsoft Corporation, Redmond, WA, USA). The number of unique 
references from each database was determined after removing duplicates. 
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Table  2.1: Full search terms used for each study databases  
Database  Publication Date 
Limits 
Search Strategies 






(Leptospirosis OR Leptospira) 
- Africa-Wide:NiPAD 





(SU (leptospirosis OR leptospira ) OR 
TX ( leptospirosis OR leptospira) AND 
(AB Africa* OR GE Africa OR SU 
Africa OR TI Africa* OR KW Africa) 
- BIOSIS Previews;  
- CABI Abstracts;  
- Web of Science Core 
Collection; 
- Zoological Record 
January 1930-
October 2014 
Search 1: Topic=(leptospirosis) OR 
Topic=(leptospira) OR 
title=(leptospirosis) OR 
title=(leptospira); Search 2: 
topic=(Africa*) OR title=(Africa*); 
Search 3: Combine Search 1 AND 
Search 2 
- Embase (Ovid; 
including Embase 
Classic and Embase) 
January 1947-
October 2014 
(leptospirosis [sh] OR leptospira [sh] 
OR leptospirosis [tw] OR leptospira 
[tw]) AND (africa*[sh] OR africa*[tw]) 
- Pubmed January 1930-
October 2014 
(leptospirosis[mesh] OR 
leptospirosis[Text Word] OR 
leptospira[Text Word] OR 
leptospira[mesh) AND (africa[mesh] 
OR africa*[Text Word]) 
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2.2.2 Study selection and criteria for exclusion by abstract review 
Abstracts and titles of references identified by database search were compiled in EndNote 
(Thomson Reuters, Philadelphia, PA, USA). Each reference was independently reviewed by 
two researchers (KA and Holly Biggs (HMB)) to determine whether each article met pre-
determined abstract inclusion and exclusion criteria. A third researcher (Jo Halliday (JEBH) 
served as a tiebreaker for any discordant decisions. References were included if they presented 
data on human or animal Leptospira spp. infection from any country within the United 
Nations (UN) definition of Africa (United Nations Statistics Division, 2012). We excluded any 
abstract that did not include original human or animal leptospirosis research data, including 
reviews, textbooks, letters to the editor, policy papers, and lay press and media stories. 
Additionally, we excluded any abstract in which did not investigate for the presence of 
naturally occurring cases of leptospirosis in human or animal populations including studies 
which described in vitro or in vivo experiments, laboratory methods descriptions or abstracts 
that described only environmental data. We excluded reports of returned travellers because of 
potential uncertainty around the specific location where infection was acquired. A full list of 
abstract exclusion criteria with coding hierarchy is given in Table ‎2.2.  
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Table  2.2: Title and abstract review exclusion criteria.  
Numbers and letters refer to hierarchy used to determine the decision for exclusion  
Category Exclusion criteria 
1. Article Type a. Review or summary article without original data 
b. Editorial, letter to the editor opinion, commentary or policy 
article without original data 
c. Textbook or handbook rather than publication of new data 
d. Lay media publications or broadcasts 
e. Abstracts with corresponding full manuscripts with the same data 
2. Language Exclude if title/abstract are NOT: ENGLISH, FRENCH, 




Exclude countries not included in the UN macro-geographical 
definition of Africa  
4. Topic focus a. Wrong agent 
b. Experimental data (in vitro or in vivo cellular, molecular, 
biochemical or other studies that do not include naturally 
occurring cases of leptospirosis in humans or animals) 
c. Laboratory methods descriptions 
d. Leptospirosis included in the diagnostic evaluation or as a 
differential diagnosis, but diagnosis of leptospirosis infection or 
exposure was not reached 
e. Social science or environmental or climate modeling data only  
f. Case reports of returned travelers  
 
 
2.2.3 Study selection and criteria for inclusion by full text review 
Articles eligible for inclusion after abstract review, as well as references for which no abstract 
was available, were retrieved in full text form. Non-English language articles identified for 
full text review (n=97) included 83 French, seven German and four Italian language articles 
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translated with the assistance of native language speakers (Ferdinand von Göetzen and Erika 
Abbondati). In addition, two Afrikaans (n=2) articles and one Dutch article were also 
identified and were translated using online translation software (Google Translate, Mountain 
View, California, USA) with support from a Dutch language speaker (Julie Woodfield). 
Case definitions for human acute leptospirosis and carrier animal status were pre-defined 
based on WHO and international reference laboratory guidelines (Table ‎2.3)(World Health 
Organization, 2011, World Organisation for Animal Health (OIE), 2014). Serological 
diagnostics were not included in the case definition for carrier animals because of incapacity 
to differentiate between prior exposure and current infection. Articles describing studies that 
used laboratory animal inoculations as a diagnostic test for leptospirosis were not considered 
eligible for inclusion in the review due to concerns over diagnostic sensitivity and the potential 
for false positive results in contaminated laboratory animal colonies (Faine, 1994).  
Full text articles were reviewed by two investigators (KA, HMB) and excluded if they failed 
to meet case definitions or if insufficient information was provided in the study methodology 
to determine whether the case definitions were met. Articles were also excluded if they were 
found to meet any of the abstract exclusion criteria during full-text review.  
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Table  2.3: Case definitions for acute human leptospirosis and animal 
Leptospira infection 
Human acute leptospirosis definition – confirmed cases 
Compatible acute illness, plus ≥1 of the following: 
≥ 4 fold rise in Microscopic Agglutination Test (MAT) titre between acute and 
convalescent serum 
Culture* and isolation of pathogenic Leptospira spp. from blood, urine, CSF or 
tissues 
Pathogenic Leptospira spp. DNA detected by Polymerase Chain Reaction (PCR) from 
blood/blood derivatives, urine, cerebrospinal fluid, or tissues 
Detection of Leptospira spp. in tissue by immunohistochemical techniques 
Human acute leptospirosis definition – probable cases 
Compatible acute illness, plus ≥1 of the following:  
MAT titre ≥1:400 in single or paired serum samples 
Presence of IgM antibodies by enzyme-linked immunosorbent assay (ELISA) or 
dipstick 
Presence of IgM or a fourfold increase in IFA antibody titre in acute and convalescent 
serum samples 
Animal Leptospira infection definition - confirmed 
Clinical signs present or absent, plus ≥ 1 of the following: 
Culture* and isolation of pathogenic Leptospira spp. from a normally sterile site 
Pathogenic Leptospira spp. DNA detected by PCR or real-time PCR (qPCR) from a 
normally sterile site 
Typing of previously isolated serovar 
Detection of Leptospira spp. in clinical specimens by immunohistochemistry  
* Culture in any of the following media: Ellinghausen-McCullough-Johnson-Harris (+/- 
5‘Fluorouracil), Fletcher, Korthoff, Stuart, Vervoot or Noguchi culture media. 
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2.2.4 Data extraction and synthesis 
Two reviewers (KA, HMB) independently extracted pre-determined qualitative and 
quantitative data from each article eligible for inclusion. Extracted data included: 
geographical location (country, locality); study year and duration; study setting (e.g. 
hospital, community, abattoir) and type (e.g. cohort study, surveillance study, case report); 
study inclusion criteria and diagnostic methodology; sample size and species tested; 
number of positive cases and prevalence estimate; incidence (human population-based 
studies only); and results of serological and genetic typing on infecting Leptospira spp. 
Data on infection prevalence and incidence were compiled for studies that used 
comparable inclusion criteria and diagnostic methodologies, Prevalence and incidence 
ranges were summarised by study type (human studies), location or host species (animal 
studies) if three or more references reporting comparable data were identified. Data on 
serological and genetic typing of Leptospira isolates or Leptospira DNA detected in 
human and animal infections were compiled and summarised by country and species. 
Additional serogroup and species data of reported serovars was obtained from the 
Leptospirosis Library, maintained by the Leptospirosis Reference Centre, Royal Tropical 
Institute (KIT), Netherlands (Royal Tropical Institute (KIT), 2014).  
 
2.2.5 Critical assessment of methodological quality and bias 
The risk of bias in included studies such as selection or reporting bias was assessed 
following an adaptation of the Cochrane guidelines for systematic reviews of medical 
interventions (Higgins and Green, 2008). Methodological quality and detection bias was 
assessed by comparison to pre-determined case definition criteria to control for 
heterogeneity in study design and diagnostic methodology (Table ‎2.3). Other types of bias 
including selection bias based on study type and design, and attrition bias were also 
evaluated for individual studies. Studies classified as high-risk for bias were not included 
in quantitative analysis of leptospirosis prevalence and incidence. In studies with 
incomplete reporting of case definitions and diagnostic criteria, data was only included 
where a valid assessment of methodological quality could be performed. For references 
where only a subset of reported positives met our study criteria, prevalence was re-
calculated after data adjustment.  
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2.3 Results 
Systematic database searches yielded 681 unique articles from a total of 1201 references. 
After abstract and full text review, 95 references were considered eligible for inclusion. 
Hand searches identified two additional articles that met inclusion criteria but were not 
identified in the original database searches. Reasons for full-text exclusion are detailed in 
Figure ‎2.1. In total, 97 articles describing acute human leptospirosis or animal Leptospira 
infection in 26 (44.8%) of 58 African countries were included in analysis (Figure ‎2.2). 
Major potential sources of bias identified in eligible studies were selection bias, attrition 
bias in studies that relied on paired serology (MAT) for confirmatory diagnosis, and 
reporting bias through incomplete reporting of diagnostic methodology and results.  
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Figure  2.1: Flow chart showing the selection of eligible articles for study 
inclusion following criteria defined in Table  2.2 and Table  2.3, based on 
PRISMA guidelines (Moher et al., 2009) 
 
 




Figure  2.2: Geographic distribution of eligible reports (number per country) 
of human leptospirosis and animal Leptospira infection in Africa 
 
2.3.1 Acute human leptospirosis studies  
Full citations and study details for eligible articles (excluding case reports) reporting 
human leptospirosis in Africa can be found in Appendix 1, where they are also cited in 
full.  
Acute human leptospirosis was reported in 46 articles from 18 African countries 
(Figure ‎2.2) (Appendix 1). Most articles came from South Africa (n = 6), Egypt (n = 5) and 
Kenya (n = 5). Leptospirosis cases were reported in 21 articles describing hospital or 
health centre-based cohort studies. Five articles reported cases detected by passive 
population-based surveillance, and two articles described an active case-finding approach 
used in the event of a febrile disease outbreak. Non-specific febrile illness was the most 
frequently described inclusion criterion for cohort or surveillance studies. However, in 
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Zimbabwe (8) 
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illness data 
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Northern Africa  
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Egypt (10) 
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Tunisia (4) 
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Ghana (4) 












Animal carrier data only 
Cameroon (1) 
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three hospital-based cohort studies, jaundice was the primary inclusion criterion. In one 
study conducted in the Democratic Republic of the Congo (DRC), leptospirosis testing was 
performed on a cohort of patients with haemoglobinuria.  
 
2.3.2 Diagnostic methodologies for human studies  
The Microscopic agglutination test (MAT) was the primary method of case diagnosis in 
the majority of human studies (89.1%; n = 46) (Appendix 1). IgM enzyme linked 
immunosorbent assay (ELISA) was used in a total of nine studies, most commonly as part 
of a multi-faceted diagnostic approach. Leptospira culture from blood in combination with 
serological diagnostics was used to diagnose infection in fifteen (32.6%) studies. Nine 
(19.5%) studies also used PCR detection as well as culture and serology in a three-tonged 
approach. Gene targets for diagnostic PCR assays included: lbf1(Bourhy et al., 2010, 
Bourhy et al., 2012), lipL32, 16S (rrs) and ligA.  
 
2.3.3 Human leptospirosis prevalence  
Reported leptospirosis prevalence was highly variable and differed with study design and 
inclusion criteria. In 11 hospital-based prospective cohort studies that recruited patients 
with non-specific febrile illness and used MAT with or without adjunct diagnostics tests to 
diagnose cases, prevalence ranged from 2.3% to 19.8%. The number of patient tested in 
these studies ranged from 39 to 2441 patients (median = 166) (Biggs et al., 2011, Collares-
Pereira et al., 1997, de Geus et al., 1969, de Geus et al., 1977b, de Geus et al., 1977a, 
Forrester et al., 1969, Hogerzeil et al., 1986, Ismail et al., 2006, Murray et al., 2011, Parker 
et al., 2006, Tagoe et al., 2010). A hospital-based prospective cohort study of febrile 
patients (n = 2523) that diagnosed leptospirosis by direct pathogen detection only (PCR 
and culture) reported 13.7% prevalence in Mayotte (Bourhy et al., 2010). Where jaundice 
was the main study enrolment criterion (three studies), prevalence of acute leptospirosis 
ranged from 2.0% to 16.1% (n = 99 – 392 patients) (Kinebuchi and Afoakwa, 1973, 
Hogerzeil et al., 1986, Ismail et al., 2006). Acute leptospirosis was also reported in eight 
(9.8%) of 82 patients affected by an outbreak of acute pneumonia in a mining camp in 
DRC (Bertherat et al., 2014) and three (25.0%) of 12 patients from an outbreak of acute 
febrile disease in a pastoralist community in northern Kenya (Ari et al., 2011). In the 
cohort of patients with haemoglobinuria, only one patient (2.3%; n = 38) met leptospirosis 
case definitions (Delacollette et al., 1995). 
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2.3.4 Human leptospirosis incidence 
Incidence estimates were calculated from five population-based surveillance studies 
(Bourhy et al., 2012, Desvars et al., 2011, Pages et al., 2014, Renault et al., 2011, Yersin et 
al., 1998) and two hospital-based prospective cohort studies (Biggs et al., 2013b, Pinn, 
1992). A regional incidence of 75 to 102 cases per 100,000 people per year was reported 
for northern Tanzania (Biggs et al., 2013b). This was the only estimate of leptospirosis 
incidence from mainland Africa identified by systematic review. Incidence was calculated 
using multipliers derived from a population-based health-care utilisation survey to generate 
population level estimates from hospital prevalence data. More estimates were available 
for island countries included in the macro-geographical definition of Africa. In the 
Seychelles, average annual incidence was estimated as 60 to101 cases per 100,000 (Pinn, 
1992, Yersin et al., 1998). In Réunion, the reported average annual incidence ranged from 
3.1 to 12.0 cases per 100,000 based on a variety of different data sources (Renault et al., 
2011, Desvars et al., 2011, Pages et al., 2014). In Mayotte, the reported average annual 
incidence was 25 cases per 100,000, calculated from data generated by four years of active 
hospital-based surveillance (Bourhy et al., 2012).  
 
2.3.5 Human case reports 
Sixteen case reports describing leptospirosis in 34 patients were eligible for study 
inclusion. Reported clinical manifestations included febrile illness, jaundice, meningitis, 
and acute respiratory distress. Case reports describe leptospirosis in patients from South 
Africa (n=6) (Gear et al., 1958, Klopper, 1969, Maze and Kirsch, 1981, Newman and 
Cohen, 1962, Samson and Pillay, 1966, Zaltzman et al., 1981), Gabon (n=3) (Koko et al., 
2001, Perret et al., 1994, Magne et al., 2013), Morocco (n=3) (Lahsen et al., 2010, 
Mailloux, 1967, Mailloux, 1971), Algeria (n=1) (Aubry et al., 1975), Mali (n=1) (Mailloux 
et al., 1974), Réunion (n=1) (Legris et al., 2014), and Senegal (n=1) (Payet et al., 1965). 
With the exception of Réunion and Senegal, case reports were the only eligible articles on 
acute human leptospirosis in these countries.  
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2.3.6 Animal Leptospira infection studies:  
Full citations and study details for eligible articles reporting animal Leptospira infection in 
Africa can be found in Appendix 2, where they are also cited in full. 
Leptospira spp. infection in animals was reported by 51 eligible references describing 
studies performed in 17 African countries (Figure ‎2.2). Wild animal surveys were the most 
common study types (41.2%; n = 51) followed by serovar typing of Leptospira spp. 
previously isolated from naturally infected animal hosts (25.5%), livestock disease 
outbreaks (13.7%) and abattoir surveys (13.7%). Four references stated that human 
leptospirosis outbreaks were the inciting cause for animal investigations.  
 
2.3.7 Carrier animal species:  
Leptospira spp. infection was demonstrated in a large number of different animal hosts 
(Appendix 2) including cattle (Bos spp.); pigs (Sus scrofa domestica); goats (Capra 
aegagrus hircus); Rusa deer (Rusa timorensis); dogs (Canis lupis familiaris); cats (Felis 
catus); rodents including the African grass rat (Arvicanthus niloticus), African giant 
pouched rat (Cricetomys gambianus), lesser tufted-tailed rat (Eliurus minor), fringe-tailed 
Gerbil (Gerbilliscus robustus), rusty-bellied brush-furred rat (Lophuromus sikapusi), 
multimammate mouse (Mastomys sp.), house mouse (Mus musculus), Norway rat (Rattus 
norvegicus), black rat (Rattus rattus), South African pouched mouse (Saccostomys 
campestris); and a variety of other free-living mammal species including shrews 
(Crocidura spp. and Suncus murinus); mongoose (Herpestes ichneumon, Mungo mungo 
and Paracynictis selousi); tenrecs (see Appendix 2 for species details);  and numerous bat 
species (see Appendix 2 for species details). Studies demonstrating infection in cattle were 
most common (n=20 of 51) followed by pigs (n = 8), black rats (n = 8), Norway rats (n = 
7) and house mice (n = 7).  
 
2.3.8 Diagnostic methodologies for animal studies 
Culture was the most common method of diagnosis for Leptospira infection in animal 
studies (43 (84.3%) of 51 studies). PCR assays were used to demonstrate Leptospira spp. 
infection in 13 (25.5%) studies, mainly of rodents and other small mammals. Culture and 
PCR were used in combination to determine infection status in three studies. As with 
human studies, a variety of genetic targets were used to detect Leptospira DNA by PCR, 
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including lipL32/hap1, secY, rrl, and rrs. Only one study used PCR assays to demonstrate 
infection in domestic animals (Desvars et al., 2013c). 
 
2.3.9 Prevalence in animal populations  
Leptospira infection prevalence varied widely between studies. Studies that used PCR 
diagnosis reported higher infection prevalence than studies that relied on Leptospira 
culture and isolation. For example, Leptospira infection prevalence reported in black rats 
ranged from 11.0% to 65.8% in six studies that used PCR to detect infection (n = 33-141; 
median = 79) (Desvars et al., 2013c, Desvars et al., 2012, Felt et al., 2011, Houemenou et 
al., 2013, Rahelinirina et al., 2010, Halliday et al., 2013). Culture was also used in two of 
these studies (Felt et al., 2011, Rahelinirina et al., 2010). Where results could be directly 
compared, prevalence estimates were substantially higher by PCR (11.0%, n=100; and 
28.7%, n=94) than by culture (4.0% and 3.2%). Across six unique studies of Norway rats, 
higher prevalence was also detected by PCR than by culture (culture: 2.7% - 8.5% (n = 
130-919, median = 256) (Chadli and Bakoss, 1965, Lazuga and Bonnefous, 1962, 
Rademan et al., 1964)) versus PCR: 10.0% - 41.7% (n = 10-96, median = 11) (Rahelinirina 
et al., 2010, Houemenou et al., 2013, Halliday et al., 2013)), although the sample size was 
relatively smaller in studies using a PCR-based approach.  In cattle however, the majority 
of reports used culture alone to diagnose infection. Four abattoir-based surveillance studies 
of cattle from Egypt, Nigeria and Zimbabwe (Feresu, 1992, Ezeh et al., 1989a, Diallo and 
Dennis, 1982, Hatem et al., 2014) detected renal Leptospira infection by culture in 1.1% to 
10.4% of sampled animals (n = 74 – 625: median = 480). In a single PCR-based study, 
prevalence was estimated as 18.2% (n = 77) in Mayotte (Desvars et al., 2013c).  
 
2.3.10 Animal disease  
Although the study was not designed to evaluate clinical disease in animals, several studies 
reported overt clinical illness associated with Leptospira infection in animals. Clinical 
leptospirosis was reported in cattle and pigs in South Africa, Botswana and Kenya (de 
Lange et al., 1987, Gummow et al., 1999, Herr et al., 1982, Herr and Winnen, 1983, Tabel 
and Losos, 1979, Te Brugge and Dreyer, 1985, Van Rensburg, 1973). Abortions and poor 
reproductive success were the most common reported clinical signs (de Lange et al., 1987, 
Gummow et al., 1999, Herr et al., 1982, Herr and Winnen, 1983, Te Brugge and Dreyer, 
1985, Van Rensburg, 1973).  Acute non-reproductive disease of cattle (anaemia, icterus, 
haemoglobinuria, death) was also reported in two articles (Gummow et al., 1999, Tabel 
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and Losos, 1979). In three reports, chronic interstitial nephritis was reported in kidney 
samples collected from abattoirs (de Lange et al., 1987, Gummow et al., 1999, Hunter et 
al., 1987). Similar histological lesions were observed in the kidneys of two culture-positive 
dogs that sampled as part of a surveillance study in Egypt (Maronpot et al., 1971). 
 
2.3.11 Serological typing of Leptospira from human and animal infections  
Isolates belonging to 15 serogroups were reported in cohort studies conducted in the DRC 
(Van Riel et al., 1956), Egypt (Murray et al., 2008, Murray et al., 2011), Ghana (Hogerzeil 
et al., 1986), Kenya (de Geus et al., 1969, de Geus et al., 1977b, de Geus et al., 1977a) and 
Mayotte (Bourhy et al., 2010, Bourhy et al., 2012), and in a case report from South Africa 
(Maze and Kirsch, 1981) (Table ‎2.4). Mini and Icterohaemorrhagiae were the most 
commonly reported serogroups in human infections. In animal studies, isolates belonging 
to 12 serogroups were reported and at least one animal host was identified within Africa 
for 11 (73.3%) of the 15 reported human-infecting serogroups (Table ‎2.4). However, only 
six serogroups were detected in human and animal populations from the same country. 
These were: serogroups Canicola, Grippotyphosa, Icterohaemorrhagiae, Pomona and 
Pyrogenes in Egypt and serogroup Autumnalis in Kenya. Cattle were identified as carrier 
hosts for the largest number of Leptospira serogroups (n=9) but several other animal 
species, such as African grass rats and black rats were also identified as carrier hosts for 
multiple serogroups. Frequently, serogroups associated with human febrile illness were 
reported in several animal species. For example: serogroup Icterohaemorrhagiae, one of 
the most commonly reported serogroups in leptospirosis cases in Africa, was isolated from 
cattle, Norway rats, Egyptian mongoose and an Egyptian fox.  
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Table  2.4: Serogroups of Leptospira isolated from human and animal 
infections by country 
 Human Studies                     Animal Studies 
Serogroup Country Host species Country 
Australis Kenya 
(de Geus et al., 
1977a) 
African grass rat 
(Arvicanthus 
niloticus) 
Nigeria (Diallo and Dennis, 1982) 
 Cattle  
(Bos spp.) 
Zimbabwe (Feresu, 1992) 
Autumnalis Kenya 
(de Geus et al., 
1977a) 
African grass rat 
(Arvicanthus 
niloticus)  
Kenya (Dikken et al., 1981)  




Tanzania (Machang'u et al., 2002, 
Machang'u et al., 2004)  
 African grass rat 
(Arvicanthus 
niloticus)  
Nigeria (Diallo and Dennis, 1982)  




Kenya (Dikken et al., 1981)  
Bataviae Egypt 
(Murray et al., 




Zimbabwe (Feresu, 1992, Feresu 





Cameroon (Le Bras et al., 1977) 
Canicola Egypt 
(Murray et al., 
2008) 
Black rat  
(Rattus rattus) 
Egypt (Felt et al., 2011), 
Madagascar (Rahelinirina et al., 
2010)  
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Kenya 
(de Geus et al., 
1977a) 
Brown rat  
(Rattus 
norvegicus) 
Madagascar (Rahelinirina et al., 
2010) 










South Africa (Van Rensburg, 
1973)  
Djasiman Ghana 
(Hogerzeil et al., 
1986) 




(Van Riel et al., 
1956) 
Black rat  
(Rattus rattus) 
Egypt (Felt et al., 2011) 
Egypt 




Kenya (Tabel and Losos, 1979), 
Zimbabwe (Feresu, 1992, Feresu 
et al., 1995) 
Mayotte  
(Bourhy et al., 
2010, Bourhy et 
al., 2012) 
House mouse  
(Mus musculus) 
Egypt (Barsoum et al., 1973, 
Brownlow and Dedeaux, 1964) 
Hebdomadis DRC 




Zimbabwe (Feresu, 1992, Feresu 
et al., 1996) 
Kenya 
(de Geus et al., 
1969, de Geus et 
al., 1977b, de 









(Murray et al., 





South Africa (Rademan et al., 
1964) 
Tunisia (Lazuga and Bonnefous, 
1962) 
 Ghana 




Egypt (Hatem et al., 2014), 
Tanzania (Mgode et al., 2006), 
Zimbabwe (Feresu, 1992, Feresu 
et al., 1993) 
Kenya 
(de Geus et al., 










Egypt (Barsoum et al., 1973) 
Mini Mayotte 
(Bourhy et al., 
2010, Bourhy et 
al., 2012) 
Not reported  
Pomona Egypt 
(Murray et al., 




Botswana (Herr and Winnen, 
1983), Egypt (Hatem et al., 2014), 
South Africa (Gummow et al., 
1999, Herr et al., 1982), 
Zimbabwe (Feresu, 1992, Feresu 
et al., 1995) 
Mayotte 





South Africa (de Lange et al., 
1987, Gummow et al., 1999, 
Hunter et al., 1987)  
Pyrogenes Egypt 
(Murray et al., 
2008) 
Black rat  
(Rattus rattus) 
Egypt (Felt et al., 2011) 
Kenya 




Nigeria (Diallo and Dennis, 1982, 
Ezeh et al., 1989a, Ezeh et al., 
1989b, Ezeh et al., 1990), 
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Mayotte 
(Bourhy et al., 
2010, Bourhy et 
al., 2012) 
Zimbabwe (Feresu, 1992, Feresu 
et al., 1994) 
Sejroe Not reported Black rat  
(Rattus rattus) 
Egypt (Felt et al., 2011) 
Cattle  
(Bos spp.) 
Nigeria (Ezeh et al., 1989a, Ezeh 
et al., 1989b) 
South Africa (Te Brugge and 
Dreyer, 1985) 
Zimbabwe (Feresu, 1992) 
Tarassovi DRC 




Zimbabwe (Feresu, 1992, Feresu 









Tunisia (Bakoss, 1969, Bakoss 
and Chadli, 1965) 
Wolfii Egypt 
(Murray et al., 
2008) 




(Bourhy et al., 
2010, Bourhy et 
al., 2012) 




(Bourhy et al., 
2012) 
Not reported  
Footnotes:  
* Cross-reactive isolates 
 2.3.12 Genetic typing of Leptospira from human and animal infections:  
Five pathogenic Leptospira species were isolated from human patients with acute disease 
(Table ‎2.5). L. interrogans was the most commonly reported species in both human and 
animal studies, followed by L. borgpetersenii and L. kirschneri. Multiple animal hosts 
were identified for these Leptospira species from a variety of countries.  
By country, the largest number of different Leptospira species was reported in Kenya, 
where two studies isolated leptospires belonging to five species – L. borgpetersenii, L. 
interrogans, L. kirschneri, L. noguchii and L. santarosai (de Geus et al., 1977b, de Geus et 
al., 1977a). However two of these, L. noguchii and L. santarosai, were not detected in any 
other study in Africa. In Mayotte, four Leptospira species –L. borgpetersenii, L. 
borgpetersenii-like, L. interrogans and L. kirschneri – were identified in people, as well as 
in concurrent study of black rats performed during the same period (Bourhy et al., 2010, 
Bourhy et al., 2012, Desvars et al., 2012). Sequencing and alignment of Leptospira isolates 
from rat kidneys (Desvars et al., 2012) showed perfect identity with isolates derived from 
people (Bourhy et al., 2012). Divergent Leptospira spp. (described as L. borgpetersenii-
like or L. borgpetersenii Group B) detected in human cases and small mammals in Mayotte 
and Madagascar (Bourhy et al., 2012, Dietrich et al., 2014, Bourhy et al., 2010, Desvars et 
al., 2012) have subsequently been reclassified as a new species L. mayottensis (Bourhy et 
al., 2014). 
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Table  2.5: Leptospira speciesa reported in human and animal infections by 
country  
 Human Studies Animal Studies 




(de Geus et al., 
1977b, de Geus 
et al., 1977a)  
African grass rat 
(Arvicanthus niloticus) 
Nigeria (Diallo and 
Dennis, 1982)  
Mayotte 
(Bourhy et al., 
2010, Bourhy et 
al., 2012) 
Black rat  
(Rattus rattus) 
Benin (Houemenou et 
al., 2013) 
Egypt (Felt et al., 
2011)  




Nigeria (Diallo and 
Dennis, 1982, Ezeh et 
al., 1989a, Ezeh et al., 
1989b, Ezeh et al., 
1990) 
South Africa (Te 
Brugge and Dreyer, 
1985) 
Zimbabwe (Feresu et 
al., 1994) 
  Comoro rousette  
(Rousettus oblivious)  
Comoros (Lagadec et 
al., 2012) 
  Fringe-tailed gerbil 
(Gerbilliscus robusta) 
Kenya (Dikken et al., 
1981) 
  Giant African pouched rat 
(Cricetomys gambianus) 
Tanzania (Machang'u 
et al., 2004) 
  Lesser tufted-tailed rat 
(Eliurus minor) 
Madagascar (Dietrich 
et al., 2014) 





et al., 2014) 
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et al., 2012) 
  Multimammate mouse 
(Mastomys sp.) 
Benin (Houemenou et 
al., 2013) 
  Pigs  
(Sus scrofa domesticus) 
Tunisia (Bakoss, 1969) 





et al., 2014) 
  South African pouched 
mouse (Saccostomys 
campestris) 







(Bourhy et al., 
2012) 
Black rat (Rattus rattus)  Mayotte (Desvars et 
al., 2012)  
Shrew tenrec (Microgale 
cowani, Microgale dobsoni) 
Madagascar (Dietrich 
et al., 2014) 
L. interrogans Egypt  
(Murray et al., 
2008)  
African giant shrew 
(Crocidura oliveri) 
Benin (Houemenou et 
al., 2013) 
Ghana 
(Hogerzeil et al., 
1986) 
African grass rat 
(Arvicanthus niloticus) 
Nigeria (Diallo and 
Dennis, 1982) 
Kenya 
(de Geus et al., 
1977b, de Geus 
et al., 1977a) 
Asian house shrew  
(Suncus murinus) 
Madagascar 
(Rahelinirina et al., 
2010)  
Mayotte 
(Bourhy et al., 
2010, Bourhy et 
al., 2012) 
Banded mongoose  
(Mungo mungo) 
Botswana (Jobbins et 
al., 2013) 
Black rat  
(Rattus rattus) 
Egypt (Felt et al., 
2011), Mayotte 
(Desvars et al., 2012), 
Madagascar 
(Rahelinirina et al., 
2010) 
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  Brown rat  
(Rattus norvegicus) 
Benin (Houemenou et 
al., 2013) 
Madagascar 
(Rahelinirina et al., 
2010)  
  Cattle  
(Bos spp.) 
Botswana (Herr and 
Winnen, 1983) 
 Nigeria (Diallo and 
Dennis, 1982) 
South Africa (Herr et 
al., 1982), Zimbabwe 
(Feresu et al., 1999a) 
  Comoro rousette bat 
(Rousettus oblivious)  
Comoros (Lagadec et 
al., 2012) 
  House mouse (Mus 
musculus) 
Kenya (Halliday et al., 
2013) 
Madagascar 
(Rahelinirina et al., 
2010)  
  Pigs (Sus scrofa domesticus) South Africa (Hunter et 
al., 1987, Van 
Rensburg, 1973)  
  Rusty-bellied brush-furred 
rat (Lophuromys sikapusi) 
Cameroon (Le Bras et 
al., 1977) 
L. kirschneri Egypt 
(Murray et al., 
2008)  
African grass rat 
(Arvicanthus niloticus) 
Kenya (Dikken et al., 
1981) 
 Kenya 
(de Geus et al., 
1977a) 
Black rat (Rattus rattus) Mayotte (Desvars et 
al., 2012) 
 Mayotte 
(Bourhy et al., 
2010, Bourhy et 
al., 2012) 
Cattle (Bos spp.) Kenya (Tabel and 
Losos, 1979), Tanzania 
(Mgode et al., 2006) 
Zimbabwe (Feresu et 
al., 1995) 
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  House mouse  
(Mus musculus) 
Kenya (Halliday et al., 
2013) 
Shrew (Crocidura spp.) Benin (Houemenou et 
al., 2013) 
Streaked tenrec 
(Hemicentetes nigriceps, H. 
semispinosus) 
Madagascar (Dietrich 
et al., 2014)  
Footnotes:  
a
Methodology includes genetic typing of isolates, DNA sequencing following PCR 
detection, extrapolation of serovar data with species determined by reference to KIT 
Leptospira library.  
b 
Miniopterus spp. include Miniopterus gleni, Miniopterus goudoti, Miniopterus griffithsi, 
Miniopterus mahafaliensis, Miniopterus majori, Miniopterus soroculus 
c
 Microgale spp. include Microgale longicaudata, Microgale majori, Microgale principula 
d
Described as L. borgpetersenii-like,(Bourhy et al., 2012) L. borgpetersenii Group B 
(Desvars et al., 2012) and recently re-classified as L. mayottensis(Bourhy et al., 2014) 
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2.4 Discussion 
This systematic review synthesizes and compiles an abundance of data on the 
epidemiology of human leptospirosis and Leptospira infection in animals, despite the fact 
that the disease is often overlooked in public health priorities in Africa. There is substantial 
evidence that acute leptospirosis is an important cause of febrile illness in people in Africa. 
As yet, few studies evaluate the population-level incidence of disease but where available, 
estimates indicate that incidence is high in both island and mainland populations. Three 
Leptospira species - Leptospira borgpetersenii, L. interrogans and L. kirschneri - 
predominate reports and a wide variety of Leptospira serogroups have been recognised in 
human and animal infections. Infection has been recognised in a wide range of domestic 
and wild animal species from across Africa but studies linking animal infections with acute 
human disease are rare.  
Acute leptospirosis was diagnosed in up to 19.8% of hospital inpatients with non-specific 
febrile illness in studies identified by this review.  In sub-Saharan Africa, recent reports 
have highlighted that clinical over-diagnosis of malaria may obscure other causes of febrile 
illness (Crump et al., 2013, Reyburn et al., 2004). The evidence synthesised here 
demonstrates that acute leptospirosis infection is geographically widespread across the 
continent. Consistent with recommendations in other tropical settings such as South 
America (Manock et al., 2009, Bharti et al., 2003) and South-East Asia (Suttinont et al., 
2006, Gasem et al., 2009, Kendall et al., 2010), leptospirosis should be considered as an 
important differential diagnosis for non-specific febrile illness in Africa.  
Few estimates of leptospirosis incidence in Africa could be identified by our review, 
revealing a major gap in research and surveillance outputs to date. The majority of 
incidence estimates identified came from the western Indian Ocean islands where annual 
incidence reports ranged from 3.1 to 101 cases per 100,000 people. In contrast, only one 
report of annual leptospirosis incidence was identified from mainland Africa but this 
estimate from Tanzania (75 to 102 cases per 100,000 people (Biggs et al., 2013b)) is 
consistent with both the Indian Ocean island data and the predicted figure of median 
African incidence (95.5 cases per 100,000) from the WHO leptospirosis burden 
epidemiology reference group (LERG) (World Health Organization, 2011). At present, 
given the lack of population level data for Africa, continental estimates of incidence should 
be interpreted with caution. However, all data that are available thus far indicate that the 
overall leptospirosis burden in Africa is likely to be high relative to other global regions. If 
incidence estimates identified by this review are representative of the true burden of 
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disease, up to 750,000 people in Africa will contract clinical leptospirosis each year, 
representing a substantial burden of febrile disease (Abela-Ridder et al., 2010).  
Literature review has revealed three predominant Leptospira species and a large number of 
pathogenic Leptospira serogroups involved in human and animal infection across the 
continent. Animal hosts including livestock and rodents were reported for the majority of 
human-infecting Leptospira species and serogroups. The findings of this review indicate 
that both livestock and rodents are important in human disease transmission but that the 
major hosts of human-infecting serovars may vary across Africa. However, there was little 
geographical overlap in serogroup reports between human and animal studies. Few articles 
were identified that described Leptospira serovar diversity in human cases and animal 
populations from the same country. Investigations that attempted to link data on acute 
human leptospirosis with evidence of Leptospira infection in local animal populations 
were scarce. Studies on the island of Mayotte were the exception to this. The same genetic 
type of Leptospira (L. borgpetersenii Group B, now classified as L. mayottensis (Bourhy et 
al., 2014)), were detected from both human and black rat infections, implicating the black 
rat as the animal source of these infections (Desvars et al., 2012, Bourhy et al., 2012). This 
result demonstrates the value of integrating human and animal research in a so-called ‗One 
Health approach‘ to identify sources and transmission routes of human leptospirosis. 
Considering the epidemiology of infection in both human and animal populations can 
provide evidence to design targeted, evidence-based intervention strategies.  
A number of limitations and potential sources of bias were identified over the course of 
this literature review. Whilst underreporting is a substantial concern for the continent as a 
whole, some regions e.g. western Indian Ocean islands may be relatively over-represented 
in this review due to reporting or publication bias. Factors such as the level of research 
investment, logistical connections or disease education should be taken into consideration 
when assessing the relative geographic distribution of disease reports. Patient selection bias 
was also observed in some human studies that limited the utility of prevalence data from 
these sources. Methodological inclusion criteria, designed to control for the quality of 
diagnostic data, may have biased the selection of eligible studies towards the later decades 
of our review period, when technologies such as PCR became available.  
Marked heterogeneity in methods and reporting criteria for serological diagnostic data was 
a major limiting factor. Differences in selected MAT panels prevented the meaningful 
synthesis and comparison of serogroup reactivity data between different human studies. 
Incomplete reporting was also a common reason for article exclusion during full-text 
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review and hence valuable disease data may have been missed as a result. Other 
methodological limitations include the use of the broad geographical database search term 
(‗Africa‘) rather than individual country names and the large number of non-English 
language articles that were identified. The inclusion of non-English language articles 
allowed data published in local language journals (e.g. in Afrikaans in South Africa and 
French in western Africa) or during the European colonial era to be evaluated. Wherever 
possible, articles were translated by a study author in close partnership with a proficient 
language speaker. However, it is possible that some eligible studies may have been 
overlooked for inclusion due to translation limitations. Finally, the nature of the systematic 
review methodology means that only the most relevant and rigorous studies were included 
in this review. Additional information on infecting Leptospira serogroups and species may 
also exist in references that were not identified by our database searches or did not meet 
the study case definitions for acute human leptospirosis for example.  
 
Therefore, the data on human leptospirosis included in this review is probably only the tip 
of the proverbial iceberg of the burden of disease in Africa. Generating good quality, 
representative data on the incidence and burden of leptospirosis on the continent will be a 
major challenge for future research. Systematic review studies such as this one can help to 
raise awareness of the human health threat among researchers and policy makers. 
However, surveillance remains limited due to lack of awareness of the disease amongst 
clinicians and poor accessibility to diagnostic tests (Soors et al., 2013, Rutherford et al., 
2010, Petti et al., 2006). For medical clinicians, the non-specific nature of the typical 
symptoms of patients with acute leptospirosis poses a substantial diagnostic challenge in 
developing countries where laboratory capacity rarely exists to diagnose the infection 
(Crump et al., 2013, Cruz et al., 2009, McBride et al., 2005). Hence, increasing clinician 
awareness of the diagnosis and treatment of alternative causes of non-malarial fever should 
be a priority in resource-limited settings (Crump et al., 2011a). Identifying risk factors for 
human disease could also help to identifying patient groups at high risk of Leptospira 
infection, and hence target surveillance and control strategies towards these groups.  
Linkages between Leptospira infections in people and animals are rarely addressed in the 
existing literature in Africa yet human and animal Leptospira infections are inextricably 
linked. Knowledge of animal hosts of human-infecting Leptospira types is critical to 
identify sources of infection and understanding the epidemiology, transmission and control 
of leptospirosis in each setting (Adler and de la Pena Moctezuma, 2010, Levett, 2001). In 
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the future, greater emphasis should be placed on performing multidisciplinary human and 
animal leptospirosis studies where a human disease problem in recognised. Linking 
investigations of animal reservoir populations with confirmed human cases may improve 
our understanding of the role of different animal species in the transmission of pathogenic 
Leptospira serovars in diverse environmental settings (Hartskeerl et al., 2011, Cleaveland 
et al.). Using an integrated ‗One Health‘ may also provide an invaluable opportunity to 
explore the direct and indirect impacts of animal Leptospira infection on human health in 
Africa (Mazet et al., 2009, Zinsstag et al., 2011).  
Finally, this review reveals that livestock are important hosts of Leptospira infection in 
Africa, and may play a more substantial role in human disease transmission than is widely 
recognised. Furthermore, the clinical and sub-clinical productivity impacts of Leptospira 
infection in domestic animal populations in Africa are poorly understood. Clinical disease 
associated with Leptospira infection was identified by this review (Chapter ‎2.3.10). 
Various Leptospira serovars of economic importance are described around the world and 
infection can be associated with production losses in a variety of livestock species 
(O'Doherty et al., 2015, Cortizo et al., 2015, Gummow et al., 1999, Ellis, 1994). More than 
300 million of the world‘s poorest people live in Africa, and at least 60% of this population 
are at least partially dependent on livestock for their livelihood (Grace et al., 2012b). 
Evaluating the impact of Leptospira infection on livestock health and productivity as well 
as human health is therefore an important priority for prospective leptospirosis research in 
Africa. Control of Leptospira infection in livestock species has considerable potential to 
directly and indirectly improve human health and well-being in Africa, through reduced 
zoonotic disease transmission and increased productivity in livestock that subsistence 
farming communities depend upon (Halliday et al., 2015, O'Doherty et al., 2015, Cortizo et 
al., 2015, Hartskeerl et al., 2011).  
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3 Core Methods 
3.1 Research questions, objectives and study components 
The following components of this thesis aim to explore animal sources for human 
Leptospira infection in the Kilimanjaro Region of northern Tanzania. Focusing on two 
groups of animal host known to be important in other settings, the following research 
questions were addressed:  
1) What are the patterns of Leptospira infection in rodents and ruminant livestock (cattle, 
sheep and goats) in this area? 
2) Which Leptospira species and subtypes infect rodents and ruminant livestock in the 
Kilimanjaro Region?  
3) Which Leptospira species and subtypes are responsible for acute leptospirosis in people 
in the Kilimanjaro Region? 
4) Can molecular and serological information about infecting Leptospira types be used to 
infer the source of human infection in this area?  
 
3.2 Study site 
The United Republic of Tanzania, comprising Tanganyika (Tanzania Mainland) and 
Zanzibar has a total population of 44.9 million (Tanzania National Bureau of Statistics, 
2012) and is projected to become the second most populous country in sub-Saharan Africa 
by 2050 based on current growth rates. The country is organised into 30 geographical 
regions, with 25 of these on the Tanzanian mainland. This study was based in the 
Kilimanjaro Region of northern Tanzania (Figure ‎3.1), which was selected on the basis of 
previous studies demonstrating that a high proportion of severe febrile illness in people can 
be attributed to acute leptospirosis (Crump et al., 2013).  
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Figure  3.1: Map of Tanzania showing the administrative regions of Tanzania (main map) and the location of the Moshi Municipal and 
Rural Districts within the Kilimanjaro Region (insert)
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The Kilimanjaro region has a population of 1.64 million with an average intercensal annual 
population growth rate of 1.8% (national average: 2.7%; 2002-2012). The population 




average: 51 per km
2
) and 
20.9% of the population are classified as urban (Tanzania National Bureau of Statistics, 
2012, Tanzania National Bureau of Statistics, 2002). The climate in the region typically 
follows a pattern of long rains from March to May and short rains from October to 
December with the coolest months coinciding with the long dry season from June to 
September.  
The Kilimanjaro Region is further sub-divided in seven administrative districts 
(Figure ‎3.2). Two study districts; Moshi Municipal and Moshi Rural Districts were chosen 
as the core study site for their proximity to hospitals (Mawenzi Regional Hospital (MRH) 
and Kilimanjaro Christian Medical Centre (KCMC)) involved in previous and on-going 
febrile disease surveillance studies and to cover both urban and rural populations.  
Moshi Municipal District is the administrative centre of the Kilimanjaro region. The 
district has a population of 184,292 across living in 21 wards (an organisational unit of 
consisting of approximately 10 villages – see Figure ‎3.2 for more details). The Tanzania 
National Census (Tanzania National Bureau of Statistics, 2012) classifies all wards in this 
district as urban, although many people grow crops and keep small numbers of livestock, 
particularly poultry for personal use. The average household size in this district is 4.0 
people (national average = 4.8 people per household) (Tanzania National Bureau of 
Statistics, 2012).  
Moshi Rural District has a population of 466,737 people (Tanzania National Bureau of 
Statistics, 2012) across 31 wards (average household size: 4.2 people). The wards in this 
district are predominantly classified as rural (Tanzania National Bureau of Statistics, 2012) 
and characterised by small scale farming systems including a mix of agriculture and 
smallholder livestock farming. The environment ranges from lush high-altitude 
mountainous regions, where coffee, bananas and avocados dominate cash crop production, 
to drier low-altitude pasture land and plains where mainly maize and beans are cultivated. 
In both environments, livestock is typically kept in small numbers and usually confined to 
zero-grazing units or tethered.  
 
  73 
 
Figure  3.2: Hierarchy of Tanzanian administrative units used in this study 
ªSubvillage or Mtaa are the names used in rural or urban areas respectively; HH = household. 
 
Both study hospitals are located within the Moshi Municipal District and are the main 
hospitals for the provision of health-care to the population of the Kilimanjaro Region. 
Mawenzi Regional Hospital (MRH) is 300-bed hospital that provides primary hospital 
care, whereas Kilimanjaro Christian Medical Centre (KCMC) is a larger, 458-bed referral 
hospital that provides tertiary care to several regions in the north of the country. The 
catchment area for these hospitals covers a diverse range of agro-ecological settings 
including small to moderate sized urban communities (e.g. Moshi), agro-pastoral 
communities living on the slopes of Kilimanjaro and the surrounding plains (e.g. villages 
within the districts of Moshi Rural) and pastoral, nomadic communities (e.g. from the 
region of Arusha). 
Aetiological febrile disease surveillance has been performed at these hospitals on two 
occasions. The first study was performed on a cohort of 870 febrile patients between 2007 
and 2008 (Crump et al., 2013). The results of this study were the inciting cause for this 
project and have been outlined in Chapter ‎1.3 of the general introduction. This study was 
also the source of data and samples analysed in Chapter ‎7. A second period of febrile 
disease surveillance was performed from February 2012 to May 2014. A total of 1,115 
patients were recruited into this study. In parallel, a cross-sectional field study of human 
and linked livestock populations was also implemented in the Kilimanjaro and Arusha 
Regions (Figure ‎3.1) to explore risk factors for human and animal exposure to leptospirosis 
and other bacterial zoonoses (BacZoo Study; 2013 to 2014). At the time of analysis, 
Region (Kilimanjaro) 
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laboratory testing of these data were not available for inclusion in this study. However, 
preliminary results are included for context in individual chapter discussions.  
 
3.3 Studies to explore Leptospira infection in northern Tanzania 
Studies undertaken by this PhD are divided into three complementary strands of work, 
exploring Leptospira infection in three linked populations in the core study area:  
i. Cross-sectional study of peri-domestic rodents (Chapter ‎5); 
ii. Abattoir surveillance of ruminant livestock (Chapter ‎6); 
iii. Febrile patients with serologically confirmed acute leptospirosis (Chapter ‎7).  
 
The following methods are considered core methodology for the following study 
components and are compiled for reference. Evaluation and validation of study diagnostic 
methodology can be found in Chapter ‎4. 
 
3.4 Ethical clearance 
The field protocol was reviewed and approved in Tanzania by the Commission for Science 
and Technology (COSTECH) Certificate No. 2012-471-ER-2005-141; National Institute of 
Medical Research (NIMR), Tanzania (protocol number: NIMR/HQ/R.8a/Vol.IX/1499) and 
the Tanzanian Wildlife Research Institute (TAWIRI). Ethical approval for human sampling 
and testing was granted from the Kilimanjaro Christian Medical Centre (KCMC) Research 
Ethics Committee, NIMR and the Institutional Review Boards of Duke University Medical 
Center and the United States for the Centers for Disease Control. In the UK, the University 
of Glasgow College of Medicine, Veterinary Medicine and Life Sciences Ethics 
Committee (protocol number: 200120020) and University of Glasgow Faculty of 
Veterinary Medicine Ethics and Welfare Committee (Ref. 01a/13 & 02a/13) also approved 
the study protocol. 
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3.5 Sample collecting and processing 
This section describes the processing and testing procedures common to multiple sample 
types or study components. Details of the design of each study component and methods for 
sample collection can be found in Chapters ‎5, ‎6 and ‎7.  
 
3.5.1 Kidney sample collection and pre-processing 
Kidney samples were collected from a cross-sectional survey of rodents (Chapter ‎5) and a 
slaughterhouse survey of cattle, sheep and goats (Chapter ‎6). For rodents, one whole 
kidney was placed into 70-96% ethanol immediately after sterile harvesting and stored at 
ambient temperature for up to one year prior to processing. For ruminants, a 1 x 2 cm piece 
of kidney tissue was dissected across the cortico-medullary junction using a sterile blade 
following surface sterilisation with a flamed blade. Kidney tissue was placed into 70-96% 
ethanol immediately after harvesting and stored at ambient temperature for up to one year 
prior to processing. 
 
3.5.2 Urine sample collection and pre-processing 
Urine samples were collected by cystocentesis directly from the urinary bladder following 
slaughter of ruminant livestock in the abattoir. Urine samples were stored at -80°C. 
Samples were thawed at room temperature and then heat-inactivated at 67°C for one hour 
prior to DNA extraction.  
 
3.5.3 Human sample collection and pre-processing 
Archived plasma and urine samples were also available from patients with acute 
leptospirosis (Chapter ‎7). These were not heat treated prior to DNA extraction. 
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3.6 DNA Extraction from samples for detection of Leptospira infection 
DNA extraction was performed using the QIAamp DNA Blood Mini Kit spin-column 
protocol (Qiagen, Maryland, USA). Modifications (described in full below) were made to 
the standard protocols to improve DNA extraction efficacy following recommendations of 
expert laboratories (WHO/FAO/OIE Collaborating Leptospirosis Laboratory, Royal 
Tropical Institute, Amsterdam (KIT); and Moredun Research Institute, Edinburgh). 
 
3.6.1 Extraction of DNA from pure Leptospira isolates  
After a minimum of ten passages, 1ml Leptospira culture (2.5-5 x 10
8
 cells/ml) was 
centrifuged at 13,000 rpm for 20 minutes and the supernatant discarded. The pellet was 
suspended in to a mix of 180μl Qiagen® lysis buffer (AL) and 20μl proteinase K and 
incubated at 56°C for one to two hours and mixed regularly by pulse vortex. Then 200μl 
AL buffer (200μl) was added to each sample and mixed. Finally, 200μl absolute ethanol 
was added before proceeding to the standard spin column extraction protocol 
(Chapter ‎3.6.5). 
 
3.6.2 Extraction from kidney tissue 
Approximately 25 milligrams (mg) kidney tissue was dissected across the cortico-
medullary junction from each kidney sample and diced finely using a sterile scalpel blade 
and petri-dish that was changed for each sample. The dissected tissue was added to a mix 
of 180μl Qiagen® tissue lysis buffer (ATL) and 20μl proteinase K, mixed vigorously by 
pulse vortex and incubated for three hours at 56°C until the tissue was completely lysed. 
For ruminant tissues, 4μl Rnase A (100mg/ml; Qiagen, Maryland, USA) was added to each 
sample and incubated at room temperature (RT) for two minutes before proceeding with 
DNA extraction. Then 200μl AL buffer was added to each sample, which was mixed again 
and incubated at 70°C for ten minutes to dissolve any residual precipitate. Finally, 200μl 
ethanol was added to each sample before proceeding with the standard spin column 
procedure (Chapter ‎3.6.5). 
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3.6.3 Extraction from urine 
DNA was extracted from urine using an extraction protocol optimised to maximise the 
yield of bacterial DNA from urine samples (Ruth Zadoks and Ian Heron, personal 
communication). Briefly, up to 1000μl of urine was centrifuged at 10,000xG for ten 
minutes. The supernatant was discarded and the remaining pellet was re-suspended in 
200μl Tris-EDTA (TE) buffer (Biotechnology grade, pH 8.0; VWR International Ltd, 
Magna Park, Lutterworth UK). The centrifuge step was repeated to wash the pellet and the 
supernatant discarded. The washed pellet was then re-suspended in an enzyme mix 
containing 50μl lysozyme (10mg/ml), 50μl mutanolysin (1mg/ml) and 4μl lysostaphin 
(1mg/ml) made up to a final volume of 200μl with TE buffer, and incubated at 37°C for 
one hour. Subsequently, a solution containing 180μl AL buffer and 20μl proteinase K were 
added to each sample and incubated at 56°C for 1 hour to complete digestion. Finally, 
200μl absolute ethanol was added before proceeding to the standard spin column extraction 
protocol (Chapter ‎3.6.5). 
 
3.6.4 DNA extraction from human plasma  
Frozen plasma samples were thawed in a Class 2 Biological Safety Cabinet (BSC) for one 
hour at room temperature. For DNA extraction, 400μl plasma was added to a mix of 360μl 
AL buffer and 40μl proteinase K and incubated at 56°C for ten minutes. Then 200μl 
absolute ethanol was added before proceeding to the standard spin column extraction 
protocol (Chapter ‎3.6.5).  
 
3.6.5 Standard spin column procedure 
The following steps were used for all extraction protocols and sample types. 
Following the addition of ethanol, the resulting mixture was then applied to a QIAamp® 
DNA Mini spin column and processed according to manufacturer‘s recommendations 
(Qiagen, 2012). Each mixture/column was incubated for three minutes at room temperature 
before centrifugation at 8000 rpm for one minute. The filtrate was discarded. Each spin 
column was washed with 500μl Qiagen® wash buffer 1 (AW1) and incubated for two 
minutes at room temperature before centrifugation at 8000 rpm for one minute. The filtrate 
was discarded. Then 500μl Qiagen® wash buffer 2 (AW2) was added to each spin column, 
which was incubated for three minutes at room temperature before centrifugation at 13,000 
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rpm for one minute. The filtrate was discarded and the spin column was centrifuged at 
13,000 rpm for four minutes and allowed to dry at ambient temperature.  
Final elution was performed in two stages with 50% final volume of Qiagen® elution 
buffer (AE) added to each spin column before incubation at room temperature for three 
minutes before centrifugation at 13,000 rpm for three minutes. This step was repeated with 
a reduced incubation time of one minute. Final elution volumes were 200μl for tissue 
samples and Leptospira isolates; 60μl for urine samples, and 100μl for plasma samples. 
DNA was quantified using a NanoDrop spectrophotometer (ThermoScientific, Waltham, 
MA) for kidney samples and the Qubit® Fluorometer (ThermoScientific) using the Qubit® 
dsDNA High Sensitivity assay kit. DNA extracts were stored at -20°C prior to qPCR 
testing. 
 
3.7 qPCR protocols for the detection of pathogenic Leptospira 
samples 
3.7.1 secY SYBR® Green qPCR assay 
The secY SYBR® Green assay was run at WHO/FAO/OIE Collaborating Leptospirosis 
Reference Laboratory, at the Royal Tropical Institute, Amsterdam (KIT) (Ahmed Ahmed 
(AA). The protocol was run as published on Biorad CFX96 qPCR platform, using the 
primer set secYIVF/secYIV to amplify a 202 base-pair (bp) fragment (Table ‎3.1)(Ahmed 
et al., 2009). Test wells with a threshold cycle (Ct) value of ≤ 35 and a melt temperature 
TaqMan® 79-84°C were considered positive (Ahmed et al., 2012). 
 
3.7.2 lipL32 TaqMan® qPCR assay  
The lipL32 TaqMan® qPCR assay was run on the ABI 7500 Real-Time PCR system 
(Applied Biosystems, Foster City, CA) following published protocols (Stoddard et al., 
2009, Stoddard, 2013). Amplification of a 245 bp product was performed using the primer 
set lipL32-45F and lipL32-286R (Table ‎3.1), and a 19bp 5‘FAM®-labelled probe with a 
3‘BHQ quencher dye.  
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Table  3.1: Primer and probe sequences used for the amplification and 
detection of Leptospira DNA by qPCR  
Reference Primer Sequence 
Ahmed et al. 
(2009) 
secYIVF 5‘-GCG ATT CAG TTT AAT CCT GC-3 
secIV 5‘-GAG TTA GAG CTC AAA TCT AAG-3‘ 
Stoddard et al. 
(2009) 
lipL32-45F 5‘-AAG CAT TAC CGC TTG TGG TG-3‘ 
lipL32-286R 5‘-GAA CTC CCA TTT CAG CGA TT-3‘ 
Probe:  
lipL32-189P 
FAM-5‘-AA AGC CAG GAC AAG CGC CG-
‗3-BHQ1 




5‘-CCC GCG TCC GAT TAG-3‘  
16S (rrs) 
Lepto R 
5‘-TCC ATT GTG GCC GRA/GA CAC-3‘  
Probe: 16S 
Lepto P 




The following reaction conditions were used: 1x Platinum® qPCR Supermix-UDG 
(Invitrogen, Carlsbad, CA), 500nmol/L forward (lipL32-45F) and 500nmol/L reverse 
(lipL32-286R) primers; 100nmol/L probe (lipL32-189P) and 5μl DNA extract for each 
sample in a total reaction volume of 25μl. The amplification protocol consisted of: a pre-
incubation step at 50°C for two minutes; denaturation at 95°C for ten minutes; followed by 
45 amplification cycles (95°C for 15 seconds, 60°C for 60 seconds) with fluorescence 
acquisition performed at the end of each cycle. The reaction was run with the addition of 
low concentration ROX (50nmol/L) to normalise fluorescent reporter signal from 
December 2014 onwards, following re-calibration of the ABI 7500 qPCR platform.  
Reactions were run using MicroAmp Optical 96-well reaction plates (Invitrogen, Carlsbad, 
CA). On each plate, PCR grade water was used as a negative control and DNA extracted 
from a pure culture of L. interrogans serovar Copenhagenii Strain Wijnberg (KIT 
Biomedical Research, Amsterdam, NL) was used as a positive control. Reaction profiles 
were analysed using Applied Biosystems 7500 System Sequence Detection (SDS) 
Software Version 1.2.4 (Applied Biosystems, Carlsbad, CA 2001-2004). Ct values were 
calculated using the automated baseline and threshold cycle (Ct) parameters, set by the 
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SDS software and manually adjusted as necessary. Test wells were considered positive 
where a Ct value of < 40 was obtained. 
 
3.7.3 Human endogenous process control for the lipL32 TaqMan® qPCR 
assay 
The published lipL32 TaqMan® qPCR assay protocol also includes methodology for a 
control qPCR reaction against an endogenous human rnaseP gene, designed to control for 
DNA extraction efficiency and PCR inhibition in individual samples (Stoddard, 2013, 
Stoddard et al., 2009). For human plasma and urine specimens tested in this thesis, a single 
replicate of the rnaseP was run for each sample on the same reaction plate as the two 
lipL32 test reactions.  
rnaseP TaqMan® qPCR assay was performed on the ABI 7500 Real-Time PCR system 
(Applied Biosystems, Foster City, CA) using the primer set rnaseP-F and rnaseP-R as 
published (Stoddard, 2013, Stoddard et al., 2009). Amplification was detected through the 
use of a 24-bp 5‘FAM®-labelled probe with a 3‘BHQ quencher dye. The qPCR assay was 
run using: 1x Platinum® qPCR Supermix-UDG (Invitrogen, Carlsbad, CA), 400nmol/L 
forward (rnaseP-F) and 400nmol/L reverse (rnaseP-R) primers; 120nmol/L probe (rnaseP) 
and 5μl DNA extract for each sample in a total reaction volume of 25μl. Low 
concentration ROX (50nmol/L) was added to normalise background fluorescence signal as 
per manufacturer‘s recommendations. The amplification was run under the same reaction 
conditions as the lipL32 qPCR reaction (Chapter ‎3.7.2) with fluorescence acquisition 
performed at the end of each cycle. Test wells were considered positive where a Ct value 
of < 40 was obtained. 
 
3.7.4 16S (rrs) TaqMan® qPCR assay  
The 16S (rrs) TaqMan® qPCR assay was performed on the ABI 7500 Real-Time PCR 
system (Applied Biosystems, Foster City, CA) following published methodology (Smythe 
et al., 2002). Amplification of an 87-bp product was performed using the primers 16S 
LeptoF and 16S LeptoR, and detected with a 24-bp 5‘FAM®-labelled probe with a 
3‘TAMRA quencher dye (Table ‎3.1).  
The qPCR assay was run using the following conditions: 1x TaqMan® Universal PCR 
Mastermix (containing ROX
TM
 Passive Reference dye) (Invitrogen, Carlsbad, CA), 
600nmol/L forward (LeptoF) and 600nmol/L reverse (LeptoR) primers; 400nmol/L probe 
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(16S LeptoP) and 5μl DNA extract for each sample in a total reaction volume of 25μl. The 
amplification protocol consisted of: pre-incubation at 50°C for two minutes; denaturation 
at 95°C for ten minutes; followed by 40 amplification cycles (95°C for 15 seconds, 60°C 
for 60 seconds) with fluorescence acquisition performed at the end of each cycle. 
Reactions were run using MicroAmp Optical 96-well reaction plates as described for 
lipL32 assay. Reaction profiles and Ct values were analysed as described above. Test wells 
were considered positive where a Ct value of < 40 was obtained. 
 
3.8 Culture and isolation of Leptospira from animal kidneys 
Culture for Leptospira bacteria was performed from a subset of rodents, cattle and goats in 
collaboration with Marga Goris (MG) and Rudy Hartskeerl (RH) at KIT. Selection of 
animals for culture is described in Chapters ‎5 and ‎6.  
For each sample, approximately 25 mg of kidney tissue was dissected across the cortico-
medullary junction using a sterile scalpel blade following surface sterilisation with a 
flamed blade. On a sterile surface the capsular surface was removed and the remaining 
sample was finely diced and then added to 1ml Ellinghausen-McCullough-Johnson-Harris 
(EMJH) media supplemented with 5-Fluorouracil (5-FU). The kidney-EMJH solution was 
agitated using a sterile 1ml syringe to form a fine homogenate. A serial ten-fold dilution 
series (1:10, 1:100, 1:1000) was then made in three 5ml tubes of EMJH-5FU (1:10 
dilution) and mixed by gently inverting the vial three times. Each aliquot was sealed and 
labelled with the animal identification number, dilution and date. Aliquots were stored at 
room temperature (18-22°C) for up to four weeks prior to shipment to KIT.  
Upon arrival, aliquots of culture media were incubated at 30°C and examined for 
Leptospira growth by dark-field microscopy every four weeks for three months and then 
again after six months of incubation (MG and KA). The presence of non-Leptospira 
organisms, such as fungi, yeast and other bacteria was recorded. Samples positive for 
Leptospira were sub-cultured in EMJH media prior to serological and genetic typing (see 
Chapter ‎3.10).  
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3.9 Serological typing of Leptospira isolates 
Serological characterisation of pathogenic Leptospira isolates was performed at KIT (MG 
and KA) following internationally agreed guidelines. Isolates were typed after ten in vitro 
passages in EMJH media. The agglutination characteristics for each isolate were 
determined in two stages: 1) using the new isolate as an antigen, a microscopic 
agglutination test (MAT) was performed using a panel of rabbit serum representative of all 
known pathogenic serogroups; and 2) typing using a panel of monoclonal antibodies 
(mAbs) (raised in BALB/c mice) to define a serovar-specific antigenic profile for each 
isolate (Hartskeerl et al., 2006, Faine, 1994).   
 
3.10 Sequence-based typing of Leptospira isolates and non-isolate 
samples 
3.10.1 Single locus sequence typing of Leptospira  
For isolates: single locus sequence typing of a ~600bp fragment of the secY gene was 
performed at KIT (AA and KA) based on the protocol described by Victoria et al. (2008). 
Briefly, amplifications were performed using 10μl genomic DNA (gDNA) template in a 
25μl reaction containing 160nmol/L secYII and secYIV primers (Table ‎3.2). All PCR 
assays included a non-template control (PCR grade water). PCR products were visualised 
by gel electrophoresis on a 1.5% agarose gel and purified using the QIAquick® PCR 
Purification Kit following to manufacturer‘s instructions (Qiagen, Maryland, USA). PCR 
products were sequenced at local facilities and compared to a database for reference 
Leptospira serovars (Victoria et al., 2008) for species determination. 
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Table  3.2: Primers and annealing temperatures used for Leptospira species 










secYII 5‘-GAA TTT CTC TTT TGA TCT TCG-3‘ 
54°C 




secYFd 5‘-ATG CCG ATC ATY TTY GCT TC-3‘ 
52°C 
secYR3 5‘-TTC ATG AAG CCT TCA TAA TTT CTC A-3‘ 
*Mixed or ‗Wobble‘ base definitions: Y = C or T 
 
For qPCR positive samples, sequence analysis of the infecting Leptospira species was 
performed using single locus amplification and sequencing of a ~ 470 bp segment of the 
secY gene using primers modified for use with non-isolate samples from the East African 
region (Madagascar and Mayotte) (Table ‎3.2)(Dietrich et al., 2014). Assays were run at the 
University of Aberdeen (Mark Moseley (MM) and KA). PCR conditions were run 
following published protocols optimized by PCR platform (Moseley et al., in preparation). 
Amplifications were performed using 5μl genomic DNA (gDNA) template in a 25μl 
reaction containing 500nmol/L secYFd and secYR3 primers (Table ‎3.2). All PCR assays 
included a non-template control (PCR grade water) and a positive control of DNA 
extracted from a pure isolate of L. interrogans or L. borgpetersenii. PCR products were 
visualised by gel electrophoresis on a 1.5% agarose gel and purified using the QIAquick® 
PCR Purification Kit following to manufacturer‘s instructions (Qiagen, Maryland, USA). 
Purified product was quantified using a Nanodrop ND1000 spectrophotometer 
(ThermoScientific, Massachusetts, USA) and sequenced by Eurofins Genomics GmbH 
(Ebersburg, Germany). 
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3.10.2 Multi-locus sequence typing 
Multi-locus sequence typing (MLST) was performed at KIT (AA) following a seven loci 
typing scheme (Boonsilp et al., 2013). DNA was extracted from pure cultures of each 
isolate after ten in vitro passages. Sequences from the PCR amplicons were compared to 
references sequences available through an online MLST database (previously available at 
http://leptospira.mlst.net, accessed 19
th
 June 2015; now available at 
http://pubmlst.org/leptospira/)(Jolley and Maiden, 2010, Jolley and Maiden, 2016). 
Leptospira species and serovar were determined by allelic profile generation. 
 
3.11 Summary 
A summary flow chart of diagnostic testing performed on different sample types is shown 
in Figure ‎3.3. The results of sampling, diagnostic testing and Leptospira sequence typing 
are presented and discussed in the following chapters.  
 
Figure  3.3: Flow chart of diagnostic testing approaches used for different 
species and sample types in this thesis
DNA Extraction 
Leptospira qPCR  




POSITIVE POSITIVE NEGATIVE NEGATIVE 
Serological typing  MLST 
Leptospira serovar 
KIDNEY PLASMA URINE KIDNEY 
PCR PIPELINE CULTURE PIPELINE 
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4 Validation of core study methods 
4.1 Introduction to molecular approaches for the diagnosis of 
Leptospira infection  
Molecular methods, such as nucleic acid amplification (NAA) are increasingly being used 
in the diagnosis of Leptospira infection. Assays mostly rely on one of two NAA-based 
approaches - traditional (end-point) polymerase chain reaction (PCR) or real-time 
polymerase chain reaction (qPCR) – both of which are designed to specifically amplify a 
specific gene fragment of target pathogen (Biassoni and Raso, 2014). PCR-based diagnosis 
of Leptospira infection has a number of advantages of more traditional methods of 
Leptospira detection. PCR is fast and typically more sensitive than culture, which may take 
several months to yield positive results (Faine, 1994, Levett, 2001, Picardeau et al., 2014). 
qPCR can be used to quantify the bacterial load in an infection (Agampodi et al., 2012), 
and sequence analysis of PCR or qPCR products also offers the opportunity to obtain 
pathogen genetic information from (Agampodi et al., 2013, Boonsilp et al., 2011). Whilst 
PCR is also subject to a number of limitations (Chapter ‎1.7.1), these approaches are have 
proved useful in both clinical and research settings and hence were selected as the major 
diagnostic test in this study. This chapter describes the selection of a PCR-based diagnostic 
assay for the diagnosis of Leptospira infection in rodent, ruminant livestock and people in 
this study, based on evaluation of the literature and validation of the analytical 
performance of each test in controlled conditions.  
 
4.1.1 Assessing the performance of PCR-based diagnostic assays  
The goal for a PCR-based test for Leptospira infection is to maximise the number of true 
positive infections diagnosed by the test (i.e. diagnostic sensitivity), whilst minimising the 
number of false positives detected (i.e. diagnostic specificity). In general, PCR-based 
diagnostic assays are evaluated by comparison of their analytical and diagnostic sensitivity 
and specificity.  
Analytical sensitivity is used in the initial assessment and validation of a diagnostic test. It 
is defined as the dilution of a known quantity of pathogen DNA below which the 
diagnostic assay fails to detect ≥ 95% of replicates (World Organisation for Animal Health 
(OIE), 2008). It is assessed in vitro using serial dilutions of purified pathogen DNA to 
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determine the lowest detectable number of genome copies or organisms within a reaction. 
This is termed the lowest limit of detection (LLOD).  
Diagnostic sensitivity is used to assess the performance of a test under ―real-world‖ 
conditions. It is defined as the proportion of truly infected individuals detected from a 
population of people or animals (Thrusfield, 1995). Evaluation of diagnostic sensitivity 
uses clinical or field samples from a population of known infection status (evaluated 
previously using a gold standard or reference test) to calculate the proportion of ‗true‘ 
positives that particular diagnostic assay can detect. As the calculation of diagnostic 
sensitivity relies on patient or animal samples it may be more sensitive to bias introduced 
by sample characteristics or study design than analytical sensitivity. 
Analytical specificity is also used in the initial assessment and validation of a diagnostic 
test. It is defined as the ability of a diagnostic assay to detect a particular target organism 
when present in a sample (World Organisation for Animal Health (OIE), 2008). For the 
diagnosis of Leptospira infection, analytical specificity is required both to the genus, to 
differentiate Leptospira from other bacterial organisms, and within the genus to detect only 
a subset of Leptospira species with pathogenic properties (Picardeau et al., 2014). In 
laboratory evaluations of analytic specificity, validation studies usually test a wide range of 
Leptospira types as well as a range of other microorganisms. 
Diagnostic specificity is also used to evaluate the performance of a test in clinical or field 
samples from a human or animal population. It is defined as the proportion of true negative 
patients or animals that are detected from a test population and is particularly important in 
a clinical setting where false positive test results may give rise to inappropriate treatment 
or over-estimation of a disease burden (Saah and Hoover, 1997, Thrusfield, 1995).  
Together the sensitivity and specificity of a test can be used to select a robust diagnostic 
approach for disease surveillance. For Leptospira detection, the analytical and diagnostic 
performance of a variety of different qPCR assays has been described in the literature.  
 
4.1.2 PCR-based assays for diagnosis of Leptospira infection in people and 
animals 
A variety of PCR assays are available for use in the diagnosis of Leptospira infection in 
people and animals. Available assays target either conserved Leptospira housekeeping 
genes where sequence-specific primers are used to differentiate between pathogenic and 
non-pathogenic species, or genes encoding specific Leptospira virulence factors, which are 
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found only in the pathogenic species. Traditional PCR protocols for the diagnosis of 
Leptospira infection were first described in the early 1990s (Gravekamp et al., 1993, 
Merien et al., 1992). These have subsequently been superseded by qPCR assays, which 
offer automated detection and quantification of the amplification reaction through the use 
of a fluorescent reporter dye that accumulates exponentially alongside the target PCR 
product (Biassoni and Raso, 2014). Automated detection of amplification increases the 
analytical sensitivity of qPCR assays over traditional assays often down to the level of a 
single genomic equivalent (GE) (Ahmed et al., 2009). Two main technologies are used to 
facilitate automatic detection of DNA amplification in qPCR assays, either SYBR® Green 
dye, a fluorescent dye that binds double-stranded DNA (dsDNA) PCR products or 
sequence-specific TaqMan® fluorescent-labelled probes, which generate detectable 
fluorescence after binding to a complementary PCR product (Applied Biosystems, 2014, 
Biassoni and Raso, 2014). TaqMan® assays generally offer greater analytical specificity 
than SYBR® Green assays, which are prone to false positives due to the non-specific 
nature of their dsDNA binding properties.  
 
4.1.3 Review of qPCR protocols for the detection of pathogenic Leptospira 
infection in people and animals  
A number of qPCR assays have been described for the detection of pathogenic Leptospira 
DNA in clinical samples (Stoddard et al., 2009, Picardeau et al., 2014). Three qPCR assays 
developed and validated at international leptospirosis reference laboratories were selected 
for detailed analytical evaluation.  
 
i) secY SYBR® Green qPCR assay 
The secY SYBR® Green qPCR assay was developed at the WHO/OIE/FAO Leptospirosis 
Reference Laboratory, Royal Tropical Institute (KIT), Amsterdam (Ahmed et al., 2009). 
The assay targets the Leptospira secY gene, a housekeeping gene located on the large 
leptospiral chromosome (cI) that encodes a pre-protein translocase important for the export 
of protein across the cytoplasmic membrane (Haake and Levett, 2015, Durack et al., 2015). 
The analytical sensitivity of the secY SYBR® Green qPCR assay is reported as 1.0 
genomic equivalents (GE) for L. interrogans, 1.2 GE for L. santarosai and 1.5 GE for L. 
weilli. 
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Table  4.1: Comparison of analytical specificity of diagnostic qPCR assays for pathogenic Leptospira spp. 
Intermediate Leptospira species are also shown for comparison of test specificity to the pathogenic species. Key: (1) Detected by qPCR 
assay in validation studies; (0) not detected by qPCR assay in validation studies; (-) not tested in validation studies 
qPCR Assay secY SYBR® Green qPCR lipL32 TaqMan® qPCR 16S (rrs) TaqMan® qPCR 
Reference 
(Ahmed et al., 
2009) 
(Bourhy et al., 
2011) 
(Stoddard et al., 
2009) 




(Smythe et al., 
2002) 
(Thaipadungpanit 
et al., 2011) 
Pathogenic spp.        
L. alstonii
* 
1 1 - 1 1 - 1 
L. alexanderi 1 1 1 1 1 - 1 
L. borgpetersenii 1 1 1 1 1 1 1 
L. interrogans 1 1 1 1 1 1 1 
L. kmetyi - 0 - 1 - - - 
L. kirschneri 1 1 1 1 1 1 1 
L. noguchii 1 1 1 1 1 1 1 
L. santarosai 1 1 1 1 1 1 1 
L. weilii 1 1 1 1 1 1 1 
L. mayottensis
†
 - 0 - 1 - - - 
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Intermediate spp.    
L. broomii 0 0 0 0 - - - 
L. fainei 0 0 0 0 - 1 - 
L. inadai
‡
 0/1 0 0 0 0 0 1 
L. licerasiae 0 0 - 0 - - - 
L. meyeri
§
 1 0 0 0 0 1 0 
L. wolfii - 0 - 0 0 - 1 
 
                                                 
*
 Also called Genomospecies 1 
† Recently reclassified from a divergent L. borgpetersenii type to a new species (Bourhy et al. (2014)  
‡ For L. inadai; 0/1 denotes varying qPCR results are obtained across validation studies using different strains and serovars  
§ Classified as saprophytic by some sources; different serovars used across validation studies.  
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The assay shows a high degree of specificity to the Leptospira genus but also amplifies 
some intermediate Leptospira species (L. inadai and L. meyeri) reducing the overall test 
specificity for detection of pathogenic Leptospira (Table ‎4.1). Independent validation trials 
have highlighted that this approach may fail to detect some of the more recently described 
pathogenic species, specifically L. kmetyi and L. mayottensis (Bourhy et al., 2014, Bourhy 
et al., 2011). Melt curve analysis is needed to determine whether an observed amplification 
is specific to pathogenic Leptospira species (Ahmed et al., 2009).  
Despite some limitations, the secY SYBR® Green qPCR assay is used routinely in the 
diagnosis of acute human leptospirosis in the Netherlands. Compared to culture alone, the 
diagnostic sensitivity and specificity are reported as 100% and 93% in this population 
(Ahmed et al., 2009). The assay has been used to demonstrate Leptospira infection in 
epidemiological studies of rodents and ruminant populations in a variety of countries 
including Kenya, Morocco and Benin (Halliday et al., 2013, Houemenou et al., 2013, 
Benkirane et al., 2014).  
 
ii) lipL32 TaqMan® qPCR Assay 
The lipL32 gene, which is also located on chromosome cI, encodes an outer membrane 
lipoprotein specific to pathogenic Leptospira species that is thought to play an important 
role in virulence (Haake et al., 2000, Murray, 2013). A TaqMan® qPCR assay targeting 
this gene was developed and validated at the United States Centers for Disease Control, 
Georgia (Stoddard et al., 2009, Galloway and Hoffmaster, 2015). A human-specific 
internal control assay using the human rnaseP housekeeping gene has also been described 
for use with this assay (Stoddard et al., 2009).  
All published validation studies for the lipL32 TaqMan® qPCR assay have demonstrated a 
high degree of analytical specificity to pathogenic Leptospira serovars (Table ‎4.1), but 
figures for the analytical sensitivity vary by study. From the original CDC validation study, 
the reported 95% LLOD ranged from 20 to 50 GE/μl L. interrogans depending on the 
qPCR platform used (Stoddard et al., 2009). A ten-fold improvement was reported 
following additional optimisation of the protocol (Galloway and Hoffmaster, 2015). 
However, an independent validation study reported the repeatable detection limit of one 
leptospire (1.0 GE) per reaction (Bourhy et al., 2011), and in direct comparisons, the 
lipL32 TaqMan® qPCR assay was more sensitive than either the secY SYBR® Green 
assay (Ahmed et al., 2009) or a third qPCR assay targeting the lfb1 gene (Merien et al., 
2005). This variation in reported analytical sensitivity may be a consequence of 
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heterogeneity in reporting methodology, but the sensitivity of this assay is also influenced 
by differences in the choice of PCR platform (Stoddard et al., 2009) or the presence of a 
passive reference dye to normalise background fluorescence (Galloway and Hoffmaster, 
2015). These factors should therefore also be considered when validating the use of this 
assay in other settings. 
The lipL32 TaqMan® qPCR assay is commonly used in both clinical and research 
applications. The assay has been used to provide early diagnosis for acute human 
leptospirosis in a variety of tropical settings including Mayotte (Bourhy et al., 2010), 
Thailand (Bourhy et al., 2010, Thaipadungpanit et al., 2011) and Uruguay, where the assay 
was able to detect infection in the acute phase of illness in 30% (n = 85) of leptospirosis 
cases confirmed by demonstration of seroconversion by MAT (Gonzalez et al., 2013). The 
assay has also been used for epidemiological surveillance of a range of animal species 
including rodents in Canada and South-East Asia (Himsworth et al., 2013, Cosson et al., 
2014), dogs in Ireland (Rojas et al., 2010) and livestock and wildlife on the island of La 
Réunion (Desvars et al., 2013c).  
 
iii) 16S (rrs) TaqMan qPCR assay  
The 16S (rrs) TaqMan® qPCR assay developed at the WHO/OIE/FAO Leptospirosis 
Reference Laboratory, Queensland Health Scientific Services, Brisbane, was the first 
diagnostic Leptospira qPCR assay to be described in the literature (Smythe et al., 2002). 
The assay targets the Leptospira 16S rRNA (rrs) gene, which is a housekeeping gene is 
common to all bacteria and used to define the taxonomy of different bacterial genera 
(Levett, 2015). Two copies of the rrs gene are located in chromosome cI in pathogenic and 
saprophytic Leptospira species (Picardeau et al., 2008). The 16S diagnostic assay is 
therefore designed based on regions of the rrs gene that are conserved between pathogenic 
species but not in non-pathogenic or intermediate species (Smythe et al., 2002). The 
analytical sensitivity is reported as approximately 2 GE for the two most common 
Leptospira species, L. interrogans and L. borgpetersenii (Smythe et al., 2002). However, 
the 16S (rrs) assay is not entirely specific to pathogenic Leptospira species and 
amplification of intermediate Leptospira species, including L. fainei, L. inadai, L. meyeri 
and L. wolfii, has been demonstrated in some validation studies (Table 4.1) 
(Thaipadungpanit et al., 2011, Smythe et al., 2002).  
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The 16S (rrs) assay has been used in epidemiological surveillance of Leptospira in wild 
animal populations including flying foxes in Australia (Cox et al., 2005) and bats and 
rodents in the Western Indian Ocean islands (Lagadec et al., 2012, Dietrich et al., 2014). 
As a human diagnostic test, the 16S (rrs) TaqMan® qPCR assay has been used widely in 
tropical settings including Australia (Smythe et al., 2002), Mayotte (Bourhy et al., 2012), 
Peru (Ganoza et al., 2010) and Thailand (Thaipadungpanit et al., 2011). In Sri Lanka, the 
16S (rrs) assay was able to detect infection in the acute phase of illness in 51% (n = 105) 
of leptospirosis cases confirmed by demonstration of seroconversion by MAT (Agampodi 
et al., 2012). In a case-control study of leptospirosis cases diagnosed by culture and/or a 
positive MAT results (based on seroconversion or a single titre ≥ 1:400) performed in 
Thailand, the 16S (rrs) assay showed higher diagnostic sensitivity than the lipL32 assay 
(56% vs. 43%, p<0.001) but lower test specificity (90% vs. 93%, p = 0.06) 
(Thaipadungpanit et al., 2011).  
 
Whilst all three diagnostic tests are used widely in human and animal studies, data from 
validation studies indicates that some differences in test sensitivity may exist, which may 
also be influenced by the testing conditions or sample type. Therefore, independent 
evaluation indicated to provide a better understanding of the sensitivity and performance of 
selected diagnostic tests for our purposes.  
 
4.1.4 Objectives 
The overall goal of this study component was to evaluate several qPCR approaches to 
select an appropriate diagnostic test for the detection of Leptospira infection in people and 
animals from Tanzania. Assays were performed at the University of Glasgow. The 
following specific study objectives were addressed:  
Objective 1: Measure and compare the analytical sensitivity for:  
i) lipL32 TaqMan® qPCR assay under different reaction conditions 
ii) 16S (rrs) TaqMan® qPCR assay under standard reaction conditions;  
Objective 2:  Evaluate the effect of sample inhibition on the lipL32 TaqMan® qPCR 
assay; 
Objective 3: Compare the diagnostic performance of the lipL32 TaqMan® qPCR assay 
(run at the University of Glasgow) with the secY SYBR® Green qPCR assay run at the 
WHO/OIE/FAO Leptospirosis Reference Laboratory, KIT. 
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4.2 Methods 
4.2.1 Preparing Leptospira DNA titration series 
Validation studies were performed using genomic DNA (gDNA) extracted from:  
i) pure culture of L. interrogans serovar Copenhagenii Strain Wijnberg obtained 
from the WHO/FAO/OIE Leptospirosis Reference Laboratory at the Royal 
Tropical Institute, Amsterdam (KIT). 
ii) pure culture of L. borgpetersenii serovar Hardjo isolated during this project 
from cattle in Tanzania (Chapter ‎6).  
 
The starting genomic DNA (gDNA) concentration was determined using the Qubit® 
dsDNA High sensitivity assay kit. A ten-fold dilution series was prepared using PCR grade 
water to a minimum concentration of 10
0
 genome copy per microlitre.  
 
4.2.2 Calculating genomic equivalence (GE)  
The number of genomic equivalents in a sample was calculated using the following 
formula (URI Genomics & Sequencing Center, 2004):  
GE  =   (amount of DNA (ng) * Avogadro‘s number)   




x average weight of 1 mol (bp) 
 
Where:  
 Avogadro‘s number: 6.022 x 1023 molecules/mole 
 The molecular weight of any double-stranded DNA template is estimated by taking 
the product of its length (in bp) and 650g (the average weight of 1 mol bp).  
 The genomic length of L. interrogans and L. borgpetersenii is estimated as 4,627 
Kilobases (Kb) and 3,391 Kb respectively (Adler and de la Pena Moctezuma, 2010, 
Nascimento et al., 2004).  
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4.2.3 Diagnostic cut-offs and case definitions 
Positive case definitions or cut-offs for positive test results were predefined as:  
secY:  A minimum of two of three replicates amplified with Ct ≤ 35, and a melt 
temperature (Tm) between 79°C and 84°C (Ahmed et al., 2012) 
lipL32:  A minimum of one or two replicates amplified with Ct ≤ 40 (Stoddard et al., 
2009) 
16S (rrs):  A minimum of one of two replicates amplifies with Ct ≤ 40 (Smythe et al., 
2002) 
 
4.2.4 Effect of ROX on analytical sensitivity of the lipL32 TaqMan® qPCR 
assay 
To measure the effect of adding ROX on the performance of the lipL32 TaqMan® qPCR 
assay, a titration series of DNA extracted from L. interrogans serovar Copenhagenii was 
made from a starting concentration of 0.133 ng/μl, equivalent to ~ 105 GE of L. 
interrogans. Each dilution step was run in triplicate a) without ROX (Stoddard et al., 2009) 
and b) with the addition of ROX to normalise baseline fluorescence (Galloway and 
Hoffmaster, 2015). Assays were run on a single plate to minimise the introduction of 
between-run variability. 
 
4.2.5 Analytical sensitivity of lipL32 TaqMan® qPCR assay  
Starting DNA concentrations for assessment of lipL32 TaqMan® qPCR performance were 
1.71 x 10
-2
 ng/μl for L. interrogans and 2.32 x 10-2 ng/μl L. borgpetersenii, equivalent to ~ 
10
4 
GE. The qPCR assay was performed as described in Chapter ‎3.7.2. Nine replicates of 
each DNA dilution step were tested, divided equally across three different plates and 
reaction runs, each with three replicates of a particular titration step. Three negative control 
replicates using PCR grade water were also used on each test plate.  
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4.2.6 Analytical sensitivity of the 16S (rrs) TaqMan® qPCR assay  
Starting DNA concentrations for assessment of 16S (rrs) TaqMan® qPCR performance 
were curves were 1.71 x 10
-2
 ng/μl for L. interrogans and 2.32 x 10-2 ng/μl L. 
borgpetersenii, equivalent to ~ 10
4 
GE. The qPCR assay was performed as described in 
Chapter ‎3.7.4. Eight replicates of each DNA dilution step were tested on three different 
plates and reaction runs (Plate 1 and 2 = 3 replicates each; Plate 3 = 2 replicates only). 
Three negative control replicates using PCR grade water were also used on each test plate.  
 
4.2.7 Assessing sample inhibition on the lipL32 TaqMan® qPCR assay 
The effect of sample inhibition on the lipL32 TaqMan® PCR assay was evaluated by 
spiking DNA extracted from rodent kidneys with known concentrations of DNA extracted 
from Leptospira interrogans serovar Copenhagenii. Samples were selected to cover the 
typical range of DNA concentrations obtained following DNA extraction from 25 
milligrams of rodent kidney (Chapter ‎3.6.2). A ten-fold titration series was made as 
described above (Chapter ‎4.2.1) using the DNA extracts in place of PCR grade water.  
 
Table  4.2: Details of rodent kidney DNA extracts used to test for PCR 
inhibition 
Sample ID Rodent species DNA concentration  
R0355 Rattus rattus 367 ng/μl 
R0379 Rattus rattus 244 ng/μl 
R0387 Mus sp. 120 ng/μl 
 
qPCR tests were run in triplicate alongside a standard curve using the same titration series 
but diluted in PCR-grade water. Negative controls were also run in triplicate for each DNA 
extract and for water. All PCR tests were run in the same plate to avoid between-batch 
variations.  
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4.2.8 Comparison of diagnostic performance of secY SYBR® Green qPCR 
assay and lipL32 TaqMan® qPCR assay in rodent tissue samples 
A double-blinded trial was performed to compare the diagnostic sensitivity and specificity 
of the secY SYBR® Green assay run at WHO/FAO/OIE Collaborating Leptospirosis 
Reference Laboratory, Royal Tropical Institute, Amsterdam (KIT) (AA) and the lipL32 
TaqMan® qPCR assay run at the University of Glasgow (KA). Ethanol-fixed rodent 
kidney samples were available from 26 Rattus norvegicus of known Leptospira infection 
status trapped in the Netherlands between 2011 and 2013. DNA was extracted at the 
University of Glasgow using the protocol described in Chapter ‎3.6.2. Each sample was 
tested in duplicate using the lipL32 TaqMan® qPCR assay as described in Chapter ‎3.7.2, 
and in triplicate using the secY SYBR® Green assay (Chapter ‎3.7.1)(Ahmed et al., 2009). 
 
4.2.9 Statistical analysis 
Statistical analyses and plots were performed in R (R Core Team, 2015). A standard curve 
for each qPCR assay and test Leptospira species was plotted using the log of the number of 
GE in each reaction as the explanatory variable. The analytic sensitivity for each 
Leptospira spp. was defined as the lowest dilution detectable in 100% of qPCR replicates 
(100% LLOD).  
The Ct value was considered the primary outcome variable for all analyses of diagnostic 
test performance. Multivariable linear models were performed to explore the statistical 
significance of candidate explanatory variables of the Ct value. Variables considered 
included the log10 transformed GE, ROX status of the test (ROX included or not), 
Leptospira species, test batch (either test plate or dilution series in the case of inhibition 
studies) and qPCR assay (lipL32 or 16S). A forward step-wise method for model building 
was used and models were compared using likelihood ratio tests (LRT) with a significance 
cut-off of p ≤ 0.05. Interaction terms were included in the models and retained if 
significant.  
For the double-blinded control study, the results of the lipL32 TaqMan® qPCR assay was 
compared to secY SYBR® Green qPCR assay run at the reference laboratory. Test 
agreement was assessed using the Cohen‘s kappa statistic.  
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4.3 Results 
4.3.1 Effect of ROX on analytical sensitivity of the lipL32 TaqMan® qPCR 
assay 
The analytical sensitivity (LLOD) for the lipL32 assay with and without ROX at which 
100% of replicates were positive was 1.33 GE (Table ‎4.3). Under both conditions, a single 
replicate (n = 1/3) was positive at the 1.33 x 10
-1
 GE concentration (data not shown).  
 
Table  4.3: Comparison of the lipL32 assay run with and without ROX using 

















-1 1.33 x 10
5
 17.1 0.227 17.9 0.137 
 1.33 x 10
4
 20.4 0.0834 21.1 0.080 
 1.33 x 10
3
 23.7 0.321 24.2 0.335 
 1.33 x 10
2 
26.9 0.165 27.4 0.550 
 1.33 x 10
1 
30.3 0.206 30.6 0.628 
 1.33 x 10
0
 33.5 1.38 35.3 0.372 
 
A linear relationship was demonstrated between the number of GE and measured Ct value 
within the tested range. By linear regression, both the log10-transformed GE and presence 
of ROX were statistically significant explanatory variables for Ct values observed 
(Table ‎4.4). Every ten-fold increase in the test log10 GE was associated with a reduction in 
the Ct value of 3.23 cycles (95% CI: -3.31 – -3.15). The addition of ROX into the reaction 
was estimated to reduce the Ct value by 0.518 (95% CI: -0.74 – -0.29). There was an 
indication of a weak interaction effect between ROX status but the addition of this 
interaction did not significant improve the model fit (p = 0.086). 
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Table ‎4.4: Logistic regression model of the effect of GE and ROX on the 
lipL32 TaqMan® qPCR assay 
Variable Level Coefficient 95% CI t-value p-value n  
Intercept  34.3 34.0 – 34.6 240 < 0.001  
Log10 GE  -3.23 -3.31 – -3.15 -83.8 < 0.001 18 
ROX Status: NoROX ref    9 
 ROX -0.52 -0.74 – -0.29 -4.75 < 0.001 9 
Adjusted R
2
 = 0.996; LRT statistic = 2.01, df  = 1; p < 0.001 
 
4.3.2 Analytical sensitivity of lipL32 TaqMan® qPCR assay  
The analytical sensitivity (100% LLOD) of the lipL32 TaqMan® qPCR assay with ROX 
was measured as 17 genome copies of L. interrogans and 32 genome copies of L. 
borgpetersenii per reaction (Table ‎4.5). At a further ten-fold dilution step, six (66.7%) out 
of nine replicates were positive for L. interrogans (1.7 genome copies per reaction), and 
seven (77.8%) out of nine replicates were positive for L. borgpetersenii (3.2 genome 
copies per reaction).  
A linear relationship was demonstrated between log10GE and observed Ct value up to the 
100% LLOD (Figure ‎4.1). By linear regression, both the log10GE and the test batch were 
significant explanatory variables and included in the final model (Table ‎4.6). Every ten-
fold increase in the test log10 GE was associated with a reduction in the Ct value of -3.44 
(95% CI: -3.45 – -3.39). A significant difference was observed in Ct values between 
batches but the magnitude of the effect was small (< 1 cycle). 
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Table ‎4.5: Mean Threshold Cycle (Ct) for a) lipL32 TaqMan® qPCR assay and b) 16S (rrs) TaqMan® qPCR assay run with a 
standard ten-fold titration series with DNA extracted from pure isolates of i) L. interrogans and ii) L. borgpetersenii 
   a) lipL32 qPCR b) 16S qPCR 
Leptospira species Starting DNA 
concentration (ng/μl) 
GE per reaction Mean Ct  
(n = 9) 
SD (Ct) Mean Ct 
(n = 8) 
SD (Ct) 




 22.8 0.355 23.9 1.03 
  1.71 x 10
3
 26.2 0.458 28.7 1.07 
  1.71 x 10
2
 29.9 0.524 33.3 1.22 
  1.71 x 10
1 
33.0 0.627 38.1 1.22 
  1.71 x 10
0 
36.3* 0.729 NA NA 
  1.71 x 10
-1
 NA NA NA NA 




 21.9 0.356 23.2 1.34 
  3.16 x 10
3
 25.4 0.307 27.8 1.35 
  3.16 x 10
2
 28.9 0.363 32.8 1.28 
  3.16 x 10
1
 32.2 0.395 37.5 1.51 
  3.16 x 10
0 
35.5** 1.03 39.8*** NA 
  3.16 x 10
-1 
NA NA NA NA 
*n= 6 of 9 replicates amplified; ** n = 7 of 9 replicates amplified; *** n = 1 of 8 replicates amplified 
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Figure ‎4.1: Standard curve for a) lipL32 TaqMan® qPCR assay and b) 16S (rrs) TaqMan® qPCR assay based on a ten-fold titration 
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Table ‎4.6: Logistic regression model for lipL32 TaqMan® qPCR assay 
Variable Level Coefficient 95% CI t-value p-value n  
Intercept  37.5 37.3 – 37.6 513 < 0.001  
Log10 GE  -3.44 -3.45 – -3.39 -163 < 0.001 72 
Batch 1 ref    24 
 2 -0.53 -0.64 – -0.41 -9.12 < 0.001 24 
 3 0.39 0.27 – 0.51 6.74 < 0.001 24 
Adjusted R
2
 = 0.997; LRT statistic = 10.2, df  = 1; p < 0.001 
 
4.3.3 Analytical sensitivity of 16S (rrs) TaqMan® qPCR assay  
The analytical sensitivity (100% LLOD) of the 16S (rrs) TaqMan® assay was measured as 
17 genome copies of L. interrogans and 32 genome copies of L. borgpetersenii per 
reaction (Table ‎4.5). Below 10
1
 GE, amplification was only observed for one (12.5%) out 
of eight L. borgpetersenii replicates, and none of the L. interrogans replicates. 
A linear relationship was demonstrated between log10GE and observed Ct value up to the 
100% LLOD (Figure ‎4.1). By linear regression the log10GE, Leptospira species and the 
test batch were significant explanatory variables and included in the final model 
(Table ‎4.7). Every ten-fold increase in the test log10 GE was associated with a reduction in 
the Ct value of 4.78 cycles (95% CI: -4.97 – -4.71). The Ct values for L. interrogans were 
significantly lower with the 16S (rrs) assay than Ct values for L. borgpetersenii. A 
significant difference was also observed in Ct values between batches.  
 
Table ‎4.7: Logistic regression model for 16S (rrs) TaqMan® qPCR assay 
Variable Level Coefficient 95% CI t-value p-value n  
Intercept  44.1 43.9 – 44.4 333 < 0.001  
Log10 GE  -4.77 -4.85 – -4.71 -133 < 0.001 64 
Leptospira 
species 
borgpetersenii ref    32 
interrogans -1.10 -1.26 – -0.94 -13.6 < 0.001 32 
Batch 1 ref    24 
 2 2.06 1.89 – 2.25 22.2 < 0.001 24 
 3 -1.02 -1.22 – -0.81 -9.80 < 0.001 16 
Adjusted R
2
 = 0.997; LRT statistic = 19.1, df = 1; p < 0.001 
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4.3.4 Comparison of analytical sensitivity and reliability between lipL32 and 
16S qPCR assays 
Finally, data from both qPCR assays were compiled into a final model to explore the effect 
of test on Ct value (Table ‎4.8), and compare the analytic sensitivity between the two 
assays. Although the 100% LLOD of detection was equivalent for the two assays, at 
concentrations < 10 GE per reaction, the lipL32 assay was able to detect 13 (72.2%) of 18 
reactions compared to the 16S (rrs) assay, which detected only 1 (6.25%) of 16 reactions 
replicates. By linear regression the log10GE, Leptospira species and lipL32 assay were 
significant explanatory variables and were included in the final model. Statistically 
significant interaction effects were observed between the qPCR test type and the log10GE, 
and the qPCR test type and the Leptospira species. The overall effect of batch was variable 
in the final model.   
 
Table ‎4.8: Final multivariable linear model for Ct value (both qPCR assays) 
Variable Level Coefficient 95% CI t-value p-value n  
Intercept  44.4 43.7 – 45.1 127 < 0.001  
Log10 GE  -4.78 -4.97 – -4.58 -48.5 < 0.001 136 
Test 16S (rrs)  ref    64 
 lipL32 -7.19 -8.09 – -6.28 -15.7 < 0.001 72 
Leptospira 
species 
borgpetersenii ref    68 
interrogans -1.10 -1.54 – -0.66 -4.97 < 0.001 68 
Batch 1 ref    48 
 2 0.77 0.41 – 1.12 4.29 < 0.001 48 
 3 -0.12 -0.49 – -0.25 -0.64 0.53 40 
Log10GE*Te
st[lipL32] 
 1.34 1.07 – 1.61 9.92 < 0.001 - 
Species[Int]*
Test[lipL32] 
 1.08 0.47 – 1.68 3.53 < 0.001 - 
Adjusted R
2
 = 0.965; LRT statistic = 9.69, df  = 1; p < 0.001 
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The final multivariable linear model was used to predict Ct values to compare the relative 
sensitivity of the qPCR assays within the range of the experimental data (i.e. between 1.5 
and 4.0 log10GE). Predicted Ct values were consistently lower for the lipL32 assay than 
those obtained from the 16S (rrs) assay used as the reference test for both L. interrogans 
and L. borgpetersenii. The greatest magnitude of effect was observed for reactions with 
low numbers of genomic copies (Table ‎4.9).  
 
Table  4.9: Predicted Ct values for the lipL32 and 16S (rrs) TaqMan® qPCR 
assays using the final multivariable linear model (Table  4.8) 
 
 
4.3.5 Assessment of qPCR inhibition in rodent samples spiked with L. 
interrogans DNA 
A significant linear relationship was demonstrated with the lipL32 TaqMan® qPCR assay 
between log10 GE and measured Ct value in all three rodent kidney DNA preparations as 
well as the water control titration series (Figure ‎4.2). Recorded Ct values for two samples, 
R0355 and R0379 were significantly different from the water control (Table ‎4.10). In both 
cases, spiked rodent samples showed statistically significantly lower Ct values than the 
standard curve. However, the effect size was in the region of 0.5 to one Ct in both cases.  
  
  
Leptospira spp. Test 
Ct values  
1.5  Log10GE 4.0  Log10GE 
L. interrogans 
lipL32 32.2 23.7 
16S (rrs) 36.4 24.4 
L. borgpetersenii lipL32 32.3 23.7 
16S (rrs) 37.5 25.5 
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Table ‎4.10: Logistic regression model to assess PCR inhibition in the lipL32 
TaqMan® qPCR assay 
Variable Level Coefficient 95% CI t-value p-value n  
Intercept  11.4 10.8 – 12.0 38.0 < 0.001 57 
Log10 GE  -3.03 -3.12 – -2.94 -64.4 < 0.001 57 
Sample H2O ref    13 
 R0355 -0.93 -1.30 – -0.55 -4.94 < 0.001 14 
 R0379 -0.44 -0.81 – -0.06 -2.36 < 0.05 15 
 R0387 -0.16 -0.53 – -0.21 -0.878 0.38 15 
Adjusted R
2 
= 0.987; LRT statistic = 6.79; p < 0.001 
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Figure  4.2: Observed Ct values for rodent kidney DNA extracts spiked with L. interrogans DNA compared with a standard control 
titration series (PCR-grade water) 




















● Control Titration Series (H20)
R0387 [DNA] 120 ng/ul
R0379 [DNA] 244 ng/ul
R0355 [DNA] 367 ng/ul
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4.3.6 Comparison of diagnostic performance of secY SYBR® Green qPCR 
assay and lipL32 TaqMan® qPCR assay in Dutch rodent kidneys  
Comparing results from secY SYBR® Green qPCR assay and lipL32 TaqMan® qPCR 
assay in Dutch rodent kidneys, the two tests showed almost perfect agreement (Cohen‘s 
kappa statistic: 0.917 (95% CI: 0.758 – 1.08) (Thrusfield, 1995). Leptospira infection was 
detected in nine (34.6%; n = 26) samples by the secY assay and 10 (38.5%) samples by 
lipL32 assay (Table ‎4.11). The observed Ct values ranged from 15 to 30 for the secY assay 
(n = 9, median = 21) and 17 to 33 for the lipL32 assay (n = 10, median = 22). For the one 
discrepant sample, amplification with the lipL32 assay was only observed in one of two 
test replicates, with a Ct value of 33.   
 
Table  4.11: Comparison of the diagnostic performance of the lipL32 












9 1 10 
lipL32 qPCR 
negative 
0 16 16 
Total 9 17 26 
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4.4 Discussion and Conclusions 
The validation data summarised in this chapter provides a quantitative assessment of two 
qPCR assays, the lipL32 TaqMan® qPCR assay and the 16S (rrs) qPCR assay, used for 
the diagnosis of Leptospira infection in people and animals from Tanzania described in 
subsequent chapters. Although both tests are widely used in both clinical and 
epidemiological settings, these analyses revealed some significant differences in analytical 
sensitivity between the two assays. Both tests demonstrated the same 100% LLOD but 
observed Ct values are significantly lower for the lipL32 assay. The lipL32 was able to 
detect more replicates at very low concentrations of Leptospira DNA than the 16S (rrs) 
assay. No significant inhibitory effects were observed when qPCR reactions were run in 
the presence of highly concentrated DNA extracts from rodent kidney samples. 
Furthermore, the diagnostic sensitivity of the lipL32 assay to detect Leptospira infection in 
naturally infected Dutch rodent kidneys was equivalent to the secY SYBR® Green assay 
carried out at an international reference laboratory. Overall, validation test results indicate 
that, under our laboratory conditions, the lipL32 assay is a highly sensitive test for the 
detection of Leptospira interrogans and L. borgpetersenii.  
The addition of ROX improved the analytic sensitivity of the lipL32 TaqMan® qPCR 
assay in line with recent published data (Galloway and Hoffmaster, 2015). ROX is a 
passive reference dye added to qPCR reactions to normalise background fluorescence. In 
this study, the addition of ROX to the lipL32 TaqMan® qPCR reaction mix was associated 
with a small but significant increase in the analytical sensitivity of the assay. Ct values for 
reactions containing ROX were detected around half a cycle earlier (i.e. 0.5 Ct lower) than 
those without. Based on the original assay protocol (Stoddard et al., 2009), ROX was not 
included in the reaction mix when testing field samples from the first year of my field 
study (Chapter ‎5 and ‎6), but was later introduced following repeat assay optimisation (see 
Chapter ‎3.7.2 for methodology). Given the small size of the effect, it is unlikely the 
addition of ROX will have substantially altered the ability of the assay to detect positive 
infections in field samples. However, the influence of ROX should be taken into account if 
the Ct values from the assay were used to quantify the leptospiral load in test samples for 
example. ROX was included in the reaction mix for all other validation studies on lipL32 
assay in this chapter. 
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In direct comparison of the analytical sensitivity of the assays, the optimised lipL32 assay 
demonstrated substantially greater analytical sensitivity than the 16S (rrs) assay. Both 
assays demonstrated a strongly significant linear relationship between the observed Ct 
value and the number of GE in each reaction. Whilst the 100% LLOD was the same for 
both tests, observed and predicted Ct values were consistently and substantially lower for 
the lipL32 assay than the 16S (rrs) assay (Figure ‎4.1 and Table ‎4.9), particularly at low 
concentrations of Leptospira per test reaction. The ability to detect low leptospiral loads is 
an important characteristic of a diagnostic test. Estimates from the literature indicate that 





organisms per millilitre (Agampodi et al., 2012), which translates roughly to 2 x 10
0
 to 2 x 
10
4
 GE per reaction for human blood samples using the methods for DNA extraction 
(Chapters ‎3.6.4) and lipL32 qPCR testing (Chapter ‎3.7.2) described in Chapter 3. The low 
end of this range is equivalent to the final detectable dilution step used in the validation 
study (Table ‎4.5; 1.7 x 10
0 
for L. interrogans and 3.2 x 10
0 
for L. borgpetersenii). In the 
titration step containing less than ten GE per reaction, the lipL32 assay was able to detect 
Leptospira DNA in 72% of replicates (n = 18) compared to only ~ 6% (n = 16) with the 
16S (rrs) assay run with the same test DNA concentrations. These results indicate that the 
lipL32 assay is more likely than the 16S (rrs) assay to detect infection in patients with low 
leptospiral loads, assuming that the sensitivity of the test is not influenced by any other 
sample or study factors. However, testing multiple replicates is also recommended to 
increase the sensitivity of the approach in this scenario.  
The mean leptospiral load in naturally infected rodents is predicted to fall within the linear 
dynamic range of the lipL32 assay demonstrated in this study. The median observed Ct 
value for naturally infected Dutch rodents (Rattus norvegicus) was 23 cycles, which is 
approximately equivalent to 10
4
 GE of L. interrogans per reaction (Table ‎4.9). This 
estimate of bacterial load corresponds with figures for Leptospira infection reported in the 
literature. In a study of black rats in Mayotte, the mean infection load in rodent kidneys has 
reported as 3.9 x 10
4 
leptospires per mg of kidney tissue (Desvars et al., 2013b). In this 
experimental set up, this leptospiral load is equivalent to 2.2 x 10
2
 GE per qPCR reaction 
and is predicted to result in a Ct value of 29.5 based on the final multivariable linear 
model. Based on the validation study of Dutch rodents and the literature on leptospiral 
load, the sensitivity range of the lipL32 appears to be appropriate for detecting Leptospira 
infection in naturally infected rodent populations. 
For the purpose of GE calculations in this study, Leptospira organisms were considered to 
contain a single copy of each of the target genes. However, some sources suggest that a 
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single leptospire may contain up to five copies of the lipL32 gene based on observations 
from other spirochaetes (e.g. Borrelia) when actively replicating during in vitro 
propagation for example (Bourhy et al., 2011), and that two copies of the rrs gene are 
present in some Leptospira species (Picardeau et al., 2008). An increased number of copies 
of the target gene per leptospire is one possible explanation for the observed difference in 
analytical sensitivity between the lipL32 and 16S (rrs) qPCR tests. More pathogen-specific 
data may become available on the number of copies of each of the target genes (or their 
homologs) as whole-genome sequencing data for Leptospira becomes available (Fouts et 
al., 2016, Xu et al., 2016).  
Inter-batch variability was observed in both assays, although the effect size was greater for 
the 16S (rrs) assay. Variation between batches is acknowledged as an unavoidable 
limitation of qPCR testing with particular consequences for studies attempting to quantify 
leptospiral load (Applied Biosystems, 2014, Desvars et al., 2013b). Universal fluctuations, 
which affect the precision of all replicates within a reaction run, results from temporal 
differences in fluorescence emission (often resolved by the addition of a passive reference 
such as ROX) or the effects of temperature and air dissolved in the samples, which tend to 
be standard within plates but can lead to variation between plates (Applied Biosystems, 
2014). Atypical optical fluctuations, such as optical warping or large air bubbles in 
samples, or errors in the reaction preparation e.g. pipetting or mixing errors, can also affect 
the results of single replicates and are harder to account for between plates. In this study, 
testing in triplicate across multiple plates reduces the influence of atypical fluctuations on 
the calculation of the analytical sensitivity of an assay.  
In the individual assay models, no difference in analytical sensitivity for the lipL32 assay 
was observed between L. interrogans and L. borgpetersenii indicating that the assay 
performance is equivalent for the two test serovars. In contrast, the Leptospira species was 
a statistically significant explanatory variable for Ct value for the 16S (rrs) assay, which 
was slightly more sensitive for L. interrogans than L. borgpetersenii (95% CI: -0.941 to -
1.26). Coupled with conclusions from the available literature on analytical specificity 
(summarised in Table ‎4.1), this data supports the conclusion that the lipL32 TaqMan® 
qPCR assay is a robust choice for the detection of pathogenic Leptospira species involved 
in human and animal infections.  
Evaluation of the analytical performance of the lipL32 assay in rodent samples found no 
evidence for PCR inhibition in rodent kidney DNA samples. The observed 100% LLOD 
was the same for all tested samples, although the assay appeared slightly more sensitive at 
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detecting Leptospira DNA diluted in rodent kidney DNA extracts than in the water control. 
The effect size, which ranged from 0.16 to 0.9 cycles, was largest in the most concentrated 
DNA samples (R0355: DNA concentration = 367 ng/μl; beta coefficient = -0.93; 95% CI -
0.55 to -1.30) but was of the same order of magnitude as the average effect of batch on the 
lipL32 assay validation study (Chapter ‎4.3.2; Table ‎4.6). High concentrations of DNA, 
along with a variety of other biological compounds are known to inhibit PCR reactions and 
reduce reaction efficiency (Burkardt, 2000). Kidney samples are particularly at risk of PCR 
inhibitors due to the high concentrations of urea that may be found in crudely processed 
samples (Schrader et al., 2012). Although this study used a small number of field samples 
to evaluate evidence for systemic inhibition, these results indicate that PCR inhibition is 
not a systemic problem within this testing pipeline. However steps to reduce the effect of 
qPCR inhibitors, such as diluting sample DNA prior to testing or the use of an internal 
control reaction (Schrader et al., 2012), should still be considered for future testing.  
Further evidence that the lipL32 qPCR assay is performing well in ‗real-world‘ samples 
comes from direct comparison of diagnostic test results for to a population of Dutch rats of 
known infection status to the secY SYBR® Green qPCR reference test. A high degree of 
agreement was observed between the test results. However, one sample tested positive by 
lipL32 testing in one out of two test replicates but failed to amplify in the secY assay. 
Assuming perfect diagnostic sensitivity and specificity for the secY assay, this observation 
could be interpreted as a false positive lipL32 result. An alternative explanation is that this 
is actually a false negative result for the secY assay. This interpretation is perhaps more 
likely given data on analytical sensitivity and specificity presented in other assay 
validation studies (Bourhy et al., 2011, Stoddard et al., 2009, Ahmed et al., 2009). More 
robust conclusions cannot be made without further analysis (e.g. repeat testing and/or 
sequencing of the product to check for reaction specificity), but this discrepancy does 
highlight the problem of selecting ‗gold standard‘ reference tests for Leptospira diagnostic 
assays (Limmathurotsakul et al., 2012). 
Overall, this chapter brings together a number of independent validation studies that 
explore the strengths and limitations of two Leptospira diagnostic qPCR assays. Each 
study component was designed and performed independently with the exception of the 
comparison of validation studies of the lipL32 TaqMan® qPCR assay and the 16S (rrs) 
TaqMan® qPCR described in sections ‎4.2.5 and ‎4.2.6, which were performed in parallel. 
Therefore, other direct comparisons between the different components of this chapter 
should be made with caution.  
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The studies were performed using the same stock control DNA (L. interrogans serovar 
Copenhagenii) over the period of approximately one year, over which time evidence of 
DNA degradation is apparent. An example of this can be seen by comparing the starting 
concentration of L. interrogans DNA for the ROX study (Table ‎4.3), which was performed 
in January 2015, with starting DNA concentration for the lipL32 and 16S (rrs) assay 
validation studies (Table ‎4.5), which were performed in February 2016. Prolonged storage 
or repeat freeze-thaw cycles may have contributed to the observed reduction in gDNA 
concentration between the tests, and concurrent loss of DNA integrity may also have 
affected the observed analytical sensitivity of each of the assays. Repeat testing with a new 
stock of control DNA could evaluate this possibility in the future. 
Efforts were made to minimise variation within each study component. However, during 
the laboratory set up of these studies, standardisation focused on the titration steps rather 
than the absolute DNA concentration or GE (e.g. difference in the starting concentrations 
of L. borgpetersenii and L. interrogans) used in each assay. This design limits direct 
comparison of the data presented in this chapter with other published validation studies, 
but does not limit the interpretation of data presented in this chapter or its relevance to the 
rest of this thesis.  
In conclusion: the primary goal of this chapter was to justify the selection of a qPCR assay 
for the detection of Leptospira infection in human and animal samples from Tanzania. The 
lipL32 assay consistently outperformed the 16S (rrs) assay and is therefore considered a 
robust choice for a primary diagnostic tool to meet the study objectives. The high 
analytical and diagnostic sensitivity demonstrated by the lipL32 assay is predicted to 
support more accurate measurement of infection prevalence in target populations, as well 
as offering a greater probability of detecting infection in patients with low leptospiral 
loads. The high degree of analytical specificity reported for this assay also supports this 
choice. The two other assays discussed - secY SYBR® Green qPCR assay and 16S (rrs) 
TaqMan® qPCR assay - were subsequently used as secondary, confirmatory tests to 
corroborate results in specific scenarios described later in this thesis (Chapter ‎5 and ‎7). 
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5 Leptospira infection in rodents in the Kilimanjaro 
Region  
 
5.1 Introduction  
Worldwide, rodents are considered to be ubiquitous hosts of Leptospira and the most 
important source of infection for people (Haake and Levett, 2015, Levett, 2001). The order 
Rodentia is extremely diverse (Wilson and Reeder, 2005) and Leptospira infection has 
been reported in a large number of different rodent species and on most continents of the 
world (reviewed in (Meerburg et al., 2009, Kosoy et al., 2015)). The tremendous variety of 
rodent hosts and settings in which these rodents are found makes it difficult to draw 
universal conclusions about the epidemiology of leptospirosis in rodent populations (Ellis, 
2015, Levett, 2001). However, for some commensal rodent species that live in close 
proximity to people, patterns of infection have been relatively well-characterised through 
more intensive laboratory or field studies. These species offer some important insights into 
the different patterns of Leptospira infection in the rodent host, which have implications 
for the maintenance and transmission of infection in different environmental settings.  
 
5.1.1 Patterns of Leptospira infection in rodents  
Rattus norvegicus (also known as the Norway or brown rat); Rattus rattus (also known as 
the black rat, ship rat or roof rat) and Mus musculus (also known as the house or laboratory 
mouse) are among the best studied and most widespread commensal rodent species. Since 
the first isolation of Leptospira from R. norvegicus and R. rattus in Japan 1915, these two 
Rattus species have been considered as the archetypal hosts of Leptospira (Adler, 2015, 
Ido et al., 1917). R. norvegicus is the main laboratory model for chronic Leptospira 
infection and infection has been shown to persist in the kidneys of these hosts for several 
months following infection (Bonilla-Santiago and Nally, 2011, Athanazio et al., 2008). 
Although no laboratory models have been reported for R. rattus, it is generally assumed 
that the dynamics and susceptibility to Leptospira infection are similar to those observed in 
R. norvegicus (Kosoy et al., 2015, Levett, 2001). However, marked variability in the 
outcome of Leptospira infection is reported in other laboratory rodent species. Some 
species, such as hamsters and guinea-pigs, are extremely sensitive to some infections and 
succumb to severe acute clinical disease that is usually fatal even with Leptospira serovars 
that are well tolerated by other rodent species (da Silva et al., 2010, Faine, 1994). Outside 
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the laboratory, there is virtually no information on clinical disease in rodent species in their 
natural habitat (Ellis, 2015) but the outcome of infection in rodents in a natural setting is 
likely to influence the ability of a particular rodent host species to maintain Leptospira 
infection for prolonged periods of time.  
 
5.1.2 Relationships between rodents and Leptospira serovars 
Another factor that determines the outcome of infection in rodent hosts is particular type of 
Leptospira involved. Some specific associations are described between common rodent 
hosts and particular Leptospira serovars. R. norvegicus appears particularly well-adapted 
carry L. interrogans serovar Copenhagenii and L. interrogans serovar Icterohaemorrhagiae 
(Levett, 2001, Bharti et al., 2003). Evidence for this association comes from laboratory 
models of infection and epidemiological data from infections in natural settings where 
extremely high loads of the pathogen appear to be tolerated and maintained (Costa et al., 
2015b, Bonilla-Santiago and Nally, 2011). A similar relationship is described between Mus 
musculus and L. borgpetersenii serovar Ballum (Adler and Faine, 1977, Matthias and 
Levett, 2002). In other species, less is known about associated Leptospira types although 
the recent application of molecular tools to investigate this question in field settings is also 
revealing trends of rodent host specificity for some Leptospira genotypes (Dietrich et al., 
2014). On the whole however, the factors that determine relationships between host 
species and Leptospira serovars are poorly understood and may be variable between 
populations and environmental settings (Bharti et al., 2003).  
 
5.1.3 Factors that influence rodent Leptospira infection prevalence 
A wide variety of risk factors for rodent Leptospira infection have been reported and 
prevalence in rodent populations appears to vary considerably between geographic 
locations. Spatial differences in infection prevalence have been reported on macro-
geographical scales, such as between countries in South-East Asia (Cosson et al., 2014), 
and on a much finer scale between city blocks or trapping grids in Vancouver and Nairobi 
for example(Halliday et al., 2013, Himsworth et al., 2013). Patterns of rodent infection 
have also been reported to vary by season and climate, with higher prevalence of rodent 
infection associated with increased rainfall at some sites (Munoz-Zanzi et al., 2014a, 
Theuerkauf et al., 2013). Fluctuations in rodent abundance are thought to influence the 
temporal dynamics of infection in a particular host (Holt et al., 2006). Infection prevalence 
also often varies by species at the same sites (e.g. between Mus musuculus and Rattus 
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rattus in Nairobi (Halliday et al., 2013) or between different Rattus species in Western 
Polynesia (Theuerkauf et al., 2013)). However a consistent relationship between 
prevalence and age and bodyweight in reported in Rattus species (Himsworth et al., 2013, 
Desvars et al., 2013b, Costa et al., 2014). Overall, risk factors for rodent infection appear 
to be complex and highly variable and site-specific investigations are warranted to identify 
locally important factors that may influence the prevalence and dynamics of infection at a 
particular site.  
 
5.1.4 Leptospira infection in rodents in Tanzania 
Substantial data exists to support the role of the rodents in the epidemiology of 
leptospirosis in Tanzania. Seroprevalence surveys of rodents indicate that rodent exposure 
to infection is common in southern and western Tanzania (Mgode et al., 2014, Assenga et 
al., 2015, Machang'u et al., 1997). Definitive evidence for rodents as hosts of Leptospira 
infection in Tanzania also exists. Four different Leptospira serovars have been isolated 
from the African giant pouched rat, Cricetomys gambianus, in the Morogoro Region in the 
central Tanzania (Mgode et al., 2015, Machang'u et al., 2004)(Table ‎5.1). C. gambianus is 
a widespread adaptable rodent species in Tanzania that lives in a diverse range of habitats 
from forests to farmland and rural villages (Kingdon, 1997). A captive population of this 
species has also been established in Tanzania, which has supported better characterisation 
of the pathogens associated with this rodent host (Machang'u et al., 2002, Machang'u et al., 
2004). In a natural setting, Leptospira infection has also been demonstrated in 
multimammate mice (Mastomys natalensis). This is another widespread indigenous rodent 
species that demonstrates dramatic population ‗outbreaks‘ associated with major crop and 
food losses for people in rural areas in Tanzania (Gratz and Arata, 1975, Leirs et al., 1996). 
Leptospira infection has been demonstrated in these species by PCR (6.3%; n = 18) and by 
culture (Table ‎5.1). Two Leptospira serovars have been isolated from this species, one of 
which is also associated with infection in C. gambianus.  
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Table  5.1: Previous reports of Leptospira isolated from rodents in Tanzania 
Serogroup Leptospira species Serovar Rodent species 
Australis L. interrogans Lora Mastomys natalensis 
(Multimammate mice) 
 (Mgode et al., 2015) 
Ballum L. borgpetersenii Kenya Cricetomys gambianus 
(African giant pouched rat) 
(Machang'u et al., 2004) 
Mastomys natalensis 
(Mgode et al., 2015) 
Canicola L. interrogans Canicola Cricetomys gambianus 
(Mgode et al., 2015) 
Ictero-
haemorrhagiae 
L. kirschneri Mwogolo Cricetomys gambianus  
(Mgode et al., 2015) 
L. kirschneri Sokoine Cricetomys gambianus  




Both C. gambianus and Mastomys natalensis are known to be present in the Kilimanjaro 
Region alongside a number of other rodent species. However, to date there are no studies 
that have investigated Leptospira infection in rodent hosts in this region despite a high 
incidence of human disease (Biggs et al., 2011, Biggs et al., 2013b, Crump et al., 2013). 
Understanding the epidemiology of Leptospira infection in rodents in this area may offer 
important insights into the sources of infection for people and be used to inform potential 
control strategies for human infection.  
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5.1.5 Study aims and objectives  
This study component aimed to explore the role of rodents in the epidemiology of 
leptospirosis in the Moshi Municipal and Moshi Rural Districts where the majority of 
human leptospirosis cases (described in more detail in Chapter ‎7) occur. This chapter 
describes a cross-sectional surveillance study of rodents establish to address the following 
research objectives:  
Objective 1: Determine the prevalence and patterns of Leptospira infection in rodents 
living in the peri-domestic environment in the Moshi Municipal and Moshi Rural Districts 
of northern Tanzania. 
Objective 2: Evaluate the potential role of rodents as a source of Leptospira infection for 
people. 
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5.2 Methods 
To explore Leptospira infection in rodents in the Kilimanjaro Region, a cross-sectional 
study of rodents was performed in randomly selected villages within the Moshi Municipal 
and Moshi Rural Districts. The majority of human leptospirosis cases identified by the 
hospital-based febrile disease surveillance, described in Chapter ‎3 and ‎7, originated from 
villages within these two districts. Rodent trapping was performed in eight-week blocks 
conducted in: 1) wet season of 2013 (8
th
 May to 27
th





 June 2014); and 3) dry season of 2014 (5
th
 August and 23
rd
 September 2014). 
Rodents were trapped in and around households in the study villages and kidney samples 
were collected for direct determination of Leptospira infection prevalence by qPCR. 
Questionnaires were also conducted in the study households to explore potential risk 
factors for rodent infection. Detailed methodology for this study is described below.  
 
5.2.1 Village sampling frame 
The geographical sampling frame was composed of villages within Moshi Municipal and 
Moshi Rural Districts from which people have sought health care at Kilimanjaro Christian 
Medical Centre (KCMC) or Mawenzi Regional Hospital (MRH) for febrile illness and 
been enrolled in the on-going fever surveillance studies between 1
st
 March 2012 and 28
th
 
February 2014 (Chapter ‎3). Village data were extracted from the Febrile Surveillance 
Clinical Review Form (CRF) database (curated by KCMC-Duke University Medical 
Center Research Collaboration) on 5
th
 April 2013 and 22
nd
 April 2014. Data were cleaned 
and de-duplicated, and village names were matched to those listed in the National Census 
of Tanzania, 2002 (Tanzania National Bureau of Statistics, 2002). Excel (Microsoft® 
Excel® for Mac 2011, Version 14.6.1) was used to randomly select 15 study villages 
without replacement. One additional village was selected by convenience as a pilot village 
for rodent trapping. Village sampling was performed in order of random selection. Where 
sampling access to a village was not possible, the next randomly selected village was taken 
as a replacement.  
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5.2.2 Subvillage selection 
Consent for study participation was obtained from the Village Chairperson of each study 
village, who also provided a list of subvillages (also known as Mtaa in urban areas; see 
Figure ‎3.2) within each village. A single subvillage was selected as the representative 
sampling location within each study village using random number allocation.  
 
5.2.3 Household selection 
Household selection was performed using a modification of the World Health 
Organization‘s (WHO) Expanded Program for Immunization (EPI) random walk method 
recommended for cluster surveys in geographic areas that lack a robust, data-based 
framework for household or population sampling (Milligan and Bennett, 2004, Bostoen 
and Chalabi, 2006). Recruitment was performed along two transects each of approximately 
500 metres in length on average. The administrative centre of the sub-village centre was 
defined as the starting point for each transect. The direction of the first sampling transect 
was determined at random by spinning a pen to select a compass bearing. In villages with 
nucleated structure (e.g. in urban areas), a second transect was established using the same 
central starting point as the first, but taking a compass bearing perpendicular (90°) to the 
first. In villages with a linear structure, for example in mountainous areas where 
settlements typically run along natural valleys and ridges, a second transect was 
established using the same central starting point but at a compass bearing of 180°C from 
the first transect. A GPS device (Garmin eTrex®10, Garmin Ltd., Olathe, Kansas, USA) 
was used to follow existing pathways and roads that best matched the selected compass 
bearing. The route of each transect was recorded using sketch mapping and GPS waypoint 
marking. The exact GPS co-ordinates for each recruited household were also recorded.  
Households
†
 were enrolled alternatively from either side of the path in a zigzag pattern. A 
minimum of ten metres was required between the compound borders of each study 
household. A total of ten households were recruited along each transect. Adaptations to 
standard methods were made where necessary based on village layout. For example: in one 
village, houses were arranged and numbered in a regular grid layout within a worker‘s 
‗camp‘ on a sugar cane plantation. At this site, households were selected through random 
number selection (without replacement) generated using Microsoft® Excel. In several 
                                                 
†
 A household is defined as a permanent structure where one or more inhabitants who share the same cooking 
facilities sleep over night for the purposes of this study. 
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villages, multi-household compounds were encountered, where up to ten or so households 
occupied a single compound. In these situations, only one household within the compound 
was selected for study participation. Manual random number generation was used to select 
a single household within the compound. Briefly, consecutive numbers were sequentially 
assigned to each household defined as a working in a clockwise direction from the 
compound entrance or gateway. Numbers were written on folded papers that were then 
mixed, with the number hidden from view. A local village representative (e.g. subvillage 
chairperson or Livestock Field Officer), who was blinded to the number allocation process, 
picked one paper and the household corresponding to the chosen number was selected for 
participation.  
 
5.2.4 Household recruitment 
The head of the household or other nominated adult household representative was 
informed of the study objectives and requirements and written consent for study 
participation was obtained (see Appendix 3 for copies of the study consent forms and 
participant information sheets). Where consent was refused or could not be obtained, the 
nearest consenting neighbour was recruited as a replacement. 
 
5.2.5 Household data collection  
Household questionnaires were performed to characterise study households and explore 
risk factors for rodent Leptospira infection. Questionnaires were also designed to 
complement questionnaires carried out in a parallel cross-sectional seroprevalence survey 
for bacterial zoonoses (brucellosis, leptospirosis and Q fever) in human and livestock 
populations within the Kilimanjaro Region (Chapter ‎3). 
Questionnaires included simple questions about household demography (e.g. household 
size, number of children), followed questions focusing on factors known to influence the 
presence of invasive rodents in a household (Gratz and Arata, 1975, Bonner et al., 2007) or 
general environmental risk factors for Leptospira transmission (Lau et al., 2010, Levett, 
2001, Sarkar et al., 2002). Risk factor question topics included the physical properties of 
the compound or household (e.g. building materials of house, presence of electricity and 
piped water and type of toilet system), environmental properties (e.g. distance to an open 
water source, flooding within the previous 12 months), household livestock ownership and 
agricultural characteristics (e.g. types and numbers of animals kept at the compound, types 
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of crops grown in the compound) and questions specifically relating to perceived rodent 
abundance (e.g. frequency of rodent sightings inside the house, food stores and animal 
housing, evidence of rodent damage to stored food, rodent control practices and perception 
of rodent abundance in different seasons of the year). Where rodent control was reported, 
the method and frequency of use was also recorded. Where possible, questions were also 
included to measure the internal validity of questioning.  
Household questionnaires were translated into Kiswahili by professional translators, and 
back translated by KA with assistance from native Kiswahili speakers. Informal piloting 
and training was performed with field staff. Questionnaires were then piloted under 
supervision at the pilot village. Where necessary, additional training was provided and 
minor amendments were made to the questionnaire. A full version of the final study 
questionnaire in English and Kiswahili can be found in Appendix 4. 
At study households, Tanzanian field assistants conducted questionnaires in Kiswahili. 
Direct observation was performed for quality control where possible. Household responses 
were recorded on paper questionnaires by study field assistants and independently 
reviewed for consistency (KA). Missed questions or ambiguities in responses were 
clarified at the household and validated by direct observation where possible. Data were 
entered manually into a Microsoft® Excel database for subsequent analysis. The study area 
(Moshi Municipal and Moshi Rural Districts) and locations for each patient was mapped 
using QGIS (Version 2.4.0-Chugiak, 2014).  
 
5.2.6 Rodent trapping  
A standard set of five rodent traps was placed within each of the study households. Where 
possible, traps were placed in standard locations including kitchens, food storage areas and 
animal housing areas. In some households trap placement was also adapted according to 
strong preferences of study participants. In the first year of trapping (2013), four large 
Sherman® traps (dimensions: 3 x 3.5 x 9 inches) and one small Sherman® trap 
(dimensions: 2 x 2.5 x 9 inches) were set (HB Sherman Traps, Tallahassee, USA) 
(Figure ‎5.1). Sherman traps were baited with a stiff mixture of peanut butter and oats and 
chopped carrots. Tomahawk traps were baited with a couple of pieces of locally available 
dried fish.  
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Figure  5.1: Examples of rodent traps used in Tanzania: a) two sizes of 
Sherman traps (note the small Sherman trap in the centre of the image; b) 
Tomahawk wire traps with a large Sherman for size comparison.  
 
A pilot study was carried out to determine the number of trap nights needed. Traps were 
set for three nights in the pilot village and four nights in the first study village, after which 
the number of nights spent in each village was extended due to concerns over the low trap 
success. For subsequent villages, the traps were set for an average of eight nights (range: 7-
10 nights) and checked every morning. Trap status for each individual trap was recorded 
as: i) open; ii) closed (empty); iii) closed (full); and iv) damaged, faulty or absent (i.e. 
missing, stolen or unable to check). Full traps were removed and replaced. Soiled or insect-
infested food was replaced. If non-target species were trapped (e.g. frogs, lizards, birds), 
traps were recorded as closed (empty) and the non-target species animal was released. In 
some villages, additional traps were also placed in non-study household sites at the request 
of local village officials and householders (e.g. maize milling sheds, bars). Rodents trapped 
in these traps were tested for Leptospira but were not included other analyses. At the end 
of each trapping period, study traps were removed and study participants were gifted a 
locally procured rodent snap trap as gesture of appreciation for taking part in the study. 
 
5.2.7 Calculating trap success as a proxy for rodent abundance 
Corrected trap success was calculated and used as an index of rodent abundance for each 
village (Table ‎5.2) (Cunningham and Moors, 1996, Nelson and Clark, 1973). Firstly, the 
number of traps nights per village was calculated as the total number of traps set 
A B 
  122 
multiplied by the number of nights spent at each location. Next, a correction factor was 
applied to account for three sources of ‗lost trap nights‘: 1) disturbed traps (i.e. closed/ 
empty traps); 2) full traps that were no longer available to trap more rodents; or 3) damage 
to the trap that prevented it from functioning normally. Lost trap nights was calculated by 
subtracting half a night from the total number of trap nights for each closed, damaged trap 
or lost traps assuming that in each case, the trap would have only been available to trap a 
rodent for half the night. Traps lost to follow up were also included in this correction for 
the first night, and then subtracted from total traps set for subsequent nights. Therefore, the 
corrected number of trap nights was calculated as the total number of trap nights minus 
the total number of trap nights lost in each location. Finally, adjusted trap success was 
calculated as an index of rodent abundance in each village by dividing total number of 
rodents caught by the total number of corrected trap nights and expressed as a percentage. 
 
Table  5.2: Summary of definitions used to calculate adjusted trap success as 
an index of rodent abundance for each village  
 Definition (Cunningham and Moors, 1996) 
Trap nights Traps (n) x Nights (n) 
Lost trap nights Closed (n) + damaged traps (n) / 2 
Corrected trap nights Traps nights – Lost trap nights 
Adjusted trap success Total rodents caught per session (n) / corrected trap nights  
n = number 
 
5.2.8 Rodent necropsy and sampling 
Traps containing rodents were removed to a central, well-ventilated processing point for 
euthanasia and tissue sampling. Euthanasia was performed following UK and international 
guidelines for humane euthanasia (Home Office, 2014, Leary et al., 2014). First, a cotton 
wool swab soaked in liquid halothane inhalant anaesthetic was placed inside a tough, 
Ziplok® bag, used as an anaesthetic chamber. Rodents were placed inside this chamber 
and monitored until deep anaesthesia was induced (judged by lack of response to external 
stimuli and a slow or agonal respiratory pattern). Euthanasia was performed by cervical 
dislocation, followed by immediate blood sampling by cardiocentesis.  
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Body weight, body length, tail length, foot and ear lengths, presence of wounds and 
presence of ectoparasites were recorded for each individual. Phenotypic characteristics and 
morphometric measurements including body length, tail length, foot and ear lengths were 
used to determine the rodent species by comparison with published data (The Field 
Museum, 2011, Cunningham and Moors, 1996). An identifying photograph of each 
individual was also taken for species validation.  
Rodent gender and age class (mature or immature) was determined using external sexual 
features using the following definitions (Cunningham and Moors, 1996): 
Immature female A sheet of translucent skin covers the vagina. 
Immature male Testes are not fully descended into the scrotum. 
Mature female The vagina is open (no sheet of skin). Nipples may be prominent. 
Mature male The testes are descended into the scrotum fully, which hides the 
anus. 
 
Full necropsy and comprehensive tissue sampling was then performed. When observed, 
external parasites were collected and stored in 70-96% ethanol. Pregnancy status of female 
animals was recorded during necropsy. For diagnosis of Leptospira infection by qPCR, 
one kidney from each rodent was collected and preserved in 70-96% ethanol. In a subset of 
rodents (n = 100) a portion of kidney tissue was use to inoculate EMJH-5FU culture media 
for Leptospira spp. culture (Chapter ‎3.8). Selection of individual rodents for Leptospira 
culture was largely governed by logistical constraints (i.e. availability of culture media and 
shipping constraints). When culture media was available, vials were inoculated for the first 
five individuals sampled each day and continued on consecutive trapping days until a 
maximum of 50 rodents had been sampled each year. Following inoculation samples were 
shipped to the WHO/FAO/OIE Collaborating Leptospirosis Reference Laboratory, Royal 
Tropical Institute, Amsterdam (KIT) for propagation, isolation and typing of positive 
samples.  
 
5.2.9 DNA extraction from rodent kidney tissues  
DNA was extracted from ethanol-fixed kidneys as described in Chapter ‎3.6.2 and 
quantified using a NanoDrop spectrophotometer (ThermoScientific, Waltham, MA). Prior 
to qPCR testing, total genomic DNA (gDNA) was diluted 1:10 in PCR-grade water (or 1:5 
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in samples with a final DNA concentration < 100ng/μl) to mitigate the effect any residual 
qPCR inhibitors.  
 
5.2.10  lipL32 TaqMan® qPCR assay for Leptospira infection 
Samples were run on MicroAmp® 96 well plates and tested in duplicate with the lipL32 
assay as described in Chapter 3.6.2 (Stoddard, 2013, Stoddard et al., 2009). The final test 
concentration of gDNA ranged from approximately 50ng to 150ng per 25μl qPCR 
reaction. Each plate included: two replicates of a Leptospira positive control; L. 
interrogans serovar Copenhagenii Strain Wijnberg at ~10
2
 genome copies numbers; two 
replicates of a non-template extraction control, and two replicates of a negative control 
(PCR-grade water). Each reaction run was considered valid when both negative controls 
were negative and at least one replicate of the Leptospira positive controls amplified with 
Ct value < 40. Samples were considered positive when at least one test well amplified the 
lipL32 target with a Ct value < 40. 
 
5.2.11 secY SYBR® Green qPCR assay for Leptospira infection 
For validation of test results, a randomly selected subset of 60 samples (30 per sampling 
year) were sent for confirmatory testing using the secY SYBR® Green qPCR assay at KIT 
(Ahmed Ahmed). Samples were tested in triplicate as described in Chapter 3.6.2. Samples 
were considered positive when at least two test wells amplified the secY target with a Ct 
value < 35 and a melt temperature (Tm) within the specific Leptospira reference range of 
79 to 84°C. 
 
5.2.12 Statistical analysis 
To allow an expected prevalence of infection of 10% to be estimated with a confidence 
level of 0.95 and a precision level of 0.95, the target sample size was calculated as 139 
rodents per trapping season (Sergeant, 2016). 
Statistical analysis was performed in R (R Core Team, 2015). Two-sample and paired t-
tests were run to compare adjusted trap success between seasons and district types (urban 
vs. rural). Binomial confidence intervals were calculated for prevalence estimates. Pie 
charts and bar plots were plotted in R.  
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5.3 Results 
5.3.1 Village and household recruitment 
Rodent trapping was performed in a total of 11 randomly selected villages and one pilot 
village shown in Figure ‎5.2. One village (Village F) were sampled in both wet and dry 
seasons of 2014. In total, six study villages and pilot villages were located in the Moshi 
Rural District and five villages were located in wards in the Moshi Municipal District. 
 
 
Figure  5.2: Map of rodent study villages labelled according to study ID 
(Table  5.3) and location of villages with human leptospirosis cases from 
febrile disease surveillance study (Figure  7.4) 
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In total, 230 households were recruited into the study. Study retention was high. Over both 
years, only four households (1.7%, n = 230) withdrew from participation following the 
start of the study and were subsequently replaced with neighbouring households. Illness in 
the family or travel was cited as the reason for withdrawal. 
 
5.3.2 Characterisation of the study villages by questionnaire  
Questionnaire data were available for analysis for 227 of 230 study households. Responses 
were used to provide summary information about each village (Table ‎5.3). Study villages 
covered a range of environments (rural and urban) and altitudes (748 to 1307 metres above 
sea-level). The population density for study villages, calculated at ward level by the 
Tanzanian 2012 Census ranged from 80 to 14,961 people per km
2
 with the highest 
densities observed in urban settings. Household population size ranged from 3.8 people per 
household in the Village G up to 13.4 people in Village F (national average = 4.8 people 
per household; (Tanzania National Bureau of Statistics, 2012)).  
Infrastructure and housing quality also varied by village. The proportion of households 
with grid electricity provision ranged from 10% to 80%. In all villages, up to 50% of 
houses were made out of mud and manure as opposed to bricks or cement, which was the 
other common building material. Pit latrines were common in all but one village. In this 
village (Village E), all questionnaire respondents had access to a communal block of squat 
toilets provided by the owners of the sugar cane plantation where this village was located.  
Overall, the majority of respondents cultivated some kind of crop at the household. 
Ruminant livestock ownership was significantly lower in urban areas compared to rural 
areas (χ2= 31.5, p < 0.001). Pigs were also kept at small number of households from 
villages in both urban and rural districts. 
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Table  5.3: Village characteristics and summary of questionnaire data  
















Longuo Kimochi Karanga 
District 
type 




1307 883 798 890 748 796 1263 792 967
i
 940 1051 898 
Ward pop.  
Density 
(people/km2) 




(n = HH) 





51.0 16.0 14.5 19.0 10.0 32.0 41.0 34.0 32.5 25.0 44.0 10.0 
Average 
size of HH 




30.0 0 5.0 0 0 30.0 
45.0  
(n = 19) 
40.0 11.1 5.0 25.0 5.0 
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% HH with 
electricity 20.0 30.0 65.0 78.9 20.0 60.0 45.0 10.0 61.1 80.0 50.0 60.0 
% HH with 
pit latrine 80.0 75.0 
47.4 
 (n = 19) 
82.4 
(n = 18) 
0 55.0 75.0 70.0 77.8 60.0 100.0 60.0 
% HH with 
flooding in 
last year  
0 20.0 35.0 21.1 0 10.0 0 30.0 22.2 10.0 
0 
(n = 19) 
10.0 
% HH with 
crops  NA NA 65.0 100 65.0 45.0 100 100 100 60.0 100 80.0 
Cattle per 
HH
d 0.4 0.6 0 0.1 0.1 0 0.25 0.3 0.25 0 0.9 0.1 
Goat/Sheep 
per HH
d 1.8 4.6 1.0 0.9 2.2 0 2.0 2.0 3.5 0.3 3.8 0.75 
Pigs per 
HH
d 3.5 0.2 0 0.5 0 0 0.6 0 0.22 0 1.25 0.65 
Dogs/cats 
per HH
d 0.2 1.9 0.5 1.1 0.1 0.5 0.5 0.8 0.4 0.7 0.6 0.3 
a
Elevation of subvillage taken from altitude of transect starting point; 
b
Number of households with complete  responses i.e. the denominator for 
subsequent calculations unless otherwise indicated; 
d
Mean number of animals per household (HH) by village. 
  129 
 
5.3.3 Rodent sightings, control and perceptions of abundance 
Rodent sightings were commonly reported by study respondents. In total, 111 (48.9%) of 
227 respondents reported seeing rodents or evidence of rodents in their house every day in 
the month prior to the sampling visit. A further 41 (18.1%) respondents reported seeing 
rodents or evidence of rodents in their house less than every day but more than once a 
week. Of 179 respondents with fields around their households, 61 (34.1%) reported seeing 
rodents or evidence of rodents in those fields more than once per week. 
The majority of respondents (89.9%) used some form of rodent control in their household. 
Chemical control (zinc phosphide poison) was the most frequently reported method of 
controlling rodents used in 86.6% of households. Domestic carnivores (cats or dogs) were 
also used as a means of rodent control in 30.8% of households.  
Questionnaire respondents reported that the dry season was the peak season for rodent 
abundance. The short rains were considered the season with the fewest rodents although 
many respondents also were unsure of rodent abundance at that time of year (Table ‎5.4). 
 
Table  5.4: Perception of rodent abundance by season (all villages; n = 227 
respondents) 
  Many Few None Don’t know NA 
Long Rains 88 109 4 23 3 
Short Rains 26 144 15 39 3 
Dry season 170 34 1 20 2 
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5.3.4 Rodent trapping results and trap success 
A summary of trapping effort and trap success by village is shown in Table ‎5.5. In total, 
384 (98.2%) of rodents were trapped in randomly selected houses over 9427 trap nights 
(8730 after adjustment for lost nights), with an overall adjusted trap success of 4.40% 
(binomial confidence interval: 3.99 – 4.85%).  By village, adjusted trap success ranged 
from 1.94% to 10.4%. Rodents were trapped in 60% of study households, with averaging 
at 1.54 rodents per household. An additional seven rodents were trapped through targeted 
trap placement in extra houses at the request of local villagers. 
No significant difference was observed between adjusted trap success (two-sample t-test: p 
= 0.716) or the number of households with rodents (two-sample t-test: p = 0.124) between 
urban and rural villages. In general, no significant difference was observed in adjusted trap 
success between wet and dry seasons (two sample t-test; p = 0.282). However, in Village F 
where the same households were visited in both the wet (F) and dry (N(F)) season of 2014, 
the adjusted trap success was significantly higher in the wet season than the dry season 
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8 8 8 8 8 8 8 8 96 
Trap 
nights (n)  150 350
iv 




143 304 650 932 738 731 773 748 742 722 751 751 747 8730 
Rodents 
trapped (n) 14 13 31 25 39 76 15 35 20 23 22 38 33 384 
Adjusted 
trap 
success (%)  
9.79 4.28 4.77 2.68 5.28 10.4 1.94 4.68 2.70 3.19 2.93 5.06 4.42 4.40 
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% HH with 
rodents  60.0 45.0 60.0 50.0 50.0 90.0 40.0 60.0 65.0 0.55 60.0 65.0 80.0 60.0 
Rodents 
per HH
v 1.40 0.65 1.55 1.25 1.95 3.80 0.75 1.75 1.00 1.15 1.10 1.90 1.65 1.54 
Extra 
rodents
 - - - - - - - 1 - 2 1 3 - 7 




14 13 29 25 39 75 15 36 19 25 22 41 32 385 
N tested by 
culture
 0 0 13 22 15 0 0 0 0 0 0 25 25 100 
i
Village N(F) is the same village as F but trapped in the dry season; 
ii 
Traps removed for three nights over the weekend hence trap nights were broken up into two consecutive trapping periods of three and four nights 
respectively;  
iii
Traps removed for three nights over the weekend hence trap nights were broken up into two consecutive trapping periods of four nights each;  
iv
In this village, only ten households were recruited for the first trap night;  
v
Mean number of animals per household (HH) by village 
Abbrev: HH = household, n = number 
 
 
       
 
5.3.5 Rodent species  
In total, the black rat (Rattus rattus) was the most common species trapped (326 (83.4%) 
of 391). Other species trapped included two mouse species: house mice (Mus musculus), (n 
= 44; 11.3%) and African pygmy mice (Mus minutoides) (n = 3; 0.77%); and a small 
number of other endemic rodents species including multimammate mice (Mastomys 
natalensis)(n = 8; 2.05%), spiny mice (Acomys sp.)(n = 7; 1.79%), the striped bush squirrel 
(Paraxerus flavovittis) (n = 3; 0.77%) (Figure ‎5.3). Rattus rattus was the most common 
species trapped in 11 (91.7%) of 12 study villages in both rural and urban locations. Mus 
musculus however was only trapped in two urban villages (Village C: n = 25 (80.6%) of 31 
rodents; and Village F: Wet season 7 (9.21%) of 76 rodents; Dry season (N(F)) 12 (36.4%) 
of 33 rodents).  
 
 
Figure  5.3: Pie chart of rodent species trapped (with sample sizes)  
  
Rattus rattus (n = 326)
Mus minutoides (n = 3)
Mus musculus (n = 44)
Mastomys natalensis (n = 8)
Acomys sp. (n = 7)
Paraxerus flavovittis (n = 3)
Pie chart of rodent species trapped
 (with sample sizes)
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5.3.6 Rodent gender and age class  
Overall, female rodents accounted for 57.4% (n = 391) of the trapped population. The 
majority of animal trapped were sexually mature (58.9%) but the proportion varied by 
village (Figure ‎5.4). For the most common species: significantly more immature R. rattus 
were trapped in during wet season sampling than in the dry season (χ2 = 20.5, p < 0.001). 
For Mus musculus, no difference was observed between seasons (χ2; p = 0.696). Pregnancy 
data collection was incomplete and could not be analysed.  
 
Figure  5.4: Age class of trapped rodents (all species) by study village and 
season 
 
5.3.7 Leptospira culture results 
Culture media was inoculated from 100 rodents between 2013 and 2014 (Table ‎5.5). 
Kidney sampled for culture were taken from R. rattus (n = 76), M. musculus (n = 18), 
Mastomys natalensis (n = 4), M minutoides (n = 1) and Mastomys natalensis (n = 1). 
Leptospira organisms were not isolated from any sample (Table ‎5.6).  
 


























Wet season 2013 Dry season 2014 Wet season 2014 
Pilot 
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5.3.8 Results from lipL32 TaqMan® qPCR testing for Leptospira infection 
Six rodent kidney samples (three R. rattus and three M. musculus) were excluded from 
qPCR testing due to DNA extraction failure, indicated by a final DNA concentration < 10 
ng/μl. In total, 0 of 385 rodent kidney samples tested by lipL32 qPCR TaqMan® assay 
were positive for Leptospira infection (Table ‎5.6).  
 
Table  5.6: Results for Leptospira testing on rodent kidneys (qPCR and 
culture) 
Leptospira diagnostic test Number of rodents 







lipL32 TaqMan® qPCR  385 0 0% 
(0.00 - 0.01%) 
Leptospira culture (EMJH-
5FU) 
100 0 0% 
0.00 – 0.04% 
secY SYBR® Green qPCR  60 0 0% 
0.00 – 0.06% 
 
5.3.9 Results from secY SYBR® Green qPCR testing for Leptospira 
infection 
The secY SYBR® Green qPCR assay (KIT) was run as a confirmatory test on DNA 
extracts from a randomly selected subset of rodent kidneys. In total, 0 of 60 rodent kidney 
samples tested by secY SYBR® Green qPCR were positive for Leptospira infection 
(Table ‎5.6).  
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5.4 Discussion 
The goal of this study component was to explore the patterns of Leptospira infection in 
rodents that live in close proximity with people in two districts of northern Tanzania where 
the incidence of human leptospirosis is high. Contrary to expectations, all rodents trapped 
and tested in this study (n = 385) were negative for Leptospira infection (Table ‎5.6). This 
was a surprising finding but is believed to be a true reflection of the infection status of 
commensal rodents living in this area. Considerable efforts were made in the design of this 
study to ensure that a representative sample of rodents was trapped and tested in this study. 
Sampling was performed over two years (and two seasons in 2014) to account for any 
short-term fluctuations in rodent infection prevalence and 12 different sites. Sites were 
randomly selected (with the exception of the pilot village) and covered a variety of 
environments from densely populated urban areas to mountainous rural villages 
(Table ‎5.3). A variety of trap types and sizes were used to ensure representative sampling 
of different ages, sizes and species of rodent, which are all factors known to influence the 
prevalence of infection in other settings (Desvars et al., 2013b, Halliday et al., 2013, Costa 
et al., 2015b). Therefore the animals trapped in this study are believed to be a reliable 
representation of rodents living in the peri-domestic environments in this geographical 
area.  
Substantial work went into the selection appropriate diagnostic tests and to validate test 
results in this study. Two complementary testing approaches (lipL32 qPCR and culture) 
were used to diagnose Leptospira infection in kidney samples. The lipL32 qPCR assay was 
selected based on evidence of high analytical sensitivity (Chapter ‎4.3.2) and excellent 
specificity for pathogenic Leptospira species (Stoddard et al., 2009, Bourhy et al., 2011), 
as well as extensive field validation in studies of Leptospira infection in rodents in other 
settings (Himsworth et al., 2013, Cosson et al., 2014, Desvars et al., 2013c, Munoz-Zanzi 
et al., 2014a). Furthermore, the validity of the entire qPCR testing pipeline from sample 
preservation through DNA extraction to qPCR was demonstrated by: i) the high level of 
agreement in test results between the lipL32 and secY qPCR assays in a batch of Dutch 
rodent samples of known infection status (Chapter ‎4.2.8) and in a randomly selected subset 
of the Tanzanian rodent samples (Chapter ‎5.3.9); ii) the utility of the same testing pipeline 
in demonstrating Leptospira infection in livestock samples (Chapter ‎6.2.6); and iii) the 
consistency between qPCR and culture results for a subset of 100 rodents (n = 391).  
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All final DNA elutions were diluted in PCR-grade water (1:10 dilution) prior to testing to 
mitigate the risk of qPCR inhibition in these samples. PCR inhibition, which can reduce 
the diagnostic sensitivity of a test in clinical samples, is a particular risk in kidney samples 
because of high concentrations of urea in the unprocessed tissue (Schrader et al., 2012). 
Systematic evaluation for qPCR inhibition was not carried out in this study although no 
evidence could be detected during a small scale validation study (Chapter ‎4.2.7) or when 
testing other batches of samples (e.g. the Dutch rodent kidney samples used to validate the 
lipL32 qPCR assay against the secY qPCR assay (Chapter ‎4.2.8) and the lipL32 qPCR 
testing of livestock samples (Chapter ‎6.2.6)). Overall, the final sample size of rodents 
tested by qPCR was considered sufficient at the 95% confidence level to demonstrate 
freedom from disease in this population even allowing for a low prevalence of infection 
(1.0%) and an imperfect test (80% sensitivity) (Sample size for freedom testing with 
imperfect tests: n = 368; population sensitivity 0.95 (Sergeant, 2016, Cameron and 
Baldock, 1998)). 
As no obvious study design or diagnostic testing limitations could be identified in the study 
to account for the absence of Leptospira infection in this rodent population, the results of 
this cross-sectional rodent study are considered to be a robust representation of the 
infection status of the rodent population at the time of sampling. Therefore on the basis of 
these study results, we can conclude that the peri-domestic rodent population was not a 
source of Leptospira infection for people living in the Moshi study area over the period of 
this study. This conclusion raises some intriguing questions about patterns and drivers of 
Leptospira infection in rodent populations in northern Tanzania. It is important to note that 
the vast majority of rodents trapped in this study have been shown to be susceptible hosts 
of infection in other nearby settings (e.g. R. rattus and M. musculus in Nairobi (Halliday et 
al., 2013), Mastomys natalensis in Morogoro (Mgode et al., 2015, Mgode et al., 2005)). 
Furthermore, this is not an isolated population of rodents that may have been protected 
from the introduction of infection by some kind of geographical barrier. Moshi is located 
on the major highway connecting the cities of Nairobi (where rodent Leptospira infection 
has been demonstrated (Halliday et al., 2013)) and Dar es Salaam, a major sea-port. 
Commensal rodents are known to exploit human transport networks to disperse and invade 
new areas (Brouat et al., 2014, Aplin et al., 2011). Therefore geographic isolation does not 
seem like a feasible explanation for the lack of Leptospira infection in the Moshi rodents.  
However, geographic and environmental factors may play a role in the absence of 
detectable infection at this site. Fine-scale and regional variation in Leptospira prevalence 
is reported in studies around the world (Cosson et al., 2014, Himsworth et al., 2013). In the 
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African region, marked variation in Leptospira infection prevalence was reported between 
the same rodent species sampled in different study sites in Madagascar (Rahelinirina et al., 
2010) and a study in Niger demonstrated Leptospira infection in rodents from irrigated 
agricultural areas but not in rodents living in densely population urban areas (Dobigny et 
al., 2015). The specific environmental factors that influence rodent Leptospira infection are 
not well understand and are likely to vary in different geographic regions and with 
different host and Leptospira species. In the future, multi-site studies in Tanzania could 
offer insights into whether the patterns of infection detected in this study are a widespread 
phenomenon or the consequence of some as yet unidentified site-specific factors.  
A variety of host population factors may influence the ability of a rodent population to 
maintain Leptospira infection in a particular setting. The presence of susceptible rodent 
species within a community is important, and these species must be present in sufficient 
abundance or density for the pathogen to be maintained within the population. In the 
disease ecology literature, this concept is referred to as the critical community size, defined 
as size of a host population below which a disease cannot persist in the long term (Lloyd-
Smith et al., 2005, Haydon et al., 2002). In general, fluctuations in the abundance of rodent 
hosts are thought to influence the dynamics of Leptospira infection in rodent communities 
(Holt et al., 2006, Davis and Calvet, 2005). Factors relating to the abundance of susceptible 
hosts are one possible explanation for the absence of Leptospira infection in peri-domestic 
rodents in Moshi in the trapping seasons of 2013-14. However, whilst factors relating to 
host abundance could be plausible for the less commonly trapped species in this study (e.g. 
Mastomys natalensis (Figure ‎5.3)), this seems improbable for R. rattus, which was trapped 
in large numbers in some villages and houses. Up to 21 R. rattus individuals were caught 
in a single house of an eight-day trapping period in one village (village F). Leptospira 
infection has also been demonstrated in similarly-abundant R. rattus populations in other 
settings (Munoz-Zanzi et al., 2014a). Therefore, if infection was absent from an apparently 
abundant population of hosts, it seems plausible that this host species (R. rattus) is in fact 
not well-adapted to maintaining the specific types of Leptospira circulating in Moshi, and 
hence is not a maintenance host in this setting. 
With regards to the composition of the rodent host community in Moshi, it was notable that 
Rattus norvegicus was absent from this site. R. norvegicus is well-described as a 
maintenance host of Leptospira both in natural settings and in the laboratory 
(Chapter ‎5.1.1). R. rattus is generally assumed to fill the same ecological niche as R. 
norvegicus in the maintenance of the common rat-associated leptospires but to date, there 
is little to no experimental evidence to support this assumption. In natural settings, studies 
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of R. norvegicus appear well-adapted to maintain infection with common rodent-associated 
serovars in the absence of other hosts (e.g. (Costa et al., 2014, Himsworth et al., 2013). 
However, in other sites in Africa, Leptospira infection has also been demonstrated as 
absent from an abundant population of R. rattus where no R. norvegicus was trapped 
(Dobigny et al., 2015). In contrast, where Leptospira has been demonstrated in R. rattus in 
the East African region, infected R. norvegicus individuals have also been identified in 
living in the same environment (e.g. Kenya (Halliday et al., 2013) and Madagascar 
(Rahelinirina et al., 2010)). It is difficult to know how representative the available 
literature is as negative results often go unpublished and representative trapping of all 
rodent species in a particular environment may not be performed. However, it is possible 
that R. rattus has a very different role in the maintenance of Leptospira infection that its 
better studied cousin, R. norvegicus. Although this hypothesis remains largely speculative 
at present, sub-Saharan Africa may offer a unique opportunity to better characterise the 
true role of R. rattus in the maintenance of Leptospira infection as this area still remains a 
stronghold of R. rattus, with R. norvegicus incursions currently limited to the coast or 
major cities (Aplin et al., 2011, Brouat et al., 2014, The Field Museum, 2011).  
As well as posing some fascinating questions about the factors that support Leptospira 
maintenance in a commensal rodent population, the findings of this study also have some 
important implications for our understanding of the sources of infection for people. 
Although rodents are often assumed to be the source of infection for people (Haake and 
Levett, 2015), the lack of infection in rodents living in close proximity to people in Moshi 
implies that other animal hosts are more important in the epidemiology of leptospirosis this 
setting. Investigations into the other potential hosts of Leptospira infection are 
recommended to further explore the epidemiology of leptospirosis in northern Tanzania 
and identify potential sources of infection for people. One such investigation, into the 
epidemiology of leptospirosis in ruminant livestock species in northern Tanzania is 
described in the next chapter of this thesis (Chapter ‎6).   
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6 Leptospira infection in ruminant livestock in the 
Kilimanjaro Region  
6.1 Introduction  
Ruminant livestock species are important hosts in the epidemiology of Leptospira 
infection. All major ruminant livestock species are susceptible, and once infected may shed 
leptospires in their urine for several years following infection (Ellis, 2015). Infected 
livestock therefore may pose a considerable zoonotic disease risk for people who live and 
work in close proximity with these animals (Haake and Levett, 2015, Mwachui et al., 
2015). Cattle are the best known ruminant livestock host of Leptospira, but infection is 
also reported in sheep, goats (Martins and Lilenbaum, 2014), water buffalo (Marianelli et 
al., 2007), camelids (Ellis, 2015) and even deer where they are farmed commercially 
(Ayanegui-Alcerreca et al., 2007, Desvars et al., 2013c). Leptospira infection also has 
detrimental effects on the health of livestock and can lead to production losses resulting 
from reproductive failure, for example abortions or infertility, or reduced milk yield (Ellis, 
1994, Ellis, 2015). As a consequence, livestock leptospirosis results in financial losses for 
livestock keepers. Although these economic impacts of infection have not yet been 
systematically quantified, in a low-income setting such as Tanzania where livestock plays 
an important role in food security, household income and the national economy (Food and 
Agriculture Organization of the United Nations, 2005), livestock leptospirosis has the 
potential to be a pervasive threat to both human and animal wellbeing. 
 
6.1.1 The epidemiology of Leptospira infection in ruminant livestock  
The epidemiology of Leptospira infection in ruminant livestock is classically described in 
two broad patterns, reviewed in more detail in the general introduction of this thesis 
(Chapter ‎1.5). A livestock host may become infected with a particular Leptospira serovar 
that is typically maintained within the population of that particular livestock species 
(Blackmore and Hathaway, 1979). Alternatively, an animal may become ‗accidentally‘ 
infected with a Leptospira serovar that spills over from another, conspecific animal 
population, for example a wildlife host of infection (Lilenbaum and Martins, 2014). Direct 
transmission through urinary contact or indirect transmission through contact with a 
contaminated environmental reservoir may occur in either epidemiological scenario. 
However, sexual transmission is also implicated in infection maintenance in livestock 
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populations as leptospires frequently colonise the genital tract of infected hosts belonging 
to several major ruminant livestock species (Lilenbaum et al., 2008, Ellis, 1994).  
Clinical disease may occur in ruminant livestock following Leptospira infection. Acute 
systemic illness is relatively rare but can present in the initial leptospiraemic phase of 
infection resulting in pyrexia, anaemia, jaundice and can be fatal in young animals (Ellis, 
2015). In dairy cattle, an acute drop in milk production is also reported in the early stage of 
infection (Dhaliwal et al., 1996a). In the second phase of infection, leptospires colonise the 
kidney of infected hosts and are shed in the urine. The bacteria may also localise to the 
uterus of pregnant females leading to vertical transmission of infection, abortion of 
infected foetuses or poor neonatal viability (Ellis et al., 1986, Ellis, 1994, Cortizo et al., 
2015). Chronic infection is typically subclinical although fertility may be persistently 
suppressed and infected animals may continue to shed Leptospira for years following the 
initial infection (Leonard et al., 1992).  
A wide variety of Leptospira serovars and serogroups have been reported in ruminant 
livestock. However, a particularly close relationship is reported between certain livestock 
species and specific Leptospira serovars (Bharti et al., 2003). The main example is the 
relationship between cattle and the Hardjo serovars. Bovine infection is frequently 
associated with one of the two Hardjo serovars, either L. borgpetersenii serovar Hardjo 
(Hardjobovis) or L. interrogans serovar Hardjo (Hardjoprajitno) (Ellis, 2015). Cattle 
appear to be well adapted to sustaining prolonged infections with these serovars (Leonard 
et al., 1992), which they are able to maintain independently of environmental factors or the 
presence other animal hosts (Ellis, 1984). Bovine Hardjo infection has been reported in 
most continents including Europe (Dhaliwal et al., 1996a, van Schaik et al., 2002), North 
and South America (Van De Weyer et al., 2011, Salgado et al., 2014), Australasia (Fang et 
al., 2014a, Elder and Ward, 1978), Asia (Odontsetseg et al., 2005, Bahaman et al., 1988) 
and Africa (Feresu et al., 1999b, Te Brugge and Dreyer, 1985). Sheep have also been 
shown to maintain L. borgpetersenii serovar Hardjo in isolation from cattle, and thus are 
also implicated as adapted maintenance hosts of this particular serovar in some settings 
(Arent et al., 2013, Vallee et al., 2015, Cousins et al., 1989). Other serovar associations 
have been reported, (e.g. cattle infections with L. interrogans serovar Kennewicki) but 
these relationships are less well-characterised and more geographically variable than the 
Hardjo-cattle association (Ellis, 2015, Lilenbaum and Martins, 2014).  
  
  142 
 
6.1.2 Risk factors for livestock Leptospira infection 
Environmental and farm management aspects are known to be risk factors for livestock 
Leptospira infection. Environmental factors such as the presence of other infected animal 
hosts, warm wet conditions that promote the ex vivo survival of Leptospira and heavy 
seasonal rainfall leading to standing water and flooding are risk factors for Leptospira 
infection that apply equally to any animal species including people (Lau et al., 2010, 
Mwachui et al., 2015, Ellis, 1984). However, specific farm management factors are also 
important for livestock infection. Firstly, biosecurity is important as infection may be 
introduced into a herd when infected animals are bought as replacement stock (Williams 
and Winden, 2014). Herd size and mixed management and grazing of multiple livestock 
species have also been shown to be risk factors for infection (Oliveira et al., 2010, 
Lilenbaum and Souza, 2003, Ryan et al., 2012, Subharat et al., 2012). In addition, certain 
strategies for reproductive management such as the use of natural service may predispose 
to infection due to the localisation of leptospires to the genital tract in the major livestock 
species, (Ellis, 2015, Lilenbaum et al., 2008). In tropical areas of the world where many 
livestock management risk factors and environmental risk factors for livestock 
leptospirosis coincide, a large proportion of the cattle population may be at risk of 
infection (Ellis, 1984).  
 
6.1.3 Livestock leptospirosis in Africa 
Although surveillance is somewhat fragmented in Africa, livestock leptospirosis appears to 
be prevalent in many parts of the continent. Serological surveys in sub-Saharan Africa 
have demonstrated that Leptospira exposure is widespread in cattle in the region (de Vries 
et al., 2014). In the systematic review described in Chapter ‎2, cattle were the most 
commonly reported animal host species of Leptospira infection in Africa and were 
associated with a wide range of serovars and serogroups (Table ‎2.4). In small ruminants 
reports of infection are fewer but serological exposure has been identified in both sheep 
and goats in sub-Saharan Africa (de Vries et al., 2014), and infection was demonstrated by 
PCR in sheep in Morocco (Benkirane et al., 2014) and goats on the island of Mayotte 
(Desvars et al., 2013c). Therefore all three of these major ruminant production animal 
species may play a role in the epidemiology of leptospirosis in Africa.  
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6.1.4 Leptospirosis in Tanzanian livestock 
In Tanzania, both serological and microbiological evidence exists for Leptospira infection 
in cattle. In the Morogoro Region of central Tanzania, two serovars – L. kirschneri serovar 
Sokoine (serogroup Icterohaemorrhagiae) and L. kirschneri serovar Grippotyphosa 
(serogroup Grippotyphosa) – were isolated from the urine of cattle sampled in the abattoir 
(Mgode et al., 2015, Mgode et al., 2006). In addition, seroprevalence surveys performed 
across the country have demonstrated widespread seroreactivity in cattle (Table ‎6.1). All 
studies used the microscopic agglutination test (MAT) for serological diagnosis of 
Leptospira exposure. In general, heterogeneity in MAT test serovars and serogroups 
limited the scope for comparisons between regions and studies. However, serogroup Sejroe 
was used in all studies and this serogroup was demonstrated as the most common reactive 
serogroup in nearly all the seroprevalence studies of cattle conducted in Tanzania 
(Karimuribo et al., 2008, Swai and Schoonman, 2012, Assenga et al., 2015, Schoonman 
and Swai, 2010, Machang'u et al., 1997).  
In goats, evidence of Leptospira exposure is limited to a single study in the Katavi Region, 
which tested cattle, goats and people from the same study households. Considerable 
seroreactivity was demonstrated in goats in this study with 17.7% of animals 
demonstrating reactivity to at least one of the six test serovars (Assenga et al., 2015). In 
goats, reactivity to Icterohaemorrhagiae using L. kirschneri serovar Sokoine, previously 
isolated from cattle in Tanzania, was most common, but reactivity to serogroup Sejroe was 
also reported (Table ‎7.1).  
As a group, data from these seroprevalence studies indicate that Leptospira exposure is 
common ruminant livestock across Tanzania. Demonstration of pathogenic leptospires in 
the urine of cattle in Morogoro indicates that this species has the potential to be source of 
human Leptospira infection in Tanzania, particularly for abattoir workers and other people 
coming into close contact with cattle. However, to date, there are no available data from 
livestock infection in the Kilimanjaro Region, where the burden of acute human 
leptospirosis is high.  
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Table  6.1: Predominant reactive serogroups from seroprevalence studies for ruminant livestock species (single MAT titre ≥ 1:160) 
 Goats Cattle 
Study region 
























et al., 2008) 
Tanga 
(n=230)  


















Serogroup: Australis 0.4% 0.82% - - - - - 
Ballum 0% 0% - - - - - 
Bataviae - - 3.9% 1.8% - 0.9% - 
Canicola 0% 0% - - 0% - - 
Grippotyphosa 1.6% 4.8% - - 2.5% 0.4% - 
Hebdomadis 0.8% 7.7% - - - - - 
Icterohaemorrhagiae 3.2% 4.7% - - 3.8% - - 
Pomona - - 0% 1.2% 2.5% 1.3% - 
Pyrogenes - - - - - - 1.9% (n=360) 
Sejroe 2.8% 17.6% 29.4% 15.0% 12.5% 3.5% 5.6% 
Tarassovi - - 17.6% 12.2% - 4.8% - 
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6.1.5 Goals and objectives of this chapter  
This study component aimed to explore patterns of Leptospira infection in cattle, sheep 
and goats, which are the three major ruminant livestock species kept for food production in 
northern Tanzania. Livestock are considered an important source of Leptospira for people 
in other settings, but little is known about the role of livestock in the epidemiology of 
human infection in Tanzania. This chapter describes an abattoir surveillance study of 
ruminant livestock established to address the following research objectives:  
Objective 1: Determine the prevalence and patterns of Leptospira infection in three 
different ruminant livestock hosts in the Kilimanjaro Region; 
Objective 2: Identify and described common types of Leptospira bacteria found in 
livestock infections;  
Objective 3: Explore serological reactivity patterns in cattle to: 
i) compare serological data on common reactive serogroups with genetic data derived 
from livestock samples;  
ii) generate serological data comparable with data available from human leptospirosis 
cases in northern Tanzania. 
Objective 4: Compare the performance of different diagnostic tests for Leptospira in the 
Tanzanian cattle population. 
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6.2 Methods 
To explore Leptospira infection in livestock the Kilimanjaro Region, an abattoir 
surveillance study was established within the Moshi Municipal District. This district is the 
administrative centre for the region and also the location of the hospital-based febrile 
disease surveillance, described in Chapter ‎3.2 and Chapter ‎7. Kidney samples were 
collected from cattle, sheep and goats and tested for Leptospira infection by qPCR and 
culture. Urine and serum samples were also collected from a subset of animals (mostly 
cattle) and the performance of different testing approaches was compared in this setting. 
Leptospira from ruminant infections were typed to characterise the pathogen in qPCR or 
culture positive cases. Detailed methodology for this study is described below.  
 
6.2.1 Slaughterhouse sampling frame 
Slaughterhouses for ruminant livestock were identified in liaison with the District 
Veterinary Officer for the Moshi Municipal District. In total, one abattoir and 17 smaller 
slaughter slabs were identified within the District (Figure ‎6.1). Data on the average number 
of cattle slaughtered at each site per week was collected from Livestock Field Officers 
(LFOs) responsible for meat inspection at each of the District slaughterhouses. The weekly 
throughput ranged from an average of 210 cattle per week at the main Moshi abattoir down 
to one animal per week at some smaller slaughter slabs (shown in labels on Figure ‎6.1). 
The main Moshi abattoir and four small slaughter slabs were selected for convenience of 
livestock sampling on the basis of moderate-to-high throughput of cattle, convenient 
locations and cooperative LFOs. 
 
6.2.2 Sample collection 
Slaughterhouse sampling was performed opportunistically in two sampling sessions that 
were performed between 1
st
 May and 18
th
 July 2013 and 5
th
 December 2013 to 11
th
 
September 2014. Sampling at the main Moshi abattoir was only performed during 2013 
due to closure for refurbishment in 2014. 
A maximum of ten animals per species were sampled each day. In liaison with LFOs, 
animal details were recorded including source of animal (market vs. household), region 
and district of origin, approximate age (adult vs. juvenile), sex and breed.  
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Figure  6.1: Map showing the location and average weekly throughput of cattle in the Moshi Municipal slaughterhouses 
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For each animal slaughtered, one kidney was collected into a clean, labelled, single-use 
Ziplok® bag. Samples of kidney tissue (3 x 1 x 1 cm) were taken across the cortico-
medullary junction within three hours of slaughter and placed directly into 70-96% 
ethanol. From a subset of animals, urine samples were taken by urinary bladder 
cystocentesis during meat inspection, and stored without preservatives at minus 80°C. 
Blood samples were also collected from a different subset of cattle prior to slaughter. 
Serum was separated by centrifugation and stored without preservatives at minus 80°C. 
 
6.2.3 Leptospira culture from cattle and goat kidneys 
In a subset of cattle (n=100) and goats (n=49), a portion of kidney tissue was used to 
inoculate EMJH-5FU culture media for Leptospira spp. culture (Chapter ‎3.8). Selection of 
individual carcasses for Leptospira culture was largely governed by logistical constraints 
(i.e. availability of culture media and shipping constraints). When culture media was 
available, vials were inoculated for up to five individuals per day and continued on 
consecutive sampling days until a maximum of 50 cattle had been sampled each year. 
Culture from goats was only attempted in 2014. Following inoculation samples were 
shipped to the WHO/FAO/OIE Leptospirosis Reference Laboratory, Royal Tropical 
Institute (KIT), Amsterdam for propagation, isolation and typing of positive samples.  
 
6.2.4 Typing of isolated Leptospira bacteria 
Serological typing of isolates (MG) was performed at KIT (MG) following standard 
Leptospira typing methods outlined in Chapter ‎3.9. DNA was extracted from pure cultures 
of each isolate (Chapter ‎3.6.1). Genotyping of isolates (AA) was performed by PCR-based 
amplification and sequencing of the secY gene based on the protocol described by Victoria 
et al. (2008) to identify Leptospira species (Chapter ‎3.10).  
Multi-locus sequence typing (MLST) was also performed to identify the Leptospira 
sequence type (ST) as described by Boonsilp et al. (2013) (Chapter ‎3.10). A set of seven 
different primer pairs targeting different loci within Leptospira housekeeping genes (glmU, 
pntA, sucA, tpiA, pfkB, mreA and caiB) were used to generate products for sequencing. 
PCR reactions, product purification and sequencing were performed at KIT (AA). 
Sequence analysis was performed by KA using sequence analysis software (Sequencher® 
version 5.3, Gene Codes Corporation MI). Trimmed sequences were aligned with 
reference sequences (n = 1046) curated by an online MLST database 
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(http://pubmlst.org/leptospira/(Jolley and Maiden, 2010, Jolley and Maiden, 2016) to 
generate a unique allelic profile for each isolate. Finally each allelic profile was compared 
to a database of 223 profiles to determine the ST and the most similar Leptospira serovar 
(Boonsilp et al., 2013).  
 
6.2.5 DNA extraction from livestock kidney and urine samples 
DNA was extracted from ethanol-fixed kidneys as described in Chapter ‎3.6.2 and 
quantified using a NanoDrop® spectrophotometer (ThermoScientific, Waltham, MA). 
Prior to PCR or qPCR testing, total genomic DNA (gDNA) was diluted 1:10 in PCR-grade 
water (or 1:5 in samples with a final DNA concentration < 100ng/μl) to mitigate the effect 
any residual qPCR inhibitors. The test concentration of gDNA ranged from approximately 
50ng to 150ng per 25μl qPCR reaction. 
DNA was extracted from urine samples as described in Chapter ‎3.6.3 and quantified by 
Qubit® Fluorometer (ThermoScientific) using the Qubit® dsDNA High Sensitivity assay 
kit. Final DNA concentrations ranged from <0.05 ng/μl to >60 ng/μl. DNA extracted from 
urine samples were tested undiluted due to low final concentrations.  
 
6.2.6 Nucleic acid amplification by lipL32 TaqMan® qPCR assay for 
Leptospira infection 
Samples were run on MicroAmp® 96 well plates and tested in duplicate with the lipL32 
assay as described in Chapter ‎3.7.2 (Stoddard, 2013, Stoddard et al., 2009). Each plate 
included: two replicates of a Leptospira positive control; L. interrogans serovar 
Copenhagenii Strain Wijnberg at ~10
2
 genome copies numbers; two replicates of a non-
template extraction control, and two replicates of a negative control (PCR-grade water). 
Each reaction run was considered valid when both negative controls were negative and at 
least one replicate of the both the Leptospira positive controls amplified with Ct value < 
40. Samples were considered positive when at least one test well amplified the lipL32 
target with a Ct value < 40. 
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6.2.7 Identification of infecting Leptospira species from PCR-positive 
samples 
Infecting Leptospira species in lipL32 qPCR-positive kidney samples were identified by 
PCR-based amplification and sequencing of the secY gene used a protocol modified for 
use with non-isolate samples from the East African region (Dietrich et al., 2014). A 470-bp 
fragment of the secY gene was amplified and sequenced as described in Chapter ‎3.10 at 
the University of Aberdeen (MM). DNA from Leptospira isolates obtained from cattle in 
Tanzania (Chapter ‎6.2.4) was also sequenced using the Dietrich et al. protocol to allow 
Leptospira sequence from qPCR-positive kidney DNA samples and kidney isolates from 
the same animal to be directly compared.  
 
6.2.8 Sequence analysis 
Analysis of secY sequences was performed using MEGA7.0 (Kumar et al., 2015). 
Electropherograms for forward sequences from secY PCR products were compiled and 
were checked by eye. Sequences were trimmed to exclude sequence of low quality at either 
end of the reads and to exclude any ambiguous base calls. Then, the most appropriate 
evolutionary model for the sequence nucleotide substitution rate was selected using the 
MEGA7.0 model test function. Finally, a phylogenetic tree of secY sequences from 
livestock Leptospira sequences was constructed using the maximum likelihood method. 
The stability of internal nodes within the tree was evaluated using 1000 bootstrap 
iterations. Sequences from each cluster as identified in the phylogenetic tree were 
compared to published sequences in GenBank® (Benson et al., 2011). Sequences from 
Leptospira serovars with a high proportion of sequence similarity (≥ 98%) were also 
included for reference in the final tree. 
 
6.2.9 Serological diagnosis of Leptospira exposure in cattle by Microscopic 
Agglutination Test (MAT) 
For a subset of cattle, sera were tested for evidence of Leptospira by MAT at KIT 
(performed by KA under supervision from MG) following standard protocols (Goris and 
Hartskeerl, 2013, Hartskeerl et al., 2006). Sera were tested against a panel of 26 Leptospira 
serovars from 17 serogroups (Table ‎6.2). Serogroups and representative serovars for 
inclusion on the panel were chosen using the following rationale:  
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1. Reference Leptospira serovars recommended for representative MAT testing by 
WHO/FAO/OIE Collaborating Reference Laboratories (Goris and Hartskeerl, 
2013) 
2. Serovars used in MAT panels in previous studies of human disease in Tanzania 
(Biggs et al., 2011) 
3. Serovars previously isolated from livestock and rodents in Tanzania (Mgode et al., 
2015) 
4. Serovars previously isolated from people and animals in other parts of Africa 
(Royal Tropical Institute (KIT), 2014).  
For each sample and test serovar, the MAT titre was defined as the highest dilution at 
which ≥ 50% of leptospires were still agglutinated (Goris and Hartskeerl, 2013). Samples 
were considered positive for seroreactivity with a MAT titre ≥1:40 against at least one 
serovar. Predominant reactive serogroups were defined for each animal as the serogroup of 
the test serovar with the highest observed titre. Where equivalent titres were observed to 
more than one serogroup, all serogroups were recorded. 
 
6.2.10 Analysis of serological reactivity profiles  
Serovar and serogroup serological reactivity was assessed within the dataset of cattle MAT 
titres. Heat maps plotted using in R (R Core Team, 2015) using the gplots package 
(Warnes et al., 2015) were used to identify distinct serological patterns in cattle titres. All 
MAT titres for cattle were included. A negative result (MAT < 1:20) was given the value 
of 10 for the purpose of analysis. Data were arranged in a matrix where each row 
represented the log10-transformed reciprocal MAT titres for a given animal and each 
column represented the MAT test serovar. Column order was fixed alphabetically by 
serovar. Initially, row ordering was generated at random to check that the results of 
subsequent clustering analyses were not influenced by the order of data entry. Next, 
Euclidean distances (i.e. square root of the sum of squared differences between the 
elements of a pair of rows) were calculated for pairwise sample comparisons between each 
row of the matrix (Everitt, 2005). A hierarchical clustering algorithm based on a complete 
linkage cluster method was performed using the core stats package in R (R Core Team, 
2015) to reorder rows. Data were plotted using the clustered arrangement of cattle samples, 
and colour coded according to the magnitude of the MAT titre.  
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Australis Australis AusAus     
Bratislava AusBra     
Lora AusLor     
Autumnalis Lambwe AusLam    
Ballum Ballum
** 
BalBal     
Bataviae Bataviae BatBat     
Canicola Canicola CanCan     
Celledoni Celledoni CelCel     
Cynopteri Cynopteri CynCyn     
Djasiman Djasiman DjaDja     
Grippotyphosa Grippotyphosa GriGri     
Hebdomadis Hebdomadis HebHeb     
Icterohaem-
orrhagiae 




    
Sokoine IctSok     
Mini Mini
†† 
MinMin     
Pomona Pomona PomPom     
Pyrogenes Kwale PyrKwa     
Pyrogenes PyrPyr     
Nigeria PyrNig     
Sejroe Hardjobovis SejHbo     
Hardjo SejHar     
Sejroe SejSej     
Semaranga Patoc SemPat     
Tarassovi Kanana TarKan     
Tarassovi TarTar     
  
                                                 
‡
 Abbreviations are used in Figures 6.5 and 6.6 in the results section of this chapter  
§
 Number refers to rationale used for selection, referred to in the text 
**
 In place of serovar Kenya (included by Assenga et al. 2015) 
††
 In place of serovar Georgia (included by Biggs et al. 2011), which was not available for use 
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Spearman rank correlation coefficients were calculated to quantify pairwise associations in 
MAT titres between serovars in cattle serum samples. Correlation coefficients for each 
pairwise comparison were displayed in a correlation matrix generated in R using the 
package corrgram (Wright, 2015). Significance levels of each coefficient were set and 
displayed at p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***).  
 
6.2.11 Statistical analysis 
Statistical analysis was performed in R (R Core Team, 2015). Binomial confidence for 
point prevalence estimates intervals (Wilson method) were calculated using the Hmisc 
package (Harrell et al., 2016). The Fisher‘s exact test was performed to compare infection 
prevalence in male and female animals. The McNemar‘s Chi-squared test was performed 
to test the significance of diagnostic test differences between kidney and urine qPCR 
results from the same animals. The degree of agreement between different diagnostic test 
approaches (e.g. kidney qPCR vs. urine qPCR; kidney qPCR vs. kidney culture; kidney 
qPCR vs. MAT) was assessed by calculating the Cohen‘s kappa statistic for inter-rater 
agreement (Thrusfield, 1995). 
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6.3 Results 
6.3.1 Summary of ruminant livestock sampling  
In total, samples were collected from 453 cattle, 167 goats and 90 sheep. Sampling was 
opportunistically divided across the five slaughterhouses as detailed in Table ‎6.3. Cattle 
were sampled at all study slaughterhouses. Goats were only sampled at the two Karanga 
slaughter slabs due to low availability at other sites.  
 
Table  6.3: Sampling summary by slaughterhouse and livestock species 
Slaughterhouse ID Ward Cattle Sheep Goats 
SS01 Rau 92 - - 
SS02 Rau 273 - - 
SS03 Boma Mbuzi 70 40 - 
SS04 Karanga 6 2 12 
SS05 Karanga 12 48 141 
NA - - - 14* 
Total - 453 90 167 
* Sampled at Karanga slabs but individual slab ID not recorded.  
 
6.3.2 Livestock origins: the journey to slaughter 
All animals sampled in this study were sourced from primary and secondary markets, 
mainly in the Arusha and Kilimanjaro Regions prior to slaughter. However, the majority of 
animals originated from regions much further afield. Of 453 cattle sampled, 384 (84.8%) 
originated from the Manyara Region, mainly from the districts of Mbulu (n= 296) and 
Babati Districts (n= 65) (Figure ‎6.2). Other regions of cattle origin included Arusha, 
Dodoma, Kilimanjaro, Mwanza, Singida, Tabora and Tanga. Manyara Region was also the 
region of origin of 115 (68.9%) goats and 48 (53.3%) sheep (Figure ‎6.3). District 
information was not available for goats but sheep also commonly came from the Babati 
District (n = 32). The rest of the small ruminants sampled came from the Arusha Region.  
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Figure  6.2: Regions and districts of origin of cattle sampled at Moshi 
slaughterhouses  
 
Figure  6.3: Regions and districts of origin of small ruminants sampled at 
Moshi slaughterhouses   
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6.3.3 Livestock demographics 
Virtually all animals sampled at the abattoir were indigenous breeds. For cattle, the vast 
majority of animals of animals sampled (99.6%; n = 453) were indigenous humped Zebu 
breeds (Bos indicus). For small ruminants, only three animals (1.17%; n = 257) were 
classed as non-indigenous breeds. The majority of animals sampled were male (81.7% (n = 
453) of cattle, 70.1% of goats (n = 167) and 53.3% of sheep (n=90)) and most animals 
were adult. Only a small number of juvenile animals were sampled (30 cattle, 11 sheep and 
4 goats).  
 
6.3.4 Summary of samples available for diagnostic testing 
In total, qPCR was performed on kidney samples from 453 cattle, 167 goats and 90 sheep. 
Urine qPCR was also performed on a subset of 73 cattle, 29 goats and 40 sheep. Serum 
samples were available for MAT serology from 56 cattle (Table ‎6.4) 
 
Table  6.4: Summary of ruminant livestock sampling by species, sample type 
and diagnostic test 
Species: Cattle Goats Sheep 
Diagnostic test:    
Kidney qPCR only 190 88 50 
Kidney qPCR and culture 100 50 0 
Kidney qPCR and urine qPCR  73 29 40 
Kidney qPCR and serology  56 0 0 
Total number of animals sampled 453 167 90 
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6.3.5 Results of the lipL32 TaqMan® qPCR assay – kidney samples 
Pathogenic Leptospira infection was detected by lipL32 qPCR in 32 (7.06%) of 453 cattle 
with kidneys available for testing. In small ruminants, Leptospira infection was detected in 
2 (1.20%) of 167 goats and 1 (1.11%) sheep of 90 tested (Table ‎6.5).  
 
Table  6.5: Leptospira qPCR results (lipL32 qPCR) for kidney and urine 
samples from livestock species  
 Cattle Goats Sheep 
 Kidney Urine Kidney Urine Kidney Urine 
Total tested 453 73 167 29 90 40 
qPCR 
negative 
420 61 165 28 89 40 
qPCR 
positive 
32 12 2 1 1 0 
Prevalence 
(%) 




5.05–9.80 9.66–26.6 0.33–4.26 0.18–17.2 0.06–6.03 0–8.76 
 
All positive small ruminants (n = 3) originated from the Manyara Region. In cattle, 
positive cases were detected in cattle from Manyara, Arusha, Singida, Dodoma and Tanga 
regions. No significant difference was observed in infection prevalence between male and 
female cattle or adult or juvenile animals (Fisher‘s exact tests; p > 0.05). 
 
6.3.6 Results of the lipL32 TaqMan® qPCR assay – urine samples 
Leptospira infection was detected in 12 (16.4%) out of 73 cattle urine samples, one 
(3.45%) of 29 goat urine samples tested and no sheep urine samples (n = 40) (Table ‎6.5). 
All kidney qPCR positive cattle and sheep were also positive by urine qPCR; however 
urine qPCR testing failed to detect infection in one kidney-qPCR positive sheep. In cattle, 
urine qPCR identified significantly more Leptospira positive animals than kidney qPCR 
(Table ‎6.6; McNemar‘s χ2 = 5.14; df = 1, p = 0.023). Overall, moderate agreement was 
observed between the two tests  (Cohen‘s kappa statistic 0.544; 95% CI 0.223 – 0.865; p = 
0.008) (Thrusfield, 1995).   
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Table  6.6: Comparison of results from kidney qPCR versus urine qPCR for 
cattle  
 Urine positive Urine negative Total 
Kidney positive 5 0 5 
Kidney negative  7 61 68 
Total 12 61 73 
 
6.3.7 Leptospira culture from cattle and goat kidneys 
Leptospira isolates were obtained for 4 out of 100 cattle kidneys tested by culture. All 
culture-positive cattle were also qPCR-positive, but culture failed to demonstrate 
Leptospira infection in two qPCR-positive cattle (Table ‎6.7). However, in general, 
substantial agreement was observed between the two tests for cattle (Cohen‘s kappa 
statistic 0.790; 95% CI 0.502 – 1.08; p = 0.005) (Thrusfield, 1995). For goats, Leptospira 
infection was not detected by either qPCR or culture in any kidneys tested by both 
methods.  
 
Table  6.7: Comparison of results from kidney qPCR versus kidney culture 
for cattle 
 Kidney qPCR positive Kidney qPCR negative Total 
Culture positive 4 0 4 
Culture negative 2 94 96 
Total 6 94 100 
 
6.3.8 Typing of Leptospira isolates 
All Leptospira isolates (n = 4) derived from culture of cattle kidneys were serologically 
typed as L. borgpetersenii serovar Hardjo (Hardjobovis), serogroup Sejroe. By MLST, an 
identical sequence profile was generated for all four isolates (ST 152), which corresponded 
to strains of L. borgpetersenii serovar Hardjo (Hardjobovis) in the reference database. 
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6.3.9 Results of secY typing of Leptospira from PCR-positive samples 
After trimming and alignment, a 435-bp fragment of the secY gene was available for 
sequence analysis from 20 (60.6%) of 33 qPCR-positive kidney samples. By host species, 
this corresponded to 18 sequences derived from cattle infections, one sequence from an 
infected goat (C0417) and one sequence from an infected sheep (C0481). The majority of 
Leptospira sequences were derived from animals that originated in the region of Manyara, 
which was the most common region of origin for this study (section ‎6.3.2).  
The phylogenetic relationships between livestock-derived secY sequences were inferred 
using a Maximum Likelihood method based on the Tamura 3-parameter model (Tamura, 
1992). From BLAST searches, secY sequences published for fully characterised 
Leptospira serovars with a high degree of similarity to livestock sequences were also 
included in the final sequence alignment of reference (Bulach et al., 2006, Victoria et al., 
2008). The resulting phylogenetic tree is shown in Figure ‎6.4. secY sequences 
corresponding to Leptospira borgpetersenii were identified in 13 (72.2%) cattle samples. 
Two distinct clusters of L. borgpetersenii sequence types, which shared 97.7% sequence 
similarity, were identified in 100% of bootstrap replicates.  
Sequences from eight (44.4%) cattle were grouped into a cluster (Figure ‎6.4: Lb1) that 
shared 100% similarity with sequences derived from reference strains of L. borgpetersenii 
serovar Hardjo (Hardjobovis strains L550 and JB197; accession number CP000348.1 
(Bulach et al., 2006)). Sequences derived from cattle originating from Manyara, Arusha 
and Tanga Regions aligned perfectly in this group. secY sequences from cattle isolates 
obtained by this study described in Chapter ‎6.3.8 also aligned perfectly (100% similarity) 
with the Lb1 cluster.  
Sequences from five cattle (27.8%) originating from Manyara and Singida were grouped 
into a cluster of L. borgpetersenii sequences (Figure ‎6.4: Lb2) that was clearly distinct 
from the serovar Hardjo cluster (Lb1). The only GenBank sequences with 100% similarity 
to this Lb2 group were reported from cattle infections in Brazil (Accession number 
KP862647.1 (Hamond et al., 2016)). However, secY sequences from several L. 
borgpetersenii reference serovars (L. borgpetersenii serovars Balcanica, Moldaviae, 
Nyanza, Tarassovi and Tunis (Victoria et al., 2008)) demonstrated 98% similarity with this 
cluster.  
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Figure  6.4: Molecular phylogenetic analysis of the Leptospira secY gene 
(435-bp fragment) by Maximum Likelihood method based on the Tamura 3-
parameter model (Tamura, 1992).  
Sequence analysis was performed on DNA extracted from PCR-positive livestock kidney 
samples. Selected reference serovars (including GenBank accession numbers) and 
isolates from Tanzanian cattle (this study) are shown for comparison. The tree with the 
highest log likelihood (-1036.7115) is shown and drawn to scale, with branch lengths 
measured in the number of substitutions per site. Nodal bootstrap support values are 
shown. Labels (Lb1, Lb2 etc.) refer to text descriptions. Livestock host species is cattle 
unless otherwise specified. Colour coding of identification (ID) numbers refers to the 
region of origin of each animal (Key). Unique ID numbers were sampled sequentially. ID 
numbers < 500 were sampled from May to July 2013. ID numbers > 500 were sampled 
from January to September 2014. Abbreviations: Lb = L. borgpetersenii; sv = serovar.   
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secY sequences corresponding to L. kirschneri were identified in samples from two 
(11.1%) cattle, one sheep and one goat (shown as L. kirschneri in Figure ‎6.4) all 
originating from the Manyara Region. Within this grouping, a subdivision of one cattle 
sample (C0552) was observed in 69% of bootstrap replicates. This sequence (C0552) 
showed lower overall similarity (98.9%) compared to the rest of the livestock-derived L. 
kirschneri sequence types. Livestock-derived sequences in the main cluster showed 100% 
similarity with secY sequences from several L. kirschneri reference serovars and including 
three serovars (Kambale, Ndahambukuje and Ndamnari) previously isolated from patients 
in the Democratic Republic of Congo (formerly Zaire) (Victoria et al., 2008, Royal 
Tropical Institute (KIT), 2014).  
Finally, a cluster of three cattle-derived Leptospira secY sequences that showed relatively 
little similarity to previously reported Leptospira secY sequences was observed (labelled 
as Unidentified genotype in (Figure ‎6.4All cattle in this group originated from the 
Manyara Region (Mbulu District) and were sampled at two neighbouring slaughter slabs 
over a two-day period. Genetic sequences in this group showed only 95% similarity to the 
L. kirschneri group (Figure ‎6.4) and the most analogous published sequence (e.g. L. 
kirschneri serovar Grippotyphosa: accession number EU358028.1 (Victoria et al., 2008). 
 
6.3.10 MAT results 
MAT serological testing was performed on 56 cattle also tested for Leptospira infection by 
kidney qPCR. Using a cut-off MAT titre ≥ 1:40, serological reactivity was demonstrated 
against eight Leptospira serogroups in 27 (48.2%) of 56 animals (Table ‎6.8). Reactivity 
against at least one of the two Hardjo serovars was also common (14.3%; n = 56). 
Overall, the pattern of predominant reactive serogroups followed the overall trend in 
seroprevalence, with the exception of serogroup Hebdomadis (Table ‎6.8). A single 
predominant serogroup could not be determined in four animals, which demonstrated 
equivalent titres to more two serogroups. These were serogroups Australis and Tarassovi 
(n=1); serogroups Icterohaemorrhagiae and Mini (n=1); serogroups Mini and Sejroe (n=1); 
and serogroups Mini and Tarassovi (n = 1).  
Within predominant serogroups, a degree of serovar-specificity was observed. For 
serogroup Australis, high titres were only observed against serovar Lora. For serogroup 
Icterohaemorrhagiae, high titres were only observed against serovar Sokoine.  
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Table  6.8: Overall serogroup prevalence (MAT titres ≥1:40) and predominant 
serogroup prevalence in cattle by MAT 
Serogroup N positive  
(Titres ≥1:40)  
Predominant serogroups 
(prevalence) 
Mini 12 (21.4%) 8 (29.6%) 
Sejroe 9 (16.1%) 5 (18.5%) 






Grippotyphosa 3 (5.36%) 3 (11.1%) 
Semarang 3 (5.36%) 1 (3.70%) 






Any serogroup 27 (48.2%) - 
* For serogroup Australis, titres ≥ 1:40 were observed to serovar Lora only;  
∞ For serogroup Icterohaemorrhagiae; titres ≥ 1:40 were observed to serovar Sokoine only. 
 
6.3.11 Assessing serological trends in cattle by heat map 
Log10 transformed MAT titres (MAT ≥ 1:20) from 54 cattle were plotted as heat maps 
shown in Figure ‎6.5. Leptospira MAT serovars (see Table ‎6.2 for full serovar details) were 
plotted on the x-axis with cattle clustered by similarity shown by the dendrogram on the y-
axis. Clustering algorithms reveal four main patterns (labelled on Figure ‎6.5) in MAT titres 
in this cattle serology dataset: 
A:  Cattle with no observed MAT titres (< 1:20) against any test serovar (n = 12).  
B: Cattle with moderate to high MAT titres (yellow) against a single serogroup, most 
commonly serogroups Grippotyphosa, Sejroe or Tarassovi (n = 8).  
C: Cattle with MAT titres to at least two of the serogroups Mini, Sejroe and 
Hebdomadis. Most commonly, high titres (yellow) are observed to both serogroups Mini 
and Sejroe. Hebdomadis titres are typically lower (dark blue) (n = 12). 
D: Cattle with low titres (dark blue) against a range of other serogroups including 
Australis, Autumnalis, Icterohaemorrhagiae (serovar Sokoine) and Tarassovi (n = 22). This 
pattern is seen mostly in the group labelled D but also in a small group of samples between 
groups B and A. 
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Figure  6.5: Heat map showing log10 transformed MAT titres by Leptospira MAT serovars for cattle. 
The dendrogram on the y-axis illustrates the clustering of cattle (rows) based on serological similarity. Colours indicate the magnitude of MAT titres 
(Colour Key). Test serovars are shown on the x-axis (see Table  6.2 for full serovar details). Patterns in animal clustering are shown on the right: A: 
Cattle with no observed MAT titres to any serovar (n = 12); B: Cattle with titres to one serogroup (n = 8); C: Cattle with titres to serogroups Mini, Sejroe 
and Hebdomadis (n = 12); D: Cattle with low titres against a range of serogroups (n = 22). NB: The hierarchical clustering algorithm of the dendrogram 
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6.3.12 Assessing correlation in MAT titres between serovars 
Spearman‘s rank correlation coefficients (r) for pairwise comparisons between MAT titres 
are shown in matrix form in Figure ‎6.6. In this figure, serovars with no evidence of 
reactivity (MAT titre < 1:20) have been excluded for ease of interpretation.  
A high degree of correlation in MAT titres was observed between test serovars of the same 
serogroup. For example, within the Tarassovi serogroup, MAT titres against serovars 
Tarassovi (TarTar) and Kanana (TarKan) were highly correlated (r = 0.64, p < 0.001). 
Significant correlations in MAT titre were observed between all of the three test serovars 
belonging to the serogroup Australis (serovars Australis (AusAus), Bratislava (AusBra) 
and Lora (AusLor); p < 0.001– see Figure ‎6.6 for pairwise correlation coefficients). 
Significant correlations were also observed between all serovars from the Sejroe serogroup 
(Hardjobovis (SejHbo), Hardjoprajitno (SejHPr) and Sejroe (SejSej); p < 0.001– see 
Figure ‎6.6 for pairwise correlation coefficients).  
In addition, significant correlation was observed between MAT titres for serovars across 
the Mini-Hebdomadis-Sejroe serogroup complex. For example, statistically significant 
correlation was demonstrated between MAT titres against the representative serovars for 
serogroups Hebdomadis (HebHeb) and Mini (MinSar) (r = 0.68, p < 0.001), and between 
both of these serogroups and all of the test Sejroe serovars (p < 0.001– see Figure ‎6.6 for 
pairwise correlation coefficients). 
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Figure  6.6: Matrix of Spearman’s rank correlation coefficients (correlogram) for MAT titres from cattle by test serovar  
See Table ‎6.2 for full serovar details Statistical significance of pairwise correlation coefficients (label) is shown by stars (p < 0.05 (*), p < 0.01 (**) and p 
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6.3.13 Comparison of serology and qPCR results for determining Leptospira 
prevalence and diversity in livestock 
Of 56 cattle tested by MAT, four were positive for Leptospira infection by kidney qPCR 
(Table ‎6.9). Of these, only two were positive by MAT using a cut-off of MAT titre ≥ 1:40. 
Overall, agreement was very low between the two testing approaches (Cohen‘s kappa 
statistic; 0.005; 95% CI -0.265 – 0.276; p = 0.485)(Thrusfield, 1995). 
 
Table  6.9: Comparison of kidney qPCR versus MAT results for any 
serogroup (MAT titre ≥ 1:40) 
 qPCR positive qPCR negative Total 
MAT positive 2 25 27 
MAT negative 2 27 29 
Total 4 52 56 
 
Table 6.10: Summary of PCR and MAT positive cattle with serological 
profiles and genotype data (no observed MAT titres ≥ 1:20) 
Cattle 
ID 
Leptospira secY  











C0518 L. borgpetersenii  
(Lb2) 
1:20 - 1:20 - - 
C0552 L. kirschneri  
 
- 1:80 - 1:20 - 
C0592 L. borgpetersenii 
(Lb2) 
- 1:80 - - - 
C0603 NA 
 
- - - - 1:20 
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Where available, data on reactive MAT titres against Leptospira serogroups was compared 
to Leptospira species information for qPCR positive cattle. For qPCR-positive cattle, 
serological reactivity was often below the pre-defined MAT cut-off titre (≥ 1:40) used to 
determine serogroup prevalence in this study (Table 6.10). Data on infecting Leptospira 
species based on secY sequence analysis was available for three animals. Two cattle were 
infected with L. borgpetersenii from the non-Hardjo cluster (Lb2). Of these, one animal 
showed serological reactivity against serogroup Mini at a titre of 1:80, and the second 
showed low levels of reactivity to serogroups Autumnalis and Pyrogenes. In one cow with 
L. kirschneri infection, serological reactivity was demonstrated to serogroups Mini and 
Sejroe. Overall, no relationship between the infecting Leptospira sequence type and MAT 
reactive serogroups could be deduced.  
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6.4 Discussion 
The results presented in this chapter indicate that Leptospira infection is common in 
ruminant livestock in this area. Using molecular methods, a high prevalence of Leptospira 
infection was detected in cattle from across northern Tanzania. Infection was demonstrated 
for the first time in small ruminants from the East African region. This study also 
represents the first reported isolation of L. borgpetersenii serovar Hardjo from cattle in 
East Africa. Serological data suggests that L. borgpetersenii exposure to this serovar is 
common in cattle, but also identified a number of other dominant sero-reactive serogroups 
in this livestock species. From the results presented in this chapter, L. borgpetersenii 
appears to be the predominant Leptospira species involved in cattle infection and was only 
detected in this host species. In contrast, L. kirschneri infection was detected in multiple 
livestock species (cattle, sheep and goats). In addition, the use of a sequence-based 
approach directly on clinical samples identified an unusual Leptospira genotype that has 
not been previously described in international databases.  
Overall, this study provided some novel and intriguing insights into the epidemiology of 
leptospirosis in livestock in Tanzania. The use of an abattoir sampling platform proved to 
be a productive method to investigate Leptospira infection in livestock in a wide 
geographic area. The majority of animals sampled in this study originated from distant 
regions and travelled long distances before arriving at slaughterslabs in Moshi (Figure ‎6.2). 
Infection was detected in animals that originated from various regions across the northern 
half of Tanzania, indicating that Leptospira infection is widespread in Tanzanian livestock. 
However, direct extrapolation of prevalence estimates from this study should be performed 
with caution. Infection prevalence data generated from animals sold for slaughter may not 
be entirely representative of the prevalence of disease in the general population due to the 
potential for selection bias (Cleaveland et al., 2007, McKenna et al., 2004). Animals may 
be culled from a herd on the basis of particular characteristics that affect the likelihood of 
infection in an endemic setting, such as older age or poor reproductive performance for 
example. In this setting where animals travel long distances to slaughter, it is also possible 
that the animals may have become infected after leaving their home regions through 
mixing with other herds in cattle-holding areas, at watering holes or markets or even the 
abattoir lairage where they may be held for several days (Juvenile Urio and Francis 
William, personal communication). Further work may be needed to understand the 
prevalence of Leptospira infection in the home grazing areas of these cattle. However, as a 
preliminary study of livestock leptospirosis in Tanzania, this work offers some important 
insights that will have real and practical benefits to future surveillance of the disease.  
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Firstly, slaughterhouse sampling enabled kidney and urine samples to be collected from a 
large number of animals for the direct detection of Leptospira organisms by qPCR. In 
Africa, molecular approaches for the diagnosis of Leptospira infection in livestock have 
previously only been used in a small number of studies (Chapter ‎2). However, where they 
have been applied, relatively high estimates of prevalence have been obtained (Desvars et 
al., 2013c). In this study, qPCR testing proved more sensitive than culture for detecting 
Leptospira infection in livestock. qPCR detected an additional 50% of infections over 
culture where kidney samples were tested by both methods, demonstrating its utility in this 
setting. The use of urine samples rather than kidney samples for qPCR testing further 
improved the probability of detecting infection in cattle. The reason for this discrepancy is 
uncertain. A number of limitations for demonstrating infection by urine testing have been 
reported including intermittent Leptospira shedding, low bacterial load and the risk of PCR 
inhibition from the high level of urea in urine samples (World Organisation for Animal 
Health (OIE), 2008, Levett, 2001, Schrader et al., 2012). However, a previous study of 
cattle and sheep performed in New Zealand demonstrated comparable results between the 
kidney and urine samples (Fang et al., 2014b). Most likely, the difference in detection 
sensitivity in this study is a consequence of the sampling approach. A single, relatively 
small volume of kidney tissue was taken from each animal for DNA extraction and 
subsequent qPCR testing, which may have missed more localised infections that are 
common in chronic Leptospira infection in cattle (Bill Ellis, personal communication). 
Urine samples may be more representative of the true infection status of the animal, as 
urine from different parts of the kidney will be pooled and mixed together, removing the 
problem of trying to target a focal area of infection in the kidney tissue. Therefore, in this 
study, figure for infection prevalence based on kidney qPCR for cattle are likely to be 
underestimates of the true prevalence of bovine infection in this setting. Urinary qPCR is 
recommended for future studies of Leptospira infection in this setting, which has clear 
advantages for surveillance of live animals as well as those destined for slaughter.  
The use of an abattoir-based study also allowed better characterisation of circulating 
Leptospira types. Leptospira culture resulted in the definitive demonstration of L. 
borgpetersenii serovar Hardjo (serogroup Sejroe) infection in Tanzanian cattle, which 
expands the known global distribution of this cattle-associated serovar. Prior to this study, 
Hardjobovis had only been reported in cattle from Nigeria, South Africa and Zimbabwe on 
the African continent (Ezeh et al., 1989a, Te Brugge and Dreyer, 1985, Feresu et al., 
1999b), although the high prevalence of serogroup Sejroe in seroprevalence studies had 
indicated its presence in East Africa for some time (see references in Table ‎6.1). The 
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almost ubiquitous nature of Hardjobovis in cattle populations worldwide confers some 
functional benefits for surveillance and control of this particular Leptospira serovar in 
Tanzanian cattle. Serovar-specific diagnostic tests for Hardjo already exist to aid the 
diagnosis of infection in cattle (Yan et al., 1999), as do vaccinations, which could be 
evaluated for their feasibility in the Tanzanian context (Dhaliwal et al., 1996b, Bolin and 
Alt, 2001).  
However, further analysis suggests that a much wider variety of serological and genetic 
types of Leptospira are circulating in Tanzanian livestock than is implicated by culture 
alone. Four distinct clusters of Leptospira genotype were identified by secY sequence 
analysis of qPCR-positive samples including two groups of L. borgpetersenii sequence 
type, a cluster of L. kirschneri and a fourth cluster of sequences from an unidentified 
Leptospira species. To date, relatively little is currently known about the genetic diversity 
of Leptospira in mainland Africa (Allan et al., 2015a), and African serovars are likely to be 
under-represented in reference collections used to develop typing schemes (Boonsilp et al., 
2013, Thaipadungpanit et al., 2007). However, where sequence-based typing approaches 
have been used in the region, a remarkable array of Leptospira genotypes has been 
reported (Dietrich et al., 2014, Gomard et al., 2016). The use of a relatively short fragment 
of a single gene to perform phylogenetic analysis in this study limits the robustness of 
distinguishing between genotypes within a Leptospira species (e.g. the two clusters within 
L. borgpetersenii sequences). However, the secY is well characterised for many known 
pathogenic Leptospira species and serovars. Based on reported proportional similarities for 
serovars of the same Leptospira species (Victoria et al., 2008), a similarity of only 95%, as 
observed between the unidentified cluster of Leptospira genotypes identified from cattle in 
this study and its nearest known neighbour (L. kirschneri), is on the threshold of 
similarities for species level distinctions for this gene locus. Analysis of additional gene 
targets for this Leptospira genotype could help to determine whether this cluster represents 
an unreported divergent form of L. kirschneri or distinct, unreported Leptospira genotype. 
Serological analysis revealed that cattle are exposed to several different serogroups in 
addition to serogroup Sejroe, including Australis, Grippotyphosa, Icterohaemorrhagiae and 
Tarassovi. Statistically significant correlations were observed in serological reactivity 
(MAT titres) for the serogroups Mini, Hebdomadis and Sejroe (Figure ‎6.6) indicating that 
titres to these serogroups could be cross-reactive or co-occur. However, for other 
serogroups, reactivity was demonstrated without any evidence of cross or correlated 
reactivity. On the basis of this analysis, at least five serological types of Leptospira are 
presumed to circulating in these cattle populations. Reactive serogroups from this study 
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will be used to in this study inform the selection of a serovar panel for future MAT testing 
in livestock in this area. 
The observed patterns of Leptospira infection in livestock, supported by background 
information about the biology and typical transmission routes of L. borgpetersenii and L. 
kirschneri, led to the hypothesis that two distinct transmission cycles may be occurring in 
Tanzanian livestock (Figure ‎6.7). L. borgpetersenii infection was seen only in cattle 
indicating a degree of host specificity in this Leptospira species. Published genomic 
analysis of L. borgpetersenii has revealed considerable loss of genes involved in 
environmental survival, indicating that L. borgpetersenii is evolving towards strict 
dependence on direct host-to-host transmission (Bulach et al., 2006, Picardeau et al., 
2008). In northern Tanzania, we hypothesize that L. borgpetersenii relies on direct cow-to-




Figure  6.7: Proposed transmission cycles for major Leptospira species 
detected in Tanzanian livestock 
 
In contrast, L. kirschneri was detected in cattle, sheep and goats sampled in this study. 
Sequence-based analysis showed perfect alignment of the secY locus in sequence derived 
from all three host species (Figure ‎6.4). This infection pattern indicates that a more 
complex, multi-host epidemiology may be important for this Leptospira species. 
Genetically L. kirschneri is similar to L. interrogans, and is thought to be able to survive in 
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the environment for several weeks enabling indirect routes of infection to play a more 
prominent role in its transmission (Fouts et al., 2016, Andre-Fontaine et al., 2015). Indirect 
or environmental transmission is hypothesised to be more important in for L. kirschneri 
than L. borgpetersenii and would better explain the multi-host infection patterns observed 
in this study. In pastoral and agropastoral systems in Tanzania, cattle and small ruminants 
are often kept in mixed flocks and share grazing areas, watering holes and overnight 
housing (Figure ‎6.8). Mixed herds are known to be an important risk factor for cattle 
Leptospira infection in other settings (Ryan et al., 2012, Lilenbaum and Souza, 2003). 
Small ruminants may be responsible for direct or indirect transmission of L. kirschneri to 
cattle in settings where they come into close contact, for example in the abattoir lairage. 
Alternatively, all three species may be infected from another animal host or environmental 
reservoir. In either scenario, small ruminants should not be overlooked when considering 
potential hosts for Leptospira infection in Tanzania. 
 
  
(i) Mixed herd management in 
pastoral farming systems 
(ii) Mixed species housing in the 
abattoir lairage 
 
Figure  6.8: Tanzania livestock are often managed in mixed herds both in 
pastoral farming systems (i) and in the abattoir lairage (ii) 
 
The epidemiology, maintenance and transmission of the two main livestock-infecting 
Leptospira types may also have implications for transmission of Leptospira infection from 
livestock to people. Reduced environmental survival of L. borgpetersenii dictates that 
close contact with the infected tissues or urine of animal is necessary for human infection. 
This may occur through milking, assisting with parturition or slaughter. In contrast, a 
propensity for greater environmental survival and cross-species transmission in L. 
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kirschneri means that there are more potential routes for people to come into contact with 
this pathogen. As livestock travel long distances before arriving at the slaughterhouses they 
have the potential to transmit infection to people (and other animals) anywhere on their 
journeys from their home grazing areas. In Moshi, the high prevalence of infection and 
urinary shedding of Leptospira suggests that infected livestock may pose a considerable 
health risk to slaughterhouse workers and butchers. Kidneys have commercial value in 
Tanzania where they are sold for consumption and hence, the handling and preparation of 
Leptospira-infected offal may also pose a zoonotic disease risk to the consumer.  
Finally, the high prevalence of infection may also pose health problem to the animals 
themselves. Very little is known about the impact of Leptospira infection on cattle in 
Africa, but the potential for production losses are considerable given how widespread the 
infection appears to be. Many questions remain unanswered and there remains a fair degree 
of uncertainty regarding transmission routes and the role that livestock play in the 
epidemiology of human disease in northern Tanzania. Exploring the similarities between 
Leptospira types detected in cattle and people is an important priority in this setting and a 
focus of the final data chapter of this thesis (Chapter ‎7).         
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7 Human leptospirosis in northern Tanzania 
7.1 Introduction  
Leptospirosis is an important but overlooked cause of human febrile illness on the African 
continent. Over the past five years, a mounting body of evidence has demonstrated that acute 
leptospirosis contributes substantially to the burden of non-malarial febrile illness in Africa 
(reviewed and discussed in Chapter ‎2). Although human disease surveillance on the continent 
is limited, available figures indicate that eastern sub-Saharan Africa is one of the most 
severely affected regions in the world (Costa et al., 2015a). Estimates of annual disease 
incidence range from 26 cases per 100,000 population in the region as a whole (Costa et al., 
2015a) to more than 100 cases per 100,000 population in Tanzania (Biggs et al., 2013b). 
However, despite demonstration of a high burden of human disease, relatively little is known 
about the types and sources of Leptospira bacteria responsible for human disease in Tanzania, 
where the disease remains overlooked in public health priorities.  
 
7.1.1 Human Leptospira exposure in Tanzania 
To date, the majority of data on Leptospira infection in people in Tanzania comes from 
serological surveillance studies, which reveal widespread exposure in the general population. 
The first serological evidence for human exposure came from an opportunistic study of 
agricultural workers from a variety of Tanzanian regions (Machang'u et al., 1997). This 
pioneering investigation was limited in scope as only a very small number of Leptospira 
serovars were used for serological testing by microscopic agglutination test (MAT) (Table ‎7.1. 
However, this study laid the foundations for leptospirosis research in Tanzania. Subsequent 
surveys have since used broader serological panels for MAT testing to generate more 
representative estimates of prevalence.  
Seroprevalence data generated from cross-sectional surveys or hospital-based cohort studies 
are available for four different regions of Tanzania (Table ‎7.1). In the Tanga Region (north-
east Tanzania), a cross-sectional survey of 199 city inhabitants demonstrated a Seroprevalence 
of 15.1% by MAT (Schoonman and Swai, 2009). Study participants were considered positive 
for Leptospira exposure with at MAT titre ≥ 1:160 to at least one Leptospira serovar from a 
panel encompassing six different serogroups. In the Katavi Region (west Tanzania), a cross-
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sectional study targeting livestock-owning households estimated human seroprevalence as 
30.0% (n= 267) (Assenga et al., 2015). In this study, sera were also tested by MAT against a 
panel of six Leptospira serogroups but only two serogroups were directly comparable between 
the Tanga and Katavi studies).  
In a hospital-based study of 370 children presenting with febrile illness at Kilosa District 
hospital in the Morogoro Region of central Tanzania, ELISA (IgM and IgG combined) was 
used to generate an estimate of 15.9% seroprevalence (Chipwaza et al., 2015). Secondary 
MAT testing was subsequently performed on 200 ELISA-positive patients using the same 
serovar panel as described for the Katavi cross-sectional study (Table ‎7.1). Reactivity to at 
least one Leptospira serovar was demonstrated by a MAT titre ≥ 1:160 in 26 (13.0%) ELISA-
positive patients. This result highlights discrepancies between the two test methodologies but 
confirms considerable exposure in this patient cohort. Finally, seroprevalence estimates are 
also available from a hospital-based study exploring the aetiology of febrile disease performed 
at two hospitals in the Kilimanjaro Region of northern Tanzania (Biggs et al., 2011, Crump et 
al., 2013). This study performed the most comprehensive MAT testing to date, using a panel 
of 20 different Leptospira serovars representing a total of 17 serogroups. Of 831 adult and 
paediatric patients tested by MAT in the Kilimanjaro study, 346 (41.6%) showed at MAT titre 
≥ 1:100 against at least one Leptospira serogroup (Table ‎7.1).  
Together, these studies demonstrate substantial Leptospira exposure in the Tanzanian 
population. Seroprevalence estimates also indicate that Leptospira exposure is common in 
patients with febrile illness who seek health-care in the Morogoro and Kilimanjaro Regions. 
However, diagnosing leptospirosis as the cause of an acute episode of febrile illness requires a 
more rigorous approach than simply demonstrating serological exposure. Definitive diagnosis 
of acute leptospirosis by MAT requires demonstration of seroconversion between acute and 
convalescent samples taken two to four weeks apart in the presence of compatible clinical 
signs (World Health Organization, 2011, Costa et al., 2015a). A single high MAT titre is also 
accepted as evidence of probable infection in the presence of compatible clinical signs. These 
case definitions were used by the Kilimanjaro febrile disease study to provide the most robust 
evidence of Leptospira infection as a cause of acute febrile illness in Tanzania. 
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Table  7.1: Leptospira exposure in people in Tanzania reported by study, Tanzanian region and Leptospira serogroup 
Study location  
(citation) 
Morogoro  






(Biggs et al., 2011) 
Katavi  





(Chipwaza et al., 
2015) 
Study type  
(n = participants) 
Opportunistic study 
(n = 375) 
Cross-sectional survey 
(n = 199) 
Febrile patients 
(n = 831) 
Livestock owners 





MAT Cut-off titre ≥1:160 ≥1:160 ≥1:100 ≥1:160 ≥1:160 
Overall seroprevalence
‡‡




Australis - - 12.1% 1.5% 1.0% 
Autumnalis - - 14.5% - - 
Ballum - - 0.2%  1.1% 3.0% 
Bataviae - 4.5% 0.6%  - - 
Canicola - - 0.8% - - 
Celledoni - - 2.4% - - 
Cynopteri - - 0.5% - - 
Djasiman - - 2.0% - - 
Grippotyphosa 0.3%  - 0.6% 4.9% 3.0% 
Hebdomadis - - 0.6% 3.4% 3.0% 
Icterohaemorrhagiae Not detected 5.5% 8.3% 9.0% 4.5% 
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Javanica - - 0.2% - - 
Mini - - 22.8% - - 
Pomona - 0.5% 0.1% - - 
Pyrogenes - - 0.7% - - 
Sejroe - 3.0% 0.5% 15.7% 0.0% 
Tarassovi - 1.0% 0.6% - - 
                                                 
**
 Some patients are positive for more than one serogroup 
††
 Selected from larger population of febrile children on the basis of positive Total IgELISA results 
‡‡
 Overall seroprevalence is the number of patients with a MAT titre ≥ threshold for any tested serogroup 
§§
 For representative serovars for each serogroup, see original references  
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Figure  7.1: Map of Tanzania showing regions and Leptospira seroprevalence estimates from published surveillance 
studies (Biggs et al., 2011, Schoonman and Swai, 2009, Chipwaza et al., 2015, Assenga et al., 2015).  
Arrowheads of labels indicate the approximate location of studies within each region.  
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7.1.2 Acute leptospirosis as a cause of human febrile illness in Tanzania 
Acute leptospirosis has been demonstrated as an important cause of febrile illness in in the 
Kilimanjaro Region of northern Tanzania (Crump et al., 2013, Biggs et al., 2011). A 
prospective cohort study was performed in two hospital facilities - Kilimanjaro Christian 
Medical Centre (KCMC) and Mawenzi Regional Hospital (MRH) - both located in the Moshi 
Municipal District, which is the administrative centre of the Kilimanjaro Region (Chapter ‎3.2). 
Between 17 September 2007 and 25 August 2008, 870 paediatric and adult patients with fever 
were enrolled into the study (Crump et al., 2013). Standard diagnostic tests including malaria 
screening by blood smear, bacterial and fungal blood culture and HIV serology were carried 
out on admission to the hospital. Retrospective serological diagnostic testing was performed 
for a range of tropical and zoonotic infections including leptospirosis at international reference 
laboratories. Cases of acute leptospirosis were identified using predefined case definitions 
based on WHO guidelines (World Health Organization, 2011). Confirmed acute leptospirosis 
was defined by a four-fold increase in MAT titre between acute and convalescent serum 
samples. Probable leptospirosis was defined as a MAT titre ≥ 1:8007 in a single serum sample.  
Of 831 patients with at least one serum sample available, 70 (8.4%) patients met the case 
definitions for confirmed or probable acute leptospirosis. Of 453 febrile patients with paired 
serum samples available, a total of 40 (8.8%) demonstrated a four-fold rise in antibody titre to 
at least one Leptospira serovar. However, attempts to isolate Leptospira bacteria from these 
patients were unsuccessful (Crump & Galloway, personal communication) and questions 
remain about the types of Leptospira involved in human disease in this region.  
  
                                                 
7
 This is a more stringent definition than suggested in WHO guidelines, which recommends a probable case 
should be defined as a single MAT titre ≥ 1:400. 
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7.1.3 Leptospira species and serovars associated with human leptospirosis in 
Tanzania 
Overall, little is known about the Leptospira serovars and species responsible for human 
leptospirosis in Tanzania. In the Kilimanjaro Region, serological data was used to identify 
common reactive serogroups in leptospirosis cases, which included serogroups Mini, 
Australis, Autumnalis and Icterohaemorrhagiae (Biggs et al., 2011). However, data from other 
studies that performed serology and Leptospira isolation in parallel indicate that the identity of 
an infecting Leptospira serovar cannot be accurately predicted with MAT, which is unable to 
reliably discriminate to the serovar level (Haake and Levett, 2015, Levett, 2003, Murray et al., 
2009). Whilst MAT reaction profiles can be useful to identify broad patterns of Leptospira 
serogroups circulating at the population level, cross reactions between serogroups are common 
in the acute phase, and may confound interpretation of MAT data (Levett, 2003, Goris and 
Hartskeerl, 2013). Therefore, definitive determination of the infecting Leptospira species, 
serovar and serogroup for individual patients requires direct serological or molecular typing of 
Leptospira isolates (Levett, 2001, Faine, 1994). Understanding and characterising Leptospira 
types responsible for human disease is vital to design locally appropriate MAT serovar panels 
for diagnosis as well as to identify sources and transmission routes for human infection. 
 
7.1.4 Limitations for diagnosis and surveillance of human leptospirosis in 
Tanzania  
The lack of robust information on human-infecting leptospires in animal hosts is a major 
limiting factor in our ability to identify sources for human infection in Tanzania. Leptospirosis 
is a complex multi-host disease and many different serovars associated with numerous animal 
hosts may be found in a single area (Bharti et al., 2003). Understanding which serovars and 
animal hosts are important for human disease is vital to target infection control strategies 
(Hartskeerl et al., 2011, Desvars et al., 2013a). A good working knowledge of Leptospira 
types in both humans and animals in a community is critical to design appropriate control 
programmes for human disease.  
 
 
  181 
For human disease surveillance and clinical management in Tanzania, providing an accurate 
and timely diagnosis of leptospirosis to patients at the point of care is an important limitation 
of the current health-care system. Laboratory diagnosis of leptospirosis remains challenging 
even in well-resourced high-income laboratory settings, which often use a complex, multi-
faceted approach to diagnose infection (Musso and La Scola, 2013). At present, little 
laboratory capacity exists to support the diagnosis of leptospirosis in most primary health-care 
facilities in Tanzania. Clinician awareness of the disease is poor (Chipwaza et al., 2014, Zhang 
et al., 2016) and leptospirosis is frequently misdiagnosed in tropical settings, as clinical signs 
in the acute phase are virtually impossible to differentiate from other causes of febrile illness, 
including malaria (Haake and Levett, 2015, Hartskeerl et al., 2011). Point-of-care diagnostic 
tests are needed to help improve case recognition in a clinical setting.  
Currently, all available diagnostic tests for Leptospira infection are associated with challenges 
or limitations that restrict their utility to provide an early diagnosis in resource-limited 
settings. Serological diagnostic tests such as the MAT can only provide a definitive diagnosis 
of leptospirosis in the convalescent stage of illness following seroconversion (Goris and 
Hartskeerl, 2013, Goris et al., 2012). Other serological approaches such as the IgM ELISA 
may be more sensitive than the MAT in the early phase of infection but lack diagnostic 
specificity in endemic settings (World Health Organization, 2011, Goris et al., 2011). The 
utility of culture and isolation to provide an acute phase diagnosis for leptospirosis is restricted 
by the long growth period of the organism (Levett, 2001). However other direct detection 
approaches such as PCR and real-time PCR (qPCR) may be of greater value to the clinician as 
they provide a rapid and more timely test result (Picardeau et al., 2014). Leptospira DNA can 
be detected in the blood of an infected patient during the first week of illness, and in urine in 
the subsequent phase weeks (Figure ‎1.2), although factors such as the timing of sampling, the 
leptospiral load and prior antibacterial use may reduce the diagnostic sensitivity of PCR assays 
in a clinical setting (Haake and Levett, 2015, Stoddard et al., 2009). However, an additional 
benefit of PCR detection is that sequence-based typing can be performed on PCR products to 
determine the infecting Leptospira species in positive cases, therefore generating additional 
epidemiological data on human infections (Boonsilp et al., 2011). PCR-based approaches have 
not yet been described for Leptospira infection in a Tanzanian health-care setting but the 
infrastructure to support PCR testing already exists in some of the larger Tanzanian hospitals. 
Hence PCR testing may offer a feasible tool to improve diagnosis of acute leptospirosis in 
Tanzania.  
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7.1.5 Goals and objectives of this study 
Although leptospirosis has been demonstrated as an important cause of febrile illness in 
northern Tanzania, little is known about the types of Leptospira that are infecting people in 
Tanzania. This lack of knowledge is limiting our ability to understand the sources and 
transmission routes for human infection and to design effective control programmes for the 
region. Furthermore, all diagnoses of acute leptospirosis in the Kilimanjaro Region have so far 
been made retrospectively at remote reference laboratories outside the country. Evaluating 
acute phase diagnostic tests for use at the point-of-care in Tanzania is an important next step in 
providing diagnostic data to inform patient care, and in establishing sustainable capacity for 
in-country disease surveillance.  
To address these limitations and knowledge gaps, this study component aims to address the 
following objectives:  
Objective 1: To pilot and evaluate the use of qPCR as a diagnostic assay to detect Leptospira 
infection in febrile patients in northern Tanzania; 
Objective 2: To explore patterns of Leptospira infection in pre-defined human cases to: 
i) identify and describe common human-infecting Leptospira types; 
ii) explore serological reactivity profiles within the cohort of cases.  
 
Objective 3: To infer possible sources of Leptospira infection by comparing available 
serological and molecular data from human patients with data from linked animal populations.  
  
  183 
 
7.2 Methods 
This study uses data and samples collected as part of the previously described hospital-based 
febrile disease cohort study performed in the Kilimanjaro Region of Tanzania. Full study 
details can be found in the following references: (Biggs et al., 2011, Crump et al., 2013). 
 
7.2.1 Selection of human samples for analysis 
Archived plasma (n = 372) and urine (n = 301) samples were available for patients enrolled in 
the febrile disease cohort study between September 2007 and August 2008. Samples and data 
from patients with acute leptospirosis were selected for further analysis on the basis of 
serological test results previously generated by the United States Centers for Disease Control 
and Prevention (US CDC) (Biggs et al., 2011). Leptospirosis testing was performed by MAT 
using a panel of 17 Leptospira serogroups (Table ‎7.2) (Biggs et al., 2011). Serological data 
available from the previous study were re-classified for this analysis based on new, more 
inclusive case definitions for acute leptospirosis. In line with current WHO recommendations, 
leptospirosis cases were defined as: 
1. Demonstration of seroconversion (four-fold rise antibody titre) by MAT on paired 
acute and convalescent serum samples; 
2. Single MAT titre of ≥ 1:400 on either acute or convalescent samples (World Health 
Organization, 2011).  
Plasma and urine samples from patients that met one or both of the case definitions were 
selected for molecular analysis. Plasma samples were also selected from five randomly 
selected febrile patients with no evidence of exposure to leptospirosis (MAT titres < 1:100 in 
paired acute and convalescent serum samples against any of the test serovars) as negative 
controls for the qPCR study.  
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Table  7.2: Serovars used for the diagnosis of human acute leptospirosis by 
Microscopic Agglutination Test (MAT) (Biggs et al., 2011) 
Serogroup Species and Serovar(s) Abbreviation* 
Australis L. interrogans serovar Australis 
L. interrogans serovar Bratislava 
AusAus 
AusBra 
Autumnalis L. interrogans serovar Autumnalis AutAut 
Ballum L. borgpetersenii serovar Ballum  BalBal 
Bataviae L. interrogans serovar Bataviae BatBat 
Canicola L. interrogans serovar Canicola CanCan 
Celledoni L. weilii serovar Celledoni CelCel 
Cynopteri L. kirschneri serovar Cynopteri CynCyn 
Djasiman L. interrogans serovar Djasiman DjaDja 
Grippotyphosa L. kirschneri serovar Grippotyphosa GriGri 
Hebdomadis L. santarosai serovar Borincana HebHeb 
Icterohaemorrhagiae L. interrogans serovar Mankarso 
L. interrogans serovar Icterohaemorragiae 
IctMan 
IctIct 
Javanica L. borgpetersenii serovar Javanica JavJav 
Mini L. santarosai serovar Georgia MinGeo 
Pomona L. interrogans serovar Pomona PomPom 
Pyrogenes L. interrogans serovar Pyrogenes 
L. santarosai serovar Alexi 
PyrPyr 
PyrAle 
Sejroe L. interrogans serovar Wolfii SejWol 
Tarassovi L. borgpetersenii serovar Tarassovi TarTar 
*Serovar abbreviations are used in the results of this chapter and included for reference here 
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7.2.2 DNA extraction from human plasma and urine samples 
DNA was extracted from archived human plasma and urine samples from the selected 
patients. DNA extraction from human plasma was performed as described in Chapter ‎3.6.4. 
DNA was extracted from human urine samples as described in Chapter ‎3.6.3.  
 
7.2.3 qPCR for the diagnosis of Leptospira infection 
 
lipL32 TaqMan® qPCR assay:  
All samples were run on MicroAmp® 96 well plates and tested in duplicate with the lipL32 
TaqMan® qPCR assay (Stoddard, 2013, Stoddard et al., 2009) and singularly with an internal 
control rnaseP qPCR assay as described in Chapter ‎3.7.2. Each plate included: two replicates 
of a Leptospira positive control; DNA extracted from L. interrogans serovar Copenhagenii 
Strain Wijnberg at ~10
2
 genome copies numbers; two replicates of DNA extracted from a 
human lymphoma cell line (HuLCL) as a positive control for the rnaseP reaction; two 
replicates of a non-template extraction control; and two replicates of a negative control (PCR-
grade water). Reaction runs were considered valid when at least one replicate of both positive 
controls (L. interrogans and rnaseP) amplified with Ct values < 40, and all replicates of the 
negative controls showed no evidence of amplification. Test reactions were considered 
positive with a Ct value < 40. 
 
16S (rrs) TaqMan® qPCR assay 
All samples were run on MicroAmp® 96 well plates and tested in duplicate with the 16S (rrs) 
TaqMan® qPCR assay (Smythe et al., 2002) as described in Chapter ‎3.7.4. Each plate 
included: two replicates of a Leptospira positive control; L. interrogans serovar Copenhagenii 
Strain Wijnberg at ~10
2
 copies numbers; two replicates of a non-template extraction control; 
and two replicates of a negative control (PCR-grade water). Reaction runs were considered 
valid when at least one replicate of the L. interrogans control amplified with Ct values < 40 
and when all replicates of the negative controls showed no evidence of amplification. Test 
reactions were considered positive with a Ct value < 40. 
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The outcome of each qPCR test was compared in contingency tables. The result of the rnaseP 
qPCR assay was used to monitor for inhibition in the samples. Samples negative for rnaseP 
amplification were excluded from further analysis.  
 
7.2.4 Analysis of patient data for leptospirosis cases 
Patient data collected by questionnaire at the time of study enrolment was extracted from the 
study database. Variables for analysis included factors that may influence the outcome of 
diagnostic testing, such as sample timing (days post onset (DPO) of illness) or patient reported 
prior antibiotic treatment; and spatial factors associated with patterns of Leptospira infection 
(home location defined by region, district and village). Region, district and village shapefiles 
were sourced from the Tanzania National Bureau of Statistics (NBS) Housing and Population 
Census 2012 (Tanzania National Bureau of Statistics, 2012). The core study area (Kilimanjaro 
Region) and home village for each patient was mapped using QGIS (Version 2.4.0-Chugiak, 
2014).  
Patients were grouped by DPO of clinical illness to assess the likely phase of their infection at 
the time of sample collection. ‗Week 1‘ defined as 1-6 DPO corresponds to the typical 
leptospiraemic phase when leptospires are most likely to be detectable in the blood 
(Figure ‎1.2). ‗Week 2‘ and ‗Week 3‘ defined as 7-13 DPO and 14-20 DPO respectively 
correspond to the typical leptospiruric phase.  
Data on urinary antibacterial activity (indicating recent antibiotic treatment) from samples 
collected at the time of study enrolment in the original febrile disease surveillance were also 
extracted from the study database. Urinary antibacterial activity was measured using a 
modified bioassay approach described for the epidemiological surveillance of antimicrobial 
use (Crump et al., 2011b, Liu et al., 1999). Briefly, filter paper discs soaked in patient urine 
were placed on plates of solid culture media pre-streaked with pure cultures of Bacillus 
subtilis, Escherichia coli, and Streptococcus pyogenes respectively. After overnight 
incubation, the diameter of the growth inhibition zone around each disc was recorded. For the 
purposes of this study, a patient sample with a zone of inhibition greater than the diameter of 
the test disc (8mm) for at least one of the three test bacteria was considered positive for 
urinary antibacterial activity. 
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7.2.5 Analysis of serological reactivity profiles in leptospirosis cases 
Serological profiles, previously generated at the CDC as described by Biggs et al. (2011), 
were also extracted from the study database for further analysis. Firstly, the predominant 
reactive serogroup, defined as either the serogroup with a four-fold rise in MAT titre for 
paired serum samples or the serogroup with the highest MAT titre for single serum samples 
(acute or convalescent) was determined for each case. The prevalence of each predominant 
reactive serogroup was calculated for the cohort of leptospirosis cases. Where equivalent titres 
were observed to more than one serogroup, all serogroups were recorded. Where patients met 
both definitions (i.e. a four-fold rise and a titre > 1:400) the predominant serogroup was 
defined as the serogroup with evidence of a four-fold rise.  
Serovar and serogroup serological reactivity was assessed within the cohort of cases. Heat 
maps plotted using in R (R Core Team, 2015) using the gplots package (Warnes et al., 2015) 
were used to identify distinct serological patterns and serogroup-specificity in acute and 
convalescent titres of leptospirosis cases. Briefly, all MAT titres for patients that met study 
case definitions were included. A negative result (MAT < 1:100) was given the value of 10 for 
the purpose of analysis. Data were arranged in a matrix where each row represented the log10-
transformed reciprocal MAT titres for a given patient and each column represented the MAT 
test serovar. Column order was fixed alphabetically by serovar. Initially, row ordering was 
generated at random to check that the results of subsequent clustering analyses were not 
influenced by the order of data entry. Next, Euclidean distances (i.e. square root of the sum of 
squared differences between the elements of a pair of rows) were calculated for pairwise 
sample comparisons between each row of the matrix (Everitt, 2005). A hierarchical clustering 
algorithm based on a complete linkage cluster methods was then used to reorder rows into 
groups of patients with similar reactivity profiles. Data were plotted using the clustered 
arrangement of patient samples, and colour coded according to the magnitude of the MAT 
titre.  
Spearman rank correlation coefficients were calculated to quantify pairwise associations in 
MAT titres between serovars in acute and convalescent serum samples respectively. 
Correlation coefficients for each pairwise comparison were displayed in a correlation matrix 
generated in R using the package corrgram (Wright, 2015). Significance levels of each 
pairwise correlation coefficient were set and displayed at p < 0.05 (*), p < 0.01 (**) and p < 
0.001 (***).  
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7.2.6 Using serological data to explore sources of human Leptospira infection  
Finally, data on human Leptospira infection was compared with data generated through linked 
animal studies, described in Chapter ‎6. Predominant serogroups from human cases were 
compared to those detected in cattle in the abattoir study and plotted in R using the 
VennDiagram package (Chen, 2015).  
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7.3 Results 
7.3.1 Samples for qPCR testing for Leptospira infection  
From the total study cohort, 73 patients met the case definitions for acute leptospirosis. 
Archived samples were available for qPCR testing from 62 (84.9%) cases. Both plasma and 
urine samples were available from 33 cases. Plasma samples only were available from 25 
patients, and urine samples only were available from four patients.  
 
7.3.2 Timing of presentation and prior antibiotic treatment  
The median time between onset of illness and study enrolment for all leptospirosis cases was 7 
days (range: 1 to 366 days) (n = 73). In total, 30 (41.1%) of 73 leptospirosis cases presented at 
hospital within the first seven days of clinical illness. Antibiotic treatment prior to study 
enrollment was reported in 21 (28.8%) cases.  For cases with plasma samples available for 
testing (n = 58), 22 (37.9%) were enrolled within the first week of febrile illness i.e. the 
leptospiraemic phase (Figure ‎7.2). Antibiotic treatment prior to study enrolment was reported 
by questionnaire in 19 cases (32.8%).  
 
Figure  7.2: Timing of presentation and reported prior antibiotic treatment for 
leptospirosis cases with plasma samples available for qPCR testing.  
Week1 Week2 Week3 Week4 Week5+
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For cases with urine samples available for testing (n = 37), 16 (43.2%) were enrolled within 
the hypothetical leptospiruric phase (7 to 21 days from the onset of febrile illness) 
(Figure ‎7.3). A further eight cases were enrolled after at least 21 days of clinical illness, when 
leptospiruria may persist intermittently. Antibiotic treatment prior to study enrolment was 
reported in 11 cases (29.7%). 
 
Figure  7.3: Timing of presentation and reported prior antibiotic treatment for 
leptospirosis cases with urine samples available for qPCR testing.  
 
7.3.3 Comparing reported antibiotic treatment with urine antibacterial activity 
Data on urinary antibacterial activity was available for 48 cases. In total, 31 (64.6%; n = 48) 
cases had evidence of urinary antibacterial activity by bioassay but only ten (20.8%; n = 48) of 
these cases had reported prior antibiotic treatment by questionnaire. Two (4.17%) patients that 
reported taking antibiotics prior to admission were negative for urinary antibacterial activity. 
Under-reporting of antibiotic use was estimated as 67.5% in this patient cohort (Table ‎7.3).   
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Table  7.3: Reported antibiotic treatment versus measured urinary antibacterial 
activity for: i) all leptospirosis cases; ii) cases with plasma available for qPCR 
testing; iii) cases with urine available for qPCR testing  
  Reported antibacterial treatment 
  i) All cases  ii) Plasma cases iii) Urine cases 




0 15 2 0 17 11 2 0 13 13 2 15 
1 21 10 0 31 15 9 0 24 12 9 21 
NA 15 9 1 25 12 8 1 21 1 0 1 
Total (n) 51 21 1 73 38 19 1 58 26 11 37 
Key: Positive (1); negative (0), not available (NA), total number (n). Discrepant results are 
highlighted in red. 
 
By week of illness, the greatest proportion of cases with evidence of urine antibacterial 
activity was observed in week 4 (100%, n = 2) and week 5 (87.5%, n = 8) although sample 
sizes were small. However, urine antibacterial activity was detected in 63.6% (n = 22) of cases 
enrolled in the first week of illness, suggesting that early antibiotic treatment prior to seeking 
hospital health-care is commonplace for patients with acute leptospirosis in the Kilimanjaro 
Region. 
 
7.3.4 qPCR for the detection of Leptospira infection  
With the exception of two urine samples, rnaseP was amplified for all tested samples (n =58 
plasma samples; 37 urine samples) indicating good DNA extraction efficiency and minimal 
PCR inhibition. No qPCR amplification was detected by either the lipL32 or 16S (rrs) 
TaqMan®® qPCR assays in DNA extracted from plasma and urine samples from leptospirosis 
cases or controls (Table ‎7.4).  
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Table  7.4: Summary of qPCR results (lipL32, 16S (rrs) and rnaseP) for plasma 
and urine samples from leptospirosis cases  
Sample 
type 
No. of seropositive 
samples tested 
No. of samples positive by qPCR assay 
rnaseP lipL32 16S (rrs) 
Plasma 58 58 0 0 
Urine 37 35 0 0 
Total: 95 93 0 0 
 
 
7.3.5 Summary of serological results from leptospirosis cases 
Paired acute and convalescent MAT titres were available for 39 (53.4%) of 73 leptospirosis 
cases that met one or both of the study case definitions. MAT titres from single serum samples 
were available for the remaining 34 patients, of which 32 were sampled in the acute phase of 
illness and two were sampled in the convalescent phase only.  
 
7.3.6 Geographic origin of leptospirosis cases  
Most of the leptospirosis cases (64.8%; n = 73) came from villages within the Kilimanjaro 
Region (Figure ‎7.4). In this region, the majority of cases came from villages within the Moshi 
districts (Moshi Rural (n = 24 patients from 20 villages) and Moshi Municipal (n = 17 patients 
from 14 villages). The remaining cases came from Hai District (14 patients from nine 
villages), two villages in Same District (n = 2) and one village in Mwanga District (n = 1). 
Cases were also detected from other Tanzanian regions including Manyara (n = 6), Arusha (n 
= 4), Tanga (n = 2) and Dodoma (n =1). Data on home location were not available for three 
cases.  
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Figure  7.4: Map of the Kilimanjaro Region showing home village locations of leptospirosis cases. 
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7.3.7 Predominant serogroups for leptospirosis cases 
In total, 11 predominant serogroups were recorded (Table ‎7.5). Serogroups Mini (30.1%), 
Australis (26.0%) and Autumnalis (13.7%) were the most prevalent predominant reactive 
serogroup in the cohort of leptospirosis cases. A single predominant serogroups could not be 
determined in six patients that demonstrated equivalent MAT titres to more than one 
serogroup. Of this six, five patients demonstrated equivalent reactivity to two serogroups by 
MAT (Autumnalis and Djasiman (n=2); Australis and Grippotyphosa (n=1); Australis and 
Mini (n=1); and Autumnalis and Mini (n=1)). In addition, one patient demonstrated equal 
titres to four serogroups (Australis, Autumnalis, Djasiman and Icterohaemorrhagiae).  
 
Table  7.5: Number and proportion (prevalence) of leptospirosis cases (n = 73) 
with each predominant serogroup  
Predominant serogroup Number of cases  Prevalence (%) 
Mini 22  30.1 
Australis 19  26.0 
Autumnalis 10  13.7 
Celledoni 6  8.22 
Icterohaemorrhagiae 3 4.11 
Djasiman 2 2.74 
Canicola 1 1.37 
Grippotyphosa 1 1.37 
Hebdomadis 1 1.37 
Pyrogenes 1 1.37 
Tarassovi 1 1.37 
Not determined* 6 8.22 
*Due to multiple serogroups with equivalent titres 
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7.3.8 Assessing serological patterns by heat map 
Acute and convalescent log10 transformed MAT titres were plotted as heat maps shown in 
Figure ‎7.5 and Figure ‎7.6. Leptospira MAT serovars (see Table ‎7.2 for full serovar details) 
were plotted on the x-axis with patients clustered by similarity shown by the dendrogram on 
the y-axis. The clustering algorithms reveal four main patterns (labelled on heat maps) in 
MAT titres that were observed in both acute and convalescent samples: 
A & AC:  Patients with no observed MAT titres (< 1:100) against any test serovar. For acute 
samples (A) this cluster comprises patients that were negative in their acute sample and 
demonstrated seroconversion between acute and convalescent samples (n = 9). For 
convalescent samples (AC), this cluster represents a group of nine patients of 39 patients with 
paired serology that met the case definition for a single elevated titre (MAT titre ≥ 1:400) on 
acute serology and did not demonstrate seroreactivity (MAT titre < 1:100) to any serovar on 
convalescent serology.  
B & BC: Patients with MAT titres against a single serogroup (B = 27; BC = 15). In both the 
acute and convalescent sample groups, several patients demonstrate high to moderate titres 
against serogroup Mini only. In the heat map showing convalescent serology data (BC), a 
second cluster of patients that show moderate to high moderate titres against Celledoni only 
can be seen.  
C & CC: Patients with titres to two to three serogroups (C = 20; CC = 11). In the acute 
serology sample set (C), patients in this group show evidence of seroreactivity mainly against 
serogroups Mini and Autumnalis, with a smaller number also demonstrating reactivity against 
serogroup Icterohaemorrhagiae. In the heat map showing convalescent serology data (CC), 
patients in this group show seroreactivity Australis, either alone or in combination with 
another serogroup (most commonly Mini but also Canicola, Djasiman or Icterohaemorrhagiae.  
D & DC: Patients with titres against more than three serogroups (D = 17; DC = 4). The heat 
map illustrating data from acute serology shows that nearly all the patients in this cluster (D) 
react to at least one Australis serovar and up to ten different Leptospira serovars. In general, 
convalescent serology data (DC) demonstrated greater serogroup specificity than acute 
serology and co-occurring reactivity between serogroups was more variable. 
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In the convalescent serology dataset, two patients show high titres (bright yellow) to multiple 
serogroups indicating a high degree of co-reactivity (EC). These hyper-reactive patients were 
excluded from further analysis of serogroup patterns for convalescent serology.  
Overall, acute MAT results from leptospirosis cases showed evidence of serological reactivity 
to 15 of 17 tested serogroups. Only Ballum and Pyrogenes (Figure ‎7.5) were not represented 
in reactive serogroups. In the convalescent serology dataset, titres were observed to fewer 
serogroups (n = 11) when the two hyper-reactive patients were excluded (Ec). The 
convalescent serology data of the remaining patients (n = 39) shows that titres were not 
observed to serogroups Bataviae, Cynopteri, Javanica, Pomona and Sejroe. Notably, titres to 
serogroup Autumnalis were seen less frequently in convalescent phase samples than in acute 
phase samples. Where observed, convalescent titres to Autumnalis were never seen without 
co-reactivity to at least one other serogroup.  
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Figure  7.5: Heat map showing log10 transformed MAT titres by Leptospira serovar for acute phase sera from human 
leptospirosis cases.  
The dendrogram on the y-axis illustrates the clustering of patients (rows) based on serological similarity. Colours indicate the magnitude MAT 
titres (Colour Key). Test serovars are shown on the x-axis (see Table  7.2 for full serovar details). Patterns in patient clustering are shown on 
the right: A: Patients with no observed MAT titres to any serovar (n = 9); B: Patients with titres to one serogroup (n = 27); C: Patients with 
titres to 2-3 serogroups (n = 20); D: Patients with titres against > 3 serogroups (n = 17). The hierarchical clustering algorithm used to make 
the dendrogram is continuous; hence sections D at the top and bottom of the axis are part of the same cluster.  
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Figure  7.6: Heat map showing log10 transformed MAT titres by Leptospira serovar for convalescent phase sera from 
human leptospirosis cases.  
The dendrogram on the y-axis illustrates the clustering of patients (rows) based on serological similarity. Colours indicate the magnitude MAT 
titres (Colour Key). Test serovars are shown on the x-axis (see Table  7.2 for full serovar details). Patterns in patient clustering are shown by 
on right: AC: Patients with no observed MAT titres to any serovar (n = 9); BC: Patients with titres to one serogroup (n = 15); CC: Patients with 
titres to 2-3 serogroups (n = 11); DC: Patients with titres against > 3 serogroups (n = 4); EC: Hyper-reactive patients not used for analysis of 
population patterns (n = 2).
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7.3.9 Assessing correlation in MAT titres between serovars 
Spearman‘s rank correlation coefficients (r) for pairwise comparisons between MAT titres are 
shown in matrix form in Figure ‎7.7 (acute serology data) and Figure ‎7.8 (convalescent 
serology data).  
A high degree of correlation in MAT titres was observed between multiple test serovars in the 
acute serology data set (Figure ‎7.7). As expected, highly significant correlations were 
observed between serovars of the same serogroup (for example; between serovar Australis 
(AusAus) and serovar Bratislava (AusBra) in the Australis serogroup (r = 0.84; p < 0.001), 
and between serovar Icterohaemorrhagiae and serovar Mankarso in the Icterohaemorrhagiae 
serogroup (r = 0.99, p < 0.001). However, strong correlations were also observed between test 
serogroups (for example, titres against serogroup Mini was significantly correlated with titres 
to the serogroups Canicola, Cynopteri, Icterohaemorrhagiae (both serovars) and Javanica).  
Much greater serogroup specificity was observed in the convalescent serology data set 
(Figure ‎7.8). Correlations between serovars belonging to the same serogroup were no longer 
significant suggesting relative serovar specificity (e.g. serovar Australis (AusAus) and serovar 
Bratislava (AusBra) in the Australis serogroup (r = 0.11; p > 0.05). However, some significant 
correlations between serogroups remained, even after exclusion of the two hyper-reactive 
patients (Ec described in Chapter ‎7.3.8). Significant correlated reactivity was observed 
between serogroup Canicola and Tarassovi (r = 0.79; p < 0.001); Canicola and Celledoni (r = 
0.56; p < 0.001); and Celledoni and Tarassovi (r = 0.56; p < 0.01) suggesting a potential 
association between all three serogroups. Weaker associations (p < 0.05) were observed 
between Autumnalis and Djasiman (r = 0.37); between Canicola and Djasiman (r = 0.32); and 
between Djasiman and Tarassovi (r = 0.32). However, no significant associations with any 
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Figure  7.7: Matrix of Spearman’s rank correlation coefficients (correlogram) for acute MAT titres from leptospirosis 
cases by test serovar. 
See Table ‎7.2 for full serovar details Statistical significance of pairwise correlation coefficients (label) is shown by stars (p < 0.05 (*), p < 0.01 
(**) and p < 0.001 (***). Shading corresponds to the numeric magnitude of the correlation coefficient ranging from -0.07 (white) to +1.00 (dark 
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Correlogram for leptospirosis cases: Acute MAT titres (n = 71)
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Figure  7.8: Matrix of Spearman’s rank correlation coefficients (correlogram) for convalescent MAT titres from 
leptospirosis cases by test serovar  
See Table ‎7.2 for full serovar details. Statistical significance of pairwise correlation coefficients (label) is shown by stars (p < 0.05 (*), p < 0.01 
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Correlogram for leptospirosis cases: Convalescent MAT titres (n = 39)
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7.3.10 Comparison of serological results between people and cattle 
Of 11 predominant serogroups observed in human cases, six serogroups - Australis, 
Grippotyphosa, Icterohaemorrhagiae, Mini and Tarassovi - were predominant reactive 
serogroups detected in cattle slaughtered at Moshi Municipal slaughter slabs (Chapter ‎6). 
The overlap between human and cattle predominant serogroups is shown in Figure ‎7.9. 
Mini was the most common predominant serogroup in both human cases (30.1%) and 
abattoir cattle (29.6%; Chapter ‎6.3.10). 
 
Figure  7.9: Comparison of predominant reactive Leptospira serogroups 


















  203 
7.4 Discussion 
This chapter aimed to advance our knowledge of the epidemiology of human leptospirosis 
in northern Tanzania by bringing together molecular and serological data from a cohort of 
leptospirosis cases.  
In-depth analysis of MAT serological profiles shows that seroreactivity to multiple 
serogroups is common in this patient cohort, particularly during the acute phase of 
infection. Convalescent serology showed much greater serogroup specificity and 
confirmed that two major Leptospira serogroups, Mini and Australis, are involved in 
human disease in northern Tanzania. None of the acute plasma or urine samples collected 
from serologically confirmed leptospirosis cases were positive by qPCR. A number of 
patient-related limiting factors including delays in seeking hospital health-care for severe 
febrile illness and widespread antibiotic use prior to presentation were identified that 
provide possible explanations for the lack of positive qPCR results in this study. Patient 
factors as well as logistical and diagnostic test limitations are therefore likely to limit the 
feasibility of qPCR as an acute-phase diagnostic test for Leptospira infection in Tanzania. 
Considerable efforts were made to control for the influence of laboratory factors on the 
outcome of qPCR testing in this study. Firstly, two complementary qPCR approaches 
targeting different Leptospira genes (lipL32, 16S (rrs)) were used. Both qPCR assays have 
been robustly validated in the literature (Stoddard et al., 2009, Galloway and Hoffmaster, 
2015, Bourhy et al., 2011, Smythe et al., 2002), and performed well in analytical validation 
studies described in this thesis (Chapter ‎4). Concurrent testing of appropriate clinical 
samples with two complementary assays has been shown to increase the probability of 
detecting DNA in an infected patient (Thaipadungpanit et al., 2011). The use of plasma 
rather than other blood derivatives was chosen as some studies have demonstrated 
relatively greater qPCR sensitivity in this sample type compared to serum or whole blood 
(Bourhy et al., 2011). The inclusion of urine samples in this study also increases the scope 
to detect infection, particularly in the later stages of infection (Haake and Levett, 2015). 
Finally, PCR inhibition has been described as a specific concern when testing urine 
samples (Burkardt, 2000, Schrader et al., 2012). The use of a human DNA control qPCR 
assay (rnaseP) run alongside the lipL32 TaqMan® qPCR allowed PCR inhibition to be 
monitored and accounted for (Stoddard et al., 2009). Only two urine samples failed to 
amplify human DNA and there was no evidence of amplification inhibition in any plasma 
sample (Table ‎7.4) detected in either plasma or urine samples. Therefore, the most 
parsimonious explanation for these results is that the amount of Leptospira DNA in these 
samples was less than the lower limit of detection (LLOD) of these qPCR assays 
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(Chapter ‎4). Factors related to sample timing or prior antibiotic treatment are considered to 
play an important role in the ability to detect Leptospira DNA in these leptospirosis cases.  
Timing of patient sampling is critically important to obtain a diagnosis of Leptospira 
infection by qPCR (Picardeau et al., 2014) The leptospiraemic phase when Leptospira 
organisms may be detected in the blood of an infected patient is limited to the first five to 
seven days of clinical illness, hence blood samples for qPCR must be taken during this 
period (Figure ‎1.2) (Haake and Levett, 2015). Less than half of the leptospirosis cases 
included in this study presented at hospital within the first week of clinical illness, and only 
22 of 58 cases with plasma samples available for qPCR were sampled during the likely 
acute leptospiraemic phase. For cases with urine samples available for testing, 24 of 37 
patients presented at the hospital after the hypothetical time of onset of the leptospiruric 
phase. However, the majority of these patients had evidence of urinary antibacterial 
activity indicating prior antibiotic treatment, which may have reduced the number of 
Leptospira organisms shed in the urine.   
Overall, prior antibiotic treatment is likely to be a major limiting factor in the ability to 
detect Leptospira DNA in samples from this patient cohort. In total, urinary antibacterial 
activity was detected in the urine of ~ 65% of leptospirosis cases, indicating that the 
majority of patients received antibiotic treatment prior to seeking health-care at either of 
the study hospitals. This was true even in patients that presented during the first week of 
clinical illness and in patients who did not report prior antibiotic use by questionnaire. 
Receiving antibiotic treatment early in the course of a clinical illness may eliminate 
Leptospira infection and reduce the number of patients experiencing secondary sequelae 
(Haake and Levett, 2015). However, early antibiotic treatment also decreases the 
probability of detecting Leptospira by qPCR, by reducing the bacterial load in the 
bloodstream in the acute phase and suppressing urinary shedding (Musso and La Scola, 
2013). Antibiotic treatment prior to study enrolment is therefore considered as an 
important limiting factor in the outcome of plasma and urine qPCR testing in this patient 
cohort. Notably, substantial under reporting of antibiotic treatment was observed in this 
patient cohort. Only around one-third (32.3%) of patients with urinary antibacterial activity 
reported prior antibiotic use by questionnaire. A lack of awareness of previous treatment 
(or of willingness to share this information) may be at least partially explained by 
understanding health-care seeking behaviours in the study community.  
The majority of leptospirosis cases came from the two Moshi Districts (Moshi Municipal 
and Moshi Rural) where a previous survey of health-seeking behaviour revealed that self-
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medication
8
 is preferred in this community as the initial response to a febrile disease 
episode (Panzner et al., 2016). Over 60% of study participants reported that they would try 
self-medication before seeking health-care at one of the study hospitals. Drugs for self-
medication are often purchased from informal drug sellers without medical supervision in 
East Africa (Bigogo et al., 2010). Informal drug markets often deal with cocktails of 
unspecified compounds (locally known as ‗dawa‘) that are marketed for particular 
symptoms or syndromes, such as fever and come with little information regarding their 
active ingredients. The use of generic drug cocktails may partially explain under-reporting 
of antibiotic use in the Moshi patients. However, antimicrobial products are also 
commonly available over the pharmacy counter in Moshi as are antimalarial drugs, many 
of which also contain antibacterial compounds (e.g. doxycycline, or Fansidar®, an 
antimalarial product that contains sulphonamide antibiotic (Murray et al., 2004, Basco, 
2004)). As malaria is still considered the main cause of febrile disease in Tanzania 
(Chipwaza et al., 2014, Reyburn et al., 2004), over-the-counter antimalarial drugs are 
likely to be a common first choice for self-medication of a fever. Furthermore, little 
regulation or medical supervision for the prescription of antimicrobial products is currently 
in force in Tanzania (Goodman et al., 2007). Factors such as these may have contributed to 
the high prevalence of urinary antibacterial activity and under-reporting antibiotic use 
reporting in study patients. However, regardless of the cause, widespread antibiotic use 
will reduce the feasibility of qPCR testing for Leptospira infection in this community and 
should be accounted for when evaluating diagnostic test performance.  
Given what we know about patient health-care seeking behaviour in northern Tanzania, 
even in the absence of positive qPCR results, the utility of implementing leptospirosis 
diagnosis by blood qPCR can now be estimated for this setting. Figures from this study 
suggest that 38% of leptospirosis cases that seek hospital health-care will do so in the first 
week of clinical illness. Of these, 64% will already have received antibacterial treatment 
and hence are not good candidates for testing. However, for approximately 14 cases out of 
every 100, qPCR still offers the possibility of a confirmatory diagnosis on an acute phase 
sample. If qPCR was used to test every patient with non-specific febrile disease that 
presented to the two study hospitals, this approach would detect one case of leptospirosis 
for every 100 patients tested (assuming that the true prevalence of disease is 8% (Biggs et 
al., 2011) and that the test has 100% diagnostic sensitivity). Investing in a diagnostic test 
that will benefit only 1% of patients seems hard to justify in a resource-limited setting. 
                                                 
8
 Self-medication is defined as deciding treatment autonomously for yourself or other members of your 
household without consulting a health-care professional 
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However, the lack of feasible diagnostic options for patient testing remains a major 
limiting factor for clinician awareness and disease surveillance on the continent. 
Continuing to explore acute phase test options for use in health-care settings in Africa 
should be an important research priority.    
The second major goal of this chapter was to explore patterns and potential sources of 
human-infecting Leptospira types. Analysis of serological data from leptospirosis cases 
was performed to explore patterns in MAT serogroup titres and identify Leptospira 
serogroups important for human infection in northern Tanzania. Consistent with prevalent 
serogroups reported in the original analysis of leptospirosis patients (Biggs et al., 2011), 
three serogroups - Mini, Australis and Autumnalis – were predominant among the reactive 
serogroups from human cases. However, patients frequently demonstrated MAT titres to 
more than one Leptospira serovar and for some patients a single predominant reactive 
serogroup could not be determined due to high MAT titres to more than one serogroup. 
Currently, traditional methods of analysing serological data typically focus on the 
serogroup with the highest titre (i.e. the predominant reactive serogroups) or serogroup-
specific seroprevalence (e.g. Table ‎7.1) (Goris and Hartskeerl, 2013). However, neither 
approach is able to account for cross-reactivity in serological profiles, which continues to 
be a major limiting factor in the use of serological data to determine infecting Leptospira 
serotypes in human cases.  
Serological reactions against multiple Leptospira serovars or serogroups may occur due to 
a number of reasons including:  
i) Co-infection with multiple different Leptospira serovars, which each generates their own 
specific antibody response; 
ii) True cross-reactivity among closely related serovars; either between two serovars within 
a serogroup, or between serogroups within a complex (e.g. Sejroe-Hebdomadis-Mini 
complex and MAT cross-reactions between these three serogroups are common (Royal 
Tropical Institute (KIT), 2014, Kmety and Dikken, 1993); 
iii) Specific immunological memory resulting from previous exposure that results in 
antibodies being produced to more than one Leptospira serovar in the event of infection or 
re-infection (Goris and Hartskeerl, 2013);  
iv) Non-specific immune response seen in the early stages of an antibody response to 
Leptospira or as part of another infectious or non-infectious disease syndrome (e.g. 
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infection with other spirochaetes or autoimmune conditions), resulting in non-specific 
agglutination of multiple serovars (Goris et al., 2012).  
Differentiating between serological reactivity to multiple serogroups as a result of co-
infection and cross-reactivity as a consequence of a non-specific immune response is 
clearly necessary to determine important human-infecting serotypes of Leptospira. As yet, 
there are few methods that have been described to tackle this important question.  
The heat maps and correlation matrices presented in this chapter represent an effort to 
explore patterns of serogroup cross-reactivity and serological reaction profiles in more 
depth. The two approaches used here are complementary. Heat maps allowed easier 
visualisation of complex seroreactivity patterns in the data set (Figure ‎7.5 and Figure ‎7.6) 
and correlation matrices offer quantitative estimations of correlated reactivity and can be 
used to improve the confidence of our infecting serogroup predictions. Heat maps have 
previously been used to explore serological data from epidemiological serosurveillance for 
leptospirosis (Lelu et al., 2015, Halliday, 2010), but to our knowledge have not been used 
to describe for MAT data from a cohort of patients with acute febrile disease. 
Both approaches demonstrated that MAT serogroup specificity is much greater in 
convalescent serology than acute serology. The high degree of correlated reactivity 
observed in acute serum samples limits the utility of MAT data from acute samples to 
determine patient infecting serogroup (Figure ‎7.7). This pattern is widely reported in the 
literature and explains in part why data from acute-phase MAT is inconsistent in 
determining infecting serogroup (Haake and Levett, 2015, Levett, 2003). However, MAT 
titres performed on convalescent serum samples showed much greater serogroup 
specificity, demonstrated quantitatively by reduced correlation between serogroups 
displayed in the correlation matrices (Figure ‎7.7 and Figure ‎7.8). This result suggests that 
analysis of serological results from convalescent patients may provide valuable 
opportunities for investigating serogroup infection patterns in human leptospirosis.  
In this patient cohort, a larger number of patients demonstrated titres to a single serogroup, 
most commonly to serogroups Mini, Australis or Celledoni in the convalescent serology 
data set than in the acute serology data. High titres to a variety of other serogroups were 
also seen although usually these co-occurred with reactivity to at least one other serogroup 
(e.g. Tarassovi or Icterohaemorrhagiae). Interestingly, very little seroreactivity to 
Autumnalis was seen in convalescent samples despite being one of the most common 
serogroups in the predominant reactive serogroup analysis presented in this chapter 
(Chapter ‎7.3.7) and in previous analysis of this dataset (Biggs et al., 2011). In the acute 
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serology dataset, MAT titres against serogroup Autumnalis were highly correlated with 
titres to many other serogroups (Figure ‎7.7), but were largely absent or very low in the 
convalescent serology dataset (Figure ‎7.6 and Figure ‎7.8). Therefore, in this patient cohort, 
reactivity to serogroup Autumnalis could be interpreted as a non-specific acute phase 
reaction rather than a true indicator of infecting serogroup.  
Visualisation and clustering of patient MAT titres by heat map revealed a group of nine 
patients with substantial MAT reactivity (≥ 1:400) in their acute phase samples, but no 
MAT titres (< 1:100) in convalescent samples (Chapter ‎7.3.8; Group AC). This finding 
suggests that the specificity of the MAT to diagnose leptospirosis could be compromised 
when relying on single acute phase samples in Tanzania. Based on our current 
understanding, antibody titres typically remain elevated for months to years following 
Leptospira infection (Cumberland et al., 2001), although early antibiotic treatment has 
been reported to interfere with the immune response to infection and some specific 
serovars are also associated with a short duration of serological reactivity (Goris et al., 
2013c, Musso and La Scola, 2013, Haake and Levett, 2015). Whilst a presumptive 
diagnosis of leptospirosis may be made on the basis of a single MAT titre ≥1:400 
according to WHO guidelines, the broad applicability of this definition is still under debate 
(Goris et al., 2012, World Health Organization, 2011). Some studies advocate the use of a 
more conservative MAT cut-off titre for diagnosis in an endemic setting (Biggs et al., 
2011, Cumberland et al., 1999, Cumberland et al., 2001). Local validation of appropriate 
case definitions is also recommended (Goris et al., 2012).  
Regardless of the method of analysis, the data presented here indicates that least two 
serogroups of Leptospira – Mini and Australis – are important human infection in northern 
Tanzania. Leptospira serovars belonging to the serogroup Australis have been previously 
isolated from people and animals in East Africa (Chapter ‎2). Within the serogroup, L. 
kirschneri serovar Ramisi was originally isolated from the blood of patient from the 
Coastal Province of Kenya in the 1970s (de Geus, 1971, Dikken et al., 1979, de Geus et al., 
1977a), and L. interrogans serovar Lora has also been isolated from multimammate mice 
(Mastomys natalensis) sampled in the Morogoro region of southern Tanzania (Mgode et 
al., 2015). Serological evidence of agglutinating antibodies to serovar Lora has also been 
previously reported in human seroprevalence studies in Tanzania (Assenga et al., 2015, 
Chipwaza et al., 2015) and in abattoir cattle in this study (Chapter ‎6 and Figure ‎7.9). 
Although both cattle and small mammals are implicated in the epidemiology of Australis 
infection in Tanzania, in other settings other animals such as pigs, dogs, hedgehogs and 
horses are considered major maintenance hosts of the Australis serovars, particularly of L. 
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interrogans serovar Bratislava (Ellis, 2015, Hamond et al., 2014). Given the high 
prevalence of Australis sero-reactivity in people, combined with the low seroprevalence in 
cattle in the abattoir study (Table ‎6.8) and absence of rodent Leptospira infection in this 
area (Chapter ‎5), it seems unlikely that cattle or rodents are the source of Australis 
infection for people in Moshi. Further investigation into other Australis hosts in the area is 
therefore warranted, particularly as pigs and dogs are both commonly kept in the two 
Moshi Districts (Table ‎5.3) 
Very little is known about serogroup Mini in Tanzania. To date, Leptospira isolates of the 
serogroup Mini have not been reported anywhere else in mainland Africa, although isolates 
belonging to the Mini serogroup have been isolated from people, rodents and other small 
mammals on the nearby islands of Mayotte and Madagascar (Chapter ‎2) (Bourhy et al., 
2010, Bourhy et al., 2014, Desvars et al., 2012, Dietrich et al., 2014). It is unclear how 
widespread human serological exposure to Mini is in Tanzania as this study is the first in 
the country to include serogroup Mini on MAT test panels (Table ‎7.1). However, exposure 
to serogroup Mini is common in cattle sampled in the abattoir surveillance component of 
this thesis (Chapter ‎6 and Figure ‎7.9), indicating that cattle are also to be involved in the 
epidemiology of Mini infection in the Kilimanjaro Region. 
Overall, Leptospira exposure in people and cattle appears closely linked in Tanzania. 
Cattle sampled in abattoirs close to the study hospitals share a number of predominant 
serogroups with human leptospirosis cases (Figure ‎7.9). Serogroup Mini was the most 
prevalent serogroup in both cohorts. Published seroprevalence surveys also indicate that 
livestock infection may be a risk factor for human exposure. Milking cattle is a risk factor 
for human seroprevalence in Tanga (OR 3.44; 95% CI 1.76 – 6.75; p < 0.001) (Schoonman 
and Swai, 2009). Rural residence, which is often associated with livestock keeping, was 
also recognised as an important risk factor for human leptospirosis in this study cohort 
(Biggs et al., 2011).  
However, attributing the sources of Leptospira infection for people requires more robust 
evidence than serological data can provide. Although serogroup patterns are a useful first 
step, most serogroups contain several distinct serovars (for example; serogroup Australis 
contains 14 known serovars (Royal Tropical Institute (KIT), 2014)). Direct demonstration 
and typing of the pathogen is necessary in both populations. Further work is needed to 
characterise infecting Leptospira in human cases and potential animal hosts to determine 
the sources and plausible transmission routes of human infections. Additional effort to 
empower clinicians to diagnose the aetiology of febrile illness in patients is particularly 
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important in areas such as Tanzania where malaria over-diagnosis is becoming endemic, 
and non-malarial causes of febrile illness often overlooked (Reyburn et al., 2004, Chandler 
et al., 2008, Crump et al., 2013). However, where human disease is recognised, livestock 
should be considered as a potentially important source of human infection.  
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8 Discussion 
8.1 Investigating the epidemiology of leptospirosis in northern 
Tanzania: study conclusions  
Leptospirosis is one of the most widespread zoonotic diseases around the world but many 
aspects of the disease remain poorly understood, particularly in Africa. The incidence of 
human disease remains poorly quantified for the continent as a whole, but robust evidence 
exists for the occurrence of acute human leptospirosis in many regions (Chapter ‎2)(Allan et 
al., 2015a) and East Africa in particular is predicted to have a high burden of human 
disease (Costa et al., 2015a). This study was established following the demonstration of 
leptospirosis as an important cause of non-malaria febrile illness (NMFI) in northern 
Tanzania (Crump et al., 2013). An integrated ‗One Health‘ approach was taken to explore 
Leptospira infection in linked human and animal populations in Moshi, with an over-
reaching goal of identifying possible animal sources of infection for people and informing 
future disease control strategies. The findings of this study have generated some novel and 
unexpected insights that both advance and challenge our understanding of the 
epidemiology of leptospirosis in this area. Although most of this thesis describes results 
from a specific site in Tanzania, the demonstration of widespread human and animal 
infection by the systematic review (Chapter ‎2) indicates that leptospirosis is an 
omnipresent health threat across Africa. Hence the findings of this thesis may have a 
broader relevance to the epidemiology of leptospirosis on the continent as a whole.  
A number of key challenges exist that continue to limit our ability to monitor and control 
leptospirosis in Africa and in other parts of the world. For people, diagnosing leptospirosis 
in the event of an acute infection or disease outbreak still remains an enormous challenge. 
In Africa, improved performance and uptake of malaria diagnostic tests have highlighted 
the growing problem of malaria-negative febrile patients and the deficit of diagnostic tools 
for alternative aetiologies of febrile disease (Chappuis et al., 2013, Petti et al., 2006, 
Chandler et al., 2008). The non-specific nature of acute leptospirosis means that it is 
clinically indistinguishable from malaria and several other infectious causes of febrile 
illness (Haake and Levett, 2015). The lack of a highly sensitive and specific acute-phase 
test for human leptospirosis is a recognised problem within the leptospirosis community 
(Picardeau et al., 2014, Hartskeerl et al., 2011) and is likely to hinder attempts to monitor 
the disease in Africa. Studies have also shown that clinician awareness of leptospirosis and 
a variety of other causes of non-malarial febrile illness (NMFI) is lacking (Zhang et al., 
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2016, Chipwaza et al., 2014). The scale of this problem was plainly demonstrated in the 
study of febrile illness from northern Tanzania that is linked with this thesis (Chapter  7). 
More than 60% of this cohort of febrile patients received a clinical diagnosis of (and 
treatment for) malaria but only 1.6% of patients were positive for acute malaria infection 
on laboratory tests (Crump et al., 2013). Leptospirosis was definitively diagnosed as the 
cause of illness in approximately 9% of these patients, but was not listed as a clinical 
diagnosis in any case (Crump et al., 2013).  
Despite a high burden of disease in the local area (Biggs et al., 2013b), laboratory testing 
for Leptospira infection is not routinely performed in Moshi. For research studies, so far 
cases have been diagnosed retrospectively by MAT serology at international reference 
laboratories, with little scope to inform acute patient care. A reliable and practical 
diagnostic approach that could empower clinicians to diagnose leptospirosis in the acute 
phase of illness is clearly needed in this setting. Acute-phase serological tests have been 
trialled in children with febrile illness in central Tanzania, but showed relatively low 
diagnostic specificity when compared to MAT for confirmatory testing (Chipwaza et al., 
2015). So far, direct detection methods of diagnosing human leptospirosis have not been 
successful at detecting infection in Tanzania (e.g. qPCR in this study (Chapter  7) and 
culture in on-going hospital febrile disease surveillance (John Crump and Renee Galloway, 
personal communication)). However, this failure to detect infection is not simply the result 
of poor test performance, but also reflects broader social issues surrounding health-care 
seeking behaviour and self-medication (Chapter  7). The widespread use of antibiotics in 
Tanzania may limit the utility of a direct detection test for Leptospira. Further work is 
needed not only to improve diagnosis and clinical management of leptospirosis but also to 
reduce the unregulated use of antimicrobials in these communities, which is of widespread 
concern with respect to antimicrobial resistance (Okeke et al., 2005, Leopold et al., 2014).  
Although qPCR did not demonstrate good utility as a diagnostic test for human disease, the 
use of this testing method proved practical and productive in animal populations sampled 
in this study. qPCR was more sensitive than culture at detecting renal Leptospira infection 
and widespread application of the assays revealed some surprising and unusual patterns of 
infection. Infection was demonstrated in cattle, sheep and goats from across northern 
Tanzania but no evidence of Leptospira infection could be detected in peri-domestic 
rodents sampled from an area with a high burden of human disease (Chapters  5 and  6).  
Worldwide, rodents are thought to be the most important source of human leptospirosis 
(Haake and Levett, 2015) and Leptospira infection in common invasive rodent species, 
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such as Rattus rattus or Mus musculus sampled in this study, is generally considered to be 
a ubiquitous phenomenon (Levett, 2001, Kosoy et al., 2015, Thiermann, 1983). However, 
based on the absence of infection in invasive rodents in this study, we can conclude that 
these rodent species are not always hosts of Leptospira infection in Tanzania and therefore 
are not always responsible for human disease. These findings were unexpected, 
particularly as many of the species tested in this study have been shown to be hosts of 
Leptospira infection in other settings (Rahelinirina et al., 2010, Felt et al., 2011, Mgode et 
al., 2005). However, similar results were also reported in a recent study of R. rattus in 
Niger (Dobigny et al., 2015) indicating that this is not a unique scenario. Further research 
is needed to explore whether this pattern of rodent infection occurs more widely in 
Tanzania and sub-Saharan Africa.  
For the febrile patients of Moshi who became unwell in 2007-08 (Crump et al., 2013, 
Biggs et al., 2011), it still remains a possibility that rodents were involved in infection 
transmission. The rodent survey (2013-14) described in this thesis was performed five 
years after the original hospital surveillance. Data emerging from more recent studies in 
Moshi indicates that the incidence of acute human leptospirosis was substantially lower 
over the same time period. Between 2012-14, human leptospirosis incidence was estimated 
as 11-18 cases per 100,000 per year compared to 75-102 cases per 100,000 per year 
between 2007-08 (Maze et al., in preparation). These rather dramatic changes in incidence 
indicate that the dynamics of infection are unstable in this population and therefore it is 
possible that similar trends also occur in the local rodent populations. Longitudinal 
monitoring of both human and animal infection is advocated to better understand the 
epidemiology of infection in this area.  
The absence of rodent infection in Moshi gave a strong indication that other animal sources 
of Leptospira are more important than rodents for the transmission of infection to people. 
Demonstration of Leptospira infection in ruminant livestock coupled with evidence of 
serogroup similarities between cattle and people with acute disease led to the hypothesis 
that ruminant livestock are an important source of Leptospira infection for people in 
northern Tanzania.  
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8.2 The livestock hypothesis: implications for disease control  
Several strands of evidence from this study support a hypothesis of livestock to human 
Leptospira transmission in this setting. Firstly, the high prevalence of Leptospira infection 
in the kidneys and urine of cattle sampled in the Moshi slaughterhouses (Chapter ‎6.3.5 
and ‎6.3.6) indicated that bovine Leptospira infection and urinary shedding is 
commonplace. Infection was demonstrated in cattle that originated from regions across the 
north of Tanzania. Leptospira infection was also demonstrated in sheep and goats, which 
are the most common ruminant livestock species kept by smallholders in the Moshi area 
(Table ‎5.4). Finally, analysis of serological data revealed similarities between predominant 
reactive serogroups seen in cattle and people with acute leptospirosis, providing the most 
robust evidence for a linkage between Leptospira infections in these two populations 
(Chapter ‎7.3.10). Collectively, this evidence led to the conclusion that ruminant livestock 
are an important reservoir of Leptospira infection for people in northern Tanzania, and that 
efforts to prevent and reduce human disease should also include control in ruminant 
livestock populations. 
Identifying livestock as a major source of human infection rather than rodents has some 
crucial implications for the control strategies that may be appropriate (Hartskeerl et al., 
2011). Disease interventions for leptospirosis, and zoonotic infectious diseases more 
broadly, can be considered in three broad groups: 1) control efforts that directly protect 
individual people from infection such as vaccination; 2) transmission blocking tactics that 
reduce the amount or types of contact that people have with a source of infection; or 3) 
interventions that control the disease ‗at source‘ by reducing infection within a reservoir of 
infection (Haydon et al., 2002). In general, human vaccination for leptospirosis is not a 
very practical means of reducing human infection (Haake and Levett, 2015, Bharti et al., 
2003), particularly in an area such as Tanzania where multiple serogroups appear to be 
circulating but remain poorly characterised. Globally, leptospirosis control efforts largely 
focus on either controlling infection in source populations (e.g. vaccination in cattle to 
reduce shedding (Bolin and Alt, 2001)) or blocking transmission between people and the 
source of infection (e.g. controlling flooding risks (Lau et al., 2010)). However, both of 
these strategies require a greater understanding of the dynamics of infection in a reservoir; 
for example, which animal hosts are critical for the maintenance of infection (Viana et al., 
2014); and also the major routes of transmission routes from the source of infection to 
people (Haydon et al., 2002).  
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An extra complicating factor for the control of livestock to human Leptospira infection is 
that multiple types of Leptospira have been identified in ruminant livestock species in 
Tanzania. Serological data (Chapter ‎6) indicates that multiple serotypes of Leptospira are 
circulating in cattle populations and as yet, these serotypes have been poorly characterised. 
Two major genetic species have been detected in ruminant livestock (L. borgpetersenii and 
L. kirschneri) that are likely to have different dynamics within a reservoir due to their 
different environmental survival capabilities for example (Bulach et al., 2006). Therefore 
livestock-associated maintenance and transmission of Leptospira is likely to be complex 
and involve multiple host species. In northern Tanzania, the specific role of each livestock 
host of Leptospira is still poorly understood. However, based on the available evidence, 
plausible scenarios for infection maintenance and transmission can be proposed with 
different implications for disease control  
 
8.2.1 Livestock maintenance of Leptospira infection in northern Tanzania 
In the disease ecology literature, an infection reservoir has been defined as ‗one or more 
epidemiologically connected populations (or environments) in which the pathogen can be 
permanently maintained, and from which infection is transmitted to the defined target 
population‘ (Haydon et al., 2002, Viana et al., 2014). In a particular setting, an infection 
reservoir may include a mixture of maintenance hosts (defined as a host population which 
is able to independently maintain infection over a prolonged period of time, without 
reintroductions (Viana et al., 2014)), non-maintenance hosts and contaminated 
environmental sources that all contribute to the transmission of infection to the target 
population. The role of different animal hosts within this reservoir has implications for 
designing effective disease control interventions (Haydon et al., 2002). A general 
framework for characterising reservoirs of disease has been laid out by (Viana et al., 2014), 
and can broadly be used to consider the potential roles of cattle in the reservoir of 
leptospirosis for people in northern Tanzania.  
Firstly cattle in northern Tanzania could be maintenance hosts of a particular type of 
Leptospira bacteria that is permanently maintained within the cattle population by direct 
cow-to-cow transmission. Most simply, human infection would be acquired through direct 
contact with an infected cow. Therefore, reducing infection within cattle populations, for 
example by vaccination or treatment, would be an effective way to reduce transmission of 
infection to people.  
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Alternatively, cattle may be non-maintenance hosts of a particular type of Leptospira in 
northern Tanzania. This definition approximately translates to the ‗incidental‘ host of 
Leptospira infection described in the leptospirosis literature (Levett, 2001). The outcome 
of Leptospira infection in a non-maintenance host may be less predictable than in a 
maintenance host and may vary by both the Leptospira type and the particular host species 
in question. In a non-maintenance host of Leptospira, infection and shedding may be short-
term or transient and hence that host may make little contribution to the overall reservoir of 
infection. This kind of infection is often termed a ‗dead-end‘ infection and is epitomised by 
the pattern of Leptospira infection in people (Haake and Levett, 2015). Alternatively, more 
persistent infection and shedding may be established in a non-maintenance host. In this 
case, the host could still be a source of infection for people (and other animals) but is 
unable to permanently maintain infection in the absence of re-introductions from other 
sources such as other livestock species or contaminated environmental sources. If cattle are 
in fact a non-maintenance host of a particular type Leptospira in northern Tanzania, 
reducing infection in cattle may still have direct benefits for human health by removing 
one potential source of infection. Furthermore, preventing or controlling infection in cattle 
may also have direct benefits to the animal, particularly if the serovar in question results in 
clinical disease. However, the design of an effective control program in this scenario 
should also consider the possibility of infection transmission from other animal hosts (i.e. 
not cattle) or environmental sources to people. Therefore, transmission-blocking strategies 
may be particularly relevant, especially where multiple animal host species are involved.  
By the species of Leptospira detected in livestock in this study, we can hypothesise that 
cattle are the most likely maintenance hosts for L. borgpetersenii in northern Tanzania. 
This hypothesis is supported by the high proportion of bovine infections attributed to this 
species; the current lack of evidence for other livestock hosts of this Leptospira type; and 
the existing literature describing the epidemiology of L. borgpetersenii in cattle 
populations in other settings around the world (Ellis, 2015). However, the presence of L. 
kirschneri in multiple host species, coupled with the likelihood of better environmental 
survival of this pathogen (Bulach et al., 2006) implies that cattle are probably part of a 
more complex multi-host reservoir community for this Leptospira species. Based on this 
evidence we would therefore recommend that interventions for L. borgpetersenii are 
targeted at cattle populations alone, but control of L. kirschneri may require a broader 
multi-species or ecosystem approach. Fully characterising and understanding the complex 
dynamics of the relationship between a host and a particular Leptospira type is not possible 
by small-scale cross-sectional sampling as performed in this study. However, these 
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hypotheses represent a critical first step towards designing intervention trials and 
identifying priorities for future research. 
 
8.2.2 Transmission of Leptospira from livestock to people in northern 
Tanzania 
Assuming that cattle-to-human transmission of Leptospira does occur, minimising the 
contact of people with infected animals is another approach that may be useful in 
preventing human disease. This is likely to be a much greater challenge in a developing 
country setting like Tanzania where more than 75% of the working population is employed 
in agriculture (Food and Agriculture Organization of the United Nations, 2005), compared 
to in high-income countries like the UK where the industry employs just 1.5% of the 
population (Department for Environment Food and Rural Affairs et al., 2012).  
Occupational exposure to infected livestock is an important risk factor for human 
leptospirosis in a number of settings (Mwachui et al., 2015). Some of the most robust data 
on occupational leptospirosis transmission comes from New Zealand where leptospirosis is 
an important work-related health threat for farmers and abattoir workers (Dreyfus et al., 
2014a, Dreyfus et al., 2014b). In Moshi, figures from the abattoir study indicate that 
around 90 of the 550 or so cattle that pass through the Moshi slaughterhouses in an average 
week will be infected with Leptospira bacteria week (Figure ‎6.2). These animals may pose 
a considerable infection risk for slaughterers, butchers and Livestock Field Officers (LFOs) 
working in these settings.  
However, in Tanzania, livestock keeping is more of a way of life in subsistence 
communities than a specific occupation. In the core Moshi study areas, ~ 38% of 
households reported keeping ruminant livestock, mostly sheep and goats (Table ‎5.3) and 
most respondents kept their livestock in zero-grazing units in close proximity to their home 
(data not shown). Contact with ruminant livestock and their waste is therefore a regular 
part of day-to-day life in this setting rather than an occupationally associated risk per se. 
Exposure through home slaughter may also be important in some settings (Qekwana and 
Oguttu, 2014, Ernest et al., 2009). 
Finally, the possibility of exposure to Leptospira infection through the meat supply chain 
of bovine meat products remains a possibility. Oral transmission (i.e. eating contaminated 
meat) is not considered to be a major source of infection but butchering and preparing raw 
offal foodstuffs may pose a risk for transmission (Dreyfus et al., 2014a). Bovine kidneys 
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are a valuable food item for people in the Moshi area and as around 7% of cattle kidneys 
sampled in this study were positive for infection with pathogenic Leptospira bacteria, 
handling kidneys during food preparation is another potential route of infection for people.  
Finally, indirect transmission of Leptospira infection from cattle to people through the 
environment may also play a role. This route is less likely to be important for L. 
borgpetersenii due to reduced environmental survival as previously mentioned (Bulach et 
al., 2006). Environmental contamination with infectious leptospires could occur anywhere 
that cattle urinate, from grazing areas and watering holes, to markets and slaughterhouse 
holding areas. However, quantifying and controlling environmental transmission of 
Leptospira is notoriously challenging (Munoz-Zanzi et al., 2014b, Faine, 1994) and 
controlling the infection in the host population may be a more feasible option.   
 
8.2.3 The impact of leptospirosis on livestock health and productivity in 
Tanzania 
Control of Leptospira in cattle populations may also be important for animal health and 
productivity as well as to prevent zoonotic transmission of infection to people. L. 
borgpetersenii serovar Hardjo, which was isolated from cattle in this study, is recognised 
as a commercially important infection in developed country settings and may result in 
abortion, infertility and reduced milk production (Dhaliwal et al., 1996a, Dhaliwal et al., 
1996b, Thiermann, 1982). However most of the information on the clinical impact of 
bovine Leptospira infection comes from countries with intensive livestock production 
systems where Bos taurus breeds predominate. To date, there is very little field or 
experimental data describing the effects of Leptospira infection on Bos indicus breeds, 
which predominate in much of sub-Saharan Africa (Mwai et al., 2015). All the Leptospira-
infected cattle reported by this study were humped Zebu cattle, a major sub-group of B. 
indicus cattle in that are commonly kept by subsistence farmers and pastoralist 
communities in East Africa (Mwai et al., 2015). Evidence generated by this study 
demonstrates that B. indicus cattle are susceptible to Leptospira infection but there is 
virtually no information in the literature regarding clinical leptospirosis or the dynamics of 
infection in a B. indicus host. Even the small number of studies reporting clinical 
leptospirosis in cattle in Africa identified by systematic review (Chapter ‎2.3.10) reported 
disease in B. taurus breeds (Burdin et al., 1958, Te Brugge and Dreyer, 1985). This lack of 
data may well be a consequence of under-reporting but it also may be the case that 
differences in disease susceptibility exist between the two bovine species. Between B. 
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taurus and B. indicus breeds, differences in resistance to tick infestations are reported 
(Piper et al., 2009) as well as varying susceptibility to parasitic diseases such as 
trypanosomiasis (Mwai et al., 2015). It is also possible that relative differences also occur 
in susceptibility to clinical leptospirosis, and more work is needed to explore the outcome 
of Leptospira infection in Tanzanian cattle. 
Quantifying the effects of Leptospira infection in Tanzanian livestock-keeping 
communities is also an important priority to help assess the true impact of Leptospira 
infection. Overall, livestock play a major role in the socio-economic development and food 
security of many communities in sub-Saharan Africa (Otte and Chilonda, 2002) and in 
Tanzania (Food and Agriculture Organization of the United Nations, 2005). In subsistence 
farming communities, which depend on ruminant livestock for food, even small-scale 
production losses may have a considerable impact on food security (Sansoucy et al., 1995). 
In particular, livestock infections that result in reduced milk production have been shown 
to have negative consequences for childhood nutrition (Shinsugi et al., 2015, Mosites et al., 
2015). Furthermore, livestock reproductive failure through abortion or infertility may have 
a considerable detrimental impact on household income, which is particularly critical for 
small-scale or subsistence farmers (Grace et al., 2012a, Zinsstag et al., 2007). Zoonotic 
diseases like leptospirosis therefore have the potential to have many detrimental effects on 
the well-being of livestock-keeping communities (Maudlin et al., 2009) and controlling 
these diseases is advocated as one method of poverty alleviation for ‗the world‘s rural 
poor‘ (Hotez, 2009, World Health Organization, 2006, Halliday et al., 2015). 
Increasingly, the argument is also being made to include animal losses into a more 
comprehensive estimate of disease impact for zoonotic diseases (Molyneux et al., 2011, 
Zinsstag et al., 2007). Typically, estimates of the global burden of disease focus only 
human illness and death in the Disability Adjusted Life Years (DALY) metric (Murray et 
al., 2012, Torgerson et al., 2015) and do not account for the insidious effects of animal 
disease on human health. Accurately estimating these effects may be difficult where 
multiple production-limiting diseases are circulating. However, specifically for Leptospira 
infection, examples exist where either case-control approaches have been used to estimate 
the impact of infection in livestock (Ayanegui-Alcerreca et al., 2007), or vaccine trials 
have allowed the magnitude of Leptospira-attributable production losses to be quantified 
(Dhaliwal et al., 1996b). Similar approaches could be used in East Africa to improve our 
understanding of the full burden of disease in this setting. 
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8.3 Future directions for leptospirosis research in Tanzania 
Over the course of this thesis, several key questions have been identified for future 
research on leptospirosis in Tanzania and elsewhere in Africa.  
Question 1: How representative is Moshi of the incidence of human infection and the 
epidemiology of leptospirosis elsewhere in Tanzania? 
An immediate question arising out of this research is whether this site in the north of 
Tanzania is unique in its high incidence of human disease and absence of Leptospira 
infection in rodents. In the initial hospital febrile surveillance study, the incidence of 
leptospirosis was estimated as 75 to 102 cases per 100,000 per annum (Biggs et al., 
2013b), which is exceptionally high when compared to regional incidence estimates from 
around the world (Costa et al., 2015a). However, more recent data has indicated that the 
incidence of infection is not consistently as high as the initial figures implied (Maze et al., 
in preparation). Hence longitudinal monitoring at this site would allow more 
representative figures for human disease incidence to be calculated, as well as to monitor 
the long-term dynamics of infection in the rodent populations in this area. Sampling at 
other sites in Tanzania to cover a broader selection of populations, ecological and 
geographic settings and climate could also offer new insights into the extent of the problem 
in Tanzania, and the factors that drive high rates of infection.  
 
Question 2: How can we improve our diagnosis of leptospirosis for people in 
Tanzania?  
Timely diagnosis of infection remains a major stumbling block for leptospirosis. Without 
robust data on the prevalence and incidence of infection it is hard to raise the profile of the 
disease amongst many health threats (Abela-Ridder et al., 2010), or to measure the effect 
of any interventions that are trialled (Hartskeerl et al., 2011). In the absence of feasible and 
accessible diagnostic tests, the management of human cases will still rely on empirical 
treatment and clinicians will have few tools to improve their management of patients with 
NMFI (Chappuis et al., 2013).  
The outcome of patients for severe illness may be improved by adherence to international 
syndromic treatment guidelines (Crump et al., 2011a) or by developing disease-specific 
diagnostic algorithms based on a combination of clinical signs, ‗rule-out‘ testing for other 
infectious aetiologies where robust rapid tests do exist, and local risk factors for infection. 
In Moshi, risk factor analysis for acute human leptospirosis from the hospital study of 
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2012-14 is on-going and is hoped to reveal important insights into high risk scenarios for 
human Leptospira infection in this area.  
Improved acute phase diagnostics for human leptospirosis remain an elusive goal for the 
global leptospirosis community (Hartskeerl et al., 2011) and the field is certainly open for 
innovative new solutions. Molecular advances have provided some important steps 
forward (Picardeau et al., 2014) but as this study shows, the performance of molecular 
diagnostic tests continue to be hampered by a number of external factors, in particular the 
accessibility of over-the-counter antimicrobial products in developing countries. Given the 
relatively low research investment in leptospirosis to date (Abela-Ridder et al., 2010), and 
the likely time scale for the development of a novel diagnostic test, perhaps the most 
immediately useful question to ask how could we use our current diagnostic tools and 
therapeutic options more effectively? 
Timing of sampling and sample selection is critical to diagnosing infection by either 
serology or direct detection methods. Based on our understanding of the health-care 
seeking behaviours in Moshi, sampling patients at hospital may not be the most appropriate 
means of detecting early infection in this population. In future studies, implementing 
testing in community locations, such as pharmacies where patients obtain their first line of 
treatment for a fever, may be more appropriate to diagnose infection in the early stages of 
illness. Testing prior to antibiotic treatment would also give the best chance of obtaining 
more information about the infecting Leptospira type through either culture or PCR-based 
sequence analysis.   
Understanding more about the background exposure and circulating serogroups in the 
healthy (i.e. non-febrile) human population could help us to improve the performance of 
available diagnostic tests in Tanzania and provide epidemiological data to underpin 
clinician assessment of prior probability of disease (Chappuis et al., 2013). Background 
prevalence and magnitude of MAT titres can inform locally appropriate serological case 
definitions and improve the specificity of case detection (Goris et al., 2012). Knowledge of 
locally circulating serovars can improve sensitivity of the MAT by selecting appropriate 
serogroups for inclusion on the test panel (Goris and Hartskeerl, 2013). So far, L. 
borgpetersenii serovar Hardjo has not been included on any diagnostic panels used to test 
patients in Moshi despite being isolated from cattle in slaughterhouses in the area. 
Including locally representative serovars on MAT panels may also help to improve the 
performance of the test in this setting.  
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Question 3: What factors drive transmission of Leptospira between livestock and 
people? 
Risk factor analysis may help to improve our understanding of the factors that influence 
zoonotic transmission of Leptospira infection from animals to people in northern Tanzania. 
This work is underway both as part of on-going febrile disease surveillance in Moshi 
(mentioned above) and in a parallel analysis of data from a cross-sectional community 
surveillance study of Leptospira exposure in human and animal populations in the 
Kilimanjaro and Arusha Regions. Analysis of serological data generated by the cross-
sectional project from linked human and cattle populations is already planned to follow-on 
from the work presented in this thesis.  
 
Question 4: What factors influence the patterns of Leptospira infection in animal 
hosts in this setting?  
One of the most intriguing questions to come out of this work was: why were the various 
rodent species trapped in and around households in the Moshi area negative for Leptospira 
infection? Several factors may influence the prevalence of infection in a rodent population 
including a range of host, population and environmental factors as discussed in Chapter ‎5. 
Longitudinal monitoring of rodent populations alongside long-term human disease 
surveillance would be fascinating study to explore whether human infection dynamics are 
also mirrored by the dynamics in the local rodent population. Expanding the study area to 
include a more diverse range of geographic or environmental settings could also shed new 
light on the factors that determine rodent infection in Tanzania.  
Another enigma to arise from this study relates to the dominance of serogroup Mini in both 
human and cattle serological data. This Leptospira type was not isolated or well 
characterised by either genetic or serological methods by this study despite its prevalence 
in the cattle serological study. Virtually nothing is known about serogroup Mini infections 
from elsewhere in sub-Saharan Africa. To add further intrigue, reactivity to this serogroup 
was conspicuously absent from human cases identified by the 2012-14 febrile disease 
study (Maze et al., in preparation). More work is needed to understand the identity, 
maintenance hosts and transmission dynamics of serogroup Mini in this setting. 
Finally, the source of serogroup Australis, which was the second most common serogroup 
in human serological data, has not been identified Moshi. Australis continues to be a 
dominant reactive serogroup in subsequent febrile disease surveillance in Moshi (Maze et 
  223 
al., in preparation) and hence poses an important public health threat to people living in 
the area. Investigation of other maintenance hosts of serovars of this serogroup such as 
pigs and dogs is also an important next step in understanding the epidemiology of infection 
and identifying appropriate disease control targets.  
 
Question 5: How can we tackle human leptospirosis ‘at-source’?  
Evaluating potential intervention strategies for human leptospirosis is an important future 
research question at this site. Various potential intervention strategies were discussed 
earlier in this chapter (Chapter ‎8.2.1) when discussing the potential role of livestock as 
hosts of infection in northern Tanzania. As well as evaluating the effectiveness of specific 
intervention to control human disease, intervention trials can also offer insights into the 
specific role of a particular animal host in the maintenance of infection (Haydon et al., 
2002) and be used to quantify the impact of infection on the animal itself (Dhaliwal et al., 
1996b).  
Based on the conclusions of this thesis, evaluating the feasibility and effectiveness of 
livestock vaccinations in Tanzania would be an obvious starting point. Vaccinations do 
exist for several Leptospira serovars in ruminant livestock hosts including L. 
borgpetersenii serovar Hardjo, which was isolated in this study. At the moment, it is not 
clear how much human infection can be attributed to this Leptospira type. As mentioned 
above, the serovar was not included on MAT panels used in either the 2007-08 or 2012-14 
febrile disease study. Virtually no reactivity to an alternative serovar of the serogroup 
Sejroe (the serogroup of L. borgpetersenii serovar Hardjo) was detected in the 2007-08 
study (Chapter ‎7) but cases have been detected in the later cohort (Maze et al., in 
preparation). MAT testing of serum samples collected by cross-sectional survey will 
include L. borgpetersenii serovar Hardjo on the testing panel, which will allow the 
proportion of human exposure to this serovar to be quantified.  
Tackling human leptospirosis ‗at-source‘ requires an integrated, multidisciplinary approach 
to disease surveillance, control and prevention. A ‗One Health‘ approach to controlling 
zoonotic disease is considered a more equitable approach to improving health in 
marginalised communities (Halliday et al., 2015, Zinsstag et al., 2007). It is important to 
note that like many other diseases that are characterised as ‗neglected‘, leptospirosis is 
more accurately a disease of ‗neglected communities‘ rather than a disease that warrants 
little international attention. Neglected diseases often highlight gross inequalities in 
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income, healthcare infrastructure or sanitation between communities and countries (Hotez, 
2009, Molyneux et al., 2011) and like many other zoonotic infections, leptospirosis is 
strongly associated with poverty in both urban and rural populations (Lau et al., 2010, 
Abela-Ridder et al., 2010). Therefore, approaches that control the disease at source have 
the potential to have broader-reaching effects than improving treatment of individual cases 
for the minority of leptospirosis cases that reach a hospital.  
In conclusion, the work presented here is only an incremental step towards understanding 
the epidemiology of leptospirosis in Tanzania, and indeed elsewhere in Africa, and many 
questions remain unanswered. The continent has a great deal to teach us about 
leptospirosis. Tackling the burden of leptospirosis both in Africa and on a global scale will 
require a universal effort to tackle poverty and health inequalities. In the meantime, general 
principles of leptospirosis epidemiology and control can be learned from better-
characterised settings and applied to attempt to minimise the impact of this important but 
neglected disease.  
 
 
       
Appendix 1: Summary of eligible cohort and surveillance studies reporting human acute 
leptospirosis in Africa, 1930-2014  
Citation Study 
year(s) 
Country Setting and 
study design 





Eligible cases*  
(n & %) 
(Van Riel 
















lysis (MAT)  














40 1 (2·5%) 
(Forrester 






Febrile illness unexplained 
by malaria, dysentery or 
pneumonia.  








Clinical suspicion of 
















65 7 (10·8%) 
(de Geus et 1967 Kenya Hospital and Febrile illness (temperature ≥ Culture (blood) 39 7 (17·9%) 
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al., 1969) health centre; 
prospective 
cohort 
38°C) without obvious 
cause; negative malaria 












Inpatients with serum 





134 3 (2·2%) 









Febrile illness (temperature ≥ 
38.3°C) without obvious 
cause; negative malaria 







91 10 (11·0%) 
(de Geus et 
al., 1977b) 








Febrile illness (temperature ≥ 
38.3°C) without obvious 
cause; negative malaria 












NA Ghana Hospital; 
prospective 
cohort 
Clinical suspicion of 
leptospirosis, mostly defined 




99 13 (13·1%) 
(Hogerzeil 








Group 1: Fever without 
obvious cause and/or any of 
the following; jaundice, 
muscle pains, meningism, 
conjunctival injection, 
albuminuria; negative 
malaria smear  
Culture (blood 
and urine) in 
Fletcher‘s or 
EMJH media; 




Group 1:  
4 (4·5%) 
  227 
Group 2: Jaundice  Group 2: 
102 
Group 2:  
2 (2·0%) 
(Delacollett







Inpatients with black or red 












Inpatients with clinical 
diagnosis of leptospirosis 
d
 











Outpatients aged 18-50 years 
with acute febrile illness 
without obvious cause; 
negative malaria smear. 












Fever or any of the following 
without obvious cause: 
myalgia, liver tenderness, 
jaundice, acute renal failure, 
bleeding tendency, 
radiographic lung infiltrates, 
or meningism  
MAT; PCR 
(rrs) 










Cases voluntarily reported to 
Centre National de 
References de Leptospiroses 















Group 1: fever (temperature 
≥38°C) for ≥3 days in the 
absence of diarrhoea, 
pneumonia, typhoid fever, 






Group 1:  
141 (15·9%) 
  228 
fever of unknown origin. 
Group 2: acute hepatitis 

















Hospitalised cases of 
leptospirosis cases in 
Réunion reported to the 
Regional Directorate for 
Health and Social 
Affairs/Regional Health 
Agency of the Indian Ocean. 
Culture (sample 














Confirmed or probable cases 
of leptospirosis in Réunion 
residents reported to the 
health watch platform of the 
French Regional Health 
Agency for the Indian 
Ocean.  
Culture (sample 
and media not 
specified), 




NA 405 cases 
(Ari et al., 
2011) 




Community members with 
new onset febrile illness 
(temperature not defined) or 
joint pains 
IgM ELISA  12 3 (25·0%) 
(Bertherat 
et al., 2014)  
2005 DRC Community; 
retrospective 
case finding 
Acute & convalescent 
patients with respiratory 
disease in a mining camp 








Fever ≥ 2 days or admission 
temperature ≥38.5°C, aged ≥ 
4 years without obvious 
cause of fever, such as 





981 194 (19·8%) 
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clinical diagnosis of typhoid 








Fever ≥ 2 days or admission 
temperature ≥38.5°C, aged ≥ 
4 years without obvious 
cause of fever; with 
laboratory evidence of co-
infection with Leptospira, 



















Fever; aged ≥ 4 years 
without obvious cause of 
fever, such as diarrhoea, 
pneumonia, or clinical 





PCR (ligA)  
2,441 98 (4·0%) 
(Tagoe et 
al., 2010) 
NA Ghana Hospital; 
prospective 
cohort 
Fever ≥ 2 days and 
temperature ≥38.0°C; aged ≥ 
4 years without obvious 
cause of fever  
IgM ELISA; 
MAT  
166 13 (7·8%) 
(Biggs et 
al., 2011, 







Inpatients aged ≥13 years 
with fever (≥38.0°C oral) or 
inpatients aged 2 months to 
12 years with history of fever 
within 48 hours or admission 
temperature ≥37.5ºC axillary 
≥38.0ºC rectal. 







Fever (temperature ≥38°C) 
for ≤7days and headache 
Culture (blood) 
in EMJH 
388 53 (13·7%), 
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Patients for which a blood 
sample was submitted for 
leptospirosis diagnosis to the 






2,523 198 (7·8%) 
Footnotes: 
*Figures reported here are based on the number of acute leptospirosis cases that met the study case definitions and therefore may vary from the values reported in the 
original citations.  
a
 Patients who refused hospital admission were not investigated.  
b
 Methods describe a change to a case-finding survey partway through the study, but full details not available 
c
 MAT performed in a subset of participants only 
d
 Clinical diagnosis defined as ≥3 of the following: headache or fever (temperature not defined), evidence of liver inflammation (defined as jaundice, tender liver, 
and/or abnormal liver function tests), evidence of renal inflammation (haematuria and/or abnormal renal function), or evidence of muscle inflammation (tenderness 
and/or elevated creatine phosphokinase) 
e
 All tested negative for Salmonella enterica serovar Typhi, Brucella spp., and Rickettsia spp. 
f
 All tested negative for Hepatitis A, B, and C. 
g
 In setting of outbreak of acute febrile illness in a well-defined population 
h
 187 patients were diagnosed with selected co-infections out of a total cohort of 1510 patients with non-specific febrile illness.   
ϖ Taken ≥ 9 days of onset of illness 
k
 Also report two imported cases from Comoros and Madagascar respectively 
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Appendix 2: Summary of eligible studies reporting Leptospira infection in animals in Africa, 1930 
- 2014  
Citation Country; 
 Study year(s) 
Study design Diagnostic tests  Animal Species tested Animals 
tested (n) 
Positive cases (n 
& prevalence) 
(Brownlow and 







House mouse (Mus 
musculus) 
44 2 (4·5%) 
(Lazuga and 







Norway rat (Rattus 
norvegicus) 
919 57 (6·2%) 








113 4 (3·5%) 








Norway rat (Rattus 
norvegicus) 









Norway rat (Rattus 
norvegicus) 
130 11 (8·5%) 
(Bakoss, 1969, 









Pigs (Sus scrofa 
domesticus) 
185 2 (1·1%) 













African grass rat 
(Arvicanthus niloticus) 
NA 
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(Maronpot et al., 
1971)  





Dogs (Canis lupis 
familiaris) 
68 2 (2·9%) 
(Barsoum et al., 
1973) 
Egypt NA Wild animal 
surveillance 




House mouse (Mus 
musculus) 
95 7 (7·6%) 
Egyptian Mongoose 
(Herpestes ichneumon) 
16 2 (12·5%) 









Pigs (Sus scrofa 
domesticus) 
10 6 (60·0%) 










African grass rat 
(Arvicanthus niloticus) 
221 8 (3·6%) 
Cattle (Bos sp.) 74 5 (6·8%) 








Cattle (Bos sp.) 9 2 (22·2%) 









furred rat Lophuromys 
sikapusi) 
NA 1 (NA) 





solid Stuart‘s & 
EMJH media 
Cattle (Bos sp.) 20 10 (50·0%) 






Dogs (Canis lupis 
familiaris) 
3693 48 (1·3%) 
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Cattle (Bos sp.) 40 1 (2·5%) 
(Ezeh et al., 1989a, 
Ezeh et al., 1989b, 




& serovar typing 
Culture (Kidney); 
EMJH media 
Cattle (Bos sp.) 525 6 (1·1%) 








Cattle (Bos sp.) 19 3 (15·8%) 






Culture (Kidney, renal 
lymph node, aborted 
foetuses); EMJH 
media 
Pigs (Sus scrofa 
domesticus) 
14 13 (92·9%) 








Pigs (Sus scrofa 
domesticus) 
30 20 (66·6%) 
(Feresu, 1992, 
Feresu et al., 1993, 
Feresu et al., 1998, 
Feresu et al., 1995, 
Feresu et al., 1994, 
Feresu et al., 1996, 









Cattle (Bos sp.) 480 50 (10·4%) 







Urine); EMJH media 
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(Machang'u et al., 
1997)  




Cattle (Bos sp.) 1021 7 (0·1%) 









medium not stated 
Pigs (Sus scrofa 
domesticus) 
13 12 (92·3%) 
Cattle (Bos sp.) 12 3 (25·0%) 
(Machang'u et al., 
2002, Machang'u et 
al., 2004) 
Tanzania NA Serovar typing Culture (Urine); 
Fletcher‘s media 
Giant African pouched 
rat (Cricetomys 
gambianus) 
83 8 (9.6%) 






PCR (Kidney); 16S 
(rrs) (Murgia et al., 
1997)  
Norway rat (Rattus 
norvegicus) 
63 8 (12·7%) 
House mouse (Mus 
musculus) 
2 1 (50·0%) 
Black rat (Rattus rattus) 2 1 (50·0%) 
(Zimmermann et 









 330 5 (1.5%) 






PCR (Kidney); 16S 




18 PCR: 1 (6·3%) 
Culture (Kidney); 
Fletcher‘s media  
Shrews (Crocidura spp.) 7 PCR: 2 (28·6%) 
Culture: 2 (28.6%) 




Serovar typing Culture (Urine); 
Fletcher & EMJH 
media 
Cattle (Bos sp.) Not given Not given 
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PCR (Kidney); lig A 
& lig B(Palaniappan et 
al., 2005) 
Culture (Kidney, 
urine, blood); EMJH 
media. 
Black rats (Rattus rattus) 100 PCR: 11 (11·0%)$ 
Culture: 4 (4·0%) 







lipL32(Stoddard et al., 
2009) 
Black rats (Rattus 
rattus)  
141 42 (29·8%) 




Culture (Kidney & 
urine); Fletcher‘s 
media 
Pigs (Sus scrofa 
domesticus) 
236 2 (0·8%) 






qPCR (Kidney); secY 
(Ahmed et al., 2009)  
House mouse (Mus 
musculus) 
194 37 (19·1%) 
Norway rat (Rattus 
norvegicus) 
10 1 (10·0%) 
Black rat (Rattus rattus) 33 3 (9·1%) 






Culture (Kidney* & 
urine); EMJH media 
qPCR (Kidney* & 
urine); 
Hap1/lipL32(Branger 
et al., 2005) 
House mouse (Mus 
musculus)  
55 PCR: 5 (10.0%)* 
Culture: 0 (0%)* 
Norway rat (Rattus 
norvegicus)  
96 PCR: 39 (40·6%)* 
Culture: 6 (6·3%)* 
Black rat (Rattus rattus) 94 PCR: 27 (28.7%)* 
Culture: 3 (3·2%)* 
Asian house shrew 
(Suncus murinus) 
23 PCR: 10 (43.5%)* 
Culture: 0 (0%)* 
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qPCR (Kidney; urine 
from bats only); 
lipL32(Stoddard et al., 
2009) 
House mouse (Mus 
musculus) 
13^ 11 (84.6%) 
Black rat (Rattus rattus) 76^ 50 (65.8%) 
Norway rat (Rattus 
norvegicus) 
6^ 4 (66.6%) 
Asian House Shrew 
(Suncus murinus) 
48^ 15 (31.2%) 
Dog (Canis lupis 
familiaris) 
24^ 7 (29.2%) 
Cat (Felis cattus) 21^ 6 (28.6%) 
Cattle (Bos sp.) 77^ 14 (18.2%) 
Goat (Capra aegagrus 
hircus)  
49^ 13 (26.5%) 
Rusa Deer (Rusa 
timorensis) 
32^ 6 (18.8%) 
Pigs (Sus scrofa 
domesticus)  
83^ 13 (15.6%) 
Bats (Mormopterus 
francoismoutoui) 
2^ 2 (100%) 






qPCR (Kidney); secY 
(Ahmed et al., 2009) 
Multimammate mice 
(Mastomys spp.) 
12 4 (33.3%) 
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Norway rats (Rattus 
norvegicus) 
11 3 (27.3%) 
    Black rats (Rattus rattus) 60 8 (13.3%) 
African giant shrew 
(Crocidura olivierii) 
6 1 (16.7%) 
Shrew (Crocidura spp.)  1 1 (100%) 






PCR (Kidney); 23S 
rDNA gene target (rrl) 
(Woo et al., 1997) 
Banded mongoose 
(Mungos mungo) 
41 17 (41.4%) 
Selous mongoose 
(Paracynictis selousi) 
1 1 (100·0%) 







qPCR (pooled kidney, 
spleen & lung); 16S 




 129 27 (20.9%) 
Dietrich et 






qPCR (pooled kidney, 
spleen & lung); 16S 
rRNA (rrs)(Smythe et 
al., 2002)  
Lesser tufted-tailed rat 
(Eliurus minor) 
112 32 (28·6%) 
Cowan‘s shrew tenrec 
(Microgale cowani) 
72 2 (2·8%) 
Dobson‘s shrew tenrec 
(Microgale dobsoni)  
54 3 (5·6%) 
Lesser long-tailed shrew 
tenrec (Microgale 
longicaudata)  
12 1 (8·3%) 
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    Major‘s long-tailed 
tenrec (Microgale 
majori) 
10 2 (20·0%) 
    Greater long-tailed shrew 
tenrec (Microgale 
principula) 
6 2 (33·3%) 
    Lowland streaked tenrec 
(Hemicentetes 
semispinosus)  
4 1 (25·0%) 
    Highland streaked tenrec 
(Hemicentetes nigriceps)  
12 1 (8·3%) 




NA 6 (NA) 
(Nimo Paintsil et 





PCR (kidney); not 
specificd 
Crocidura sp.  NA 1 (NA) 






Culture  (Rats: kidney; 
cattle: blood, milk 
and/or urine); EMJH 
media 
Rats (Species not stated) 200 9 (4·5%) 
Domestic animal 
surveillance 
Cattle (Bos sp.) 625 7 (1·1%) 
Footnotes: $ Numbers adjusted to report results for pathogenic Leptospira spp. only; § Prevalence of carriers cannot be calculated due to incomplete reporting) 
# Species include: Rattus rattus, Mus musculus, Crocidura spp., Mastomys spp.; individual species counts not given 
* Only kidney results reported here. See original reference for full breakdown of positives by sample type; ^ Samples with PCR inhibition are excluded from 
denominator data 
& Bat species include: Chaerephon pusillus, Miniopterus gleni, M.griffithsi, M. griveaudi, M.mahafaliensis, Mormopterus francoismoutoui, Mormopterus jugularis, 
Mytotis goudoti, Otomops madagascariensis, Rousettus obliviosus, Triaenops furculus, Triaenops menamena 
&& Miniopterus species includes: M. gleni, M. goudoti, M. griffithsi, M. mahafaliensis, M. majori, M. soroculus, 
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Appendix 3: Rodent study participant information sheet 
and consent forms 
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Leptospirosis in northern Tanzania: investigating the role of rodents and cattle in a 
neglected public health problem 
 
Participant Information Sheet 
 
INTRODUCTION 
You are being invited to take part in a research study because your household has been 
selected for inclusion in our study. Before you decide it is important for you to understand 
why the research is being done and what it will involve. Please read this information sheet 
and the consent form carefully and take your time making your decision. As the study 
representative discusses this study with you, please ask him/her to explain any words or 
information that you do not clearly understand. We encourage you to talk with your family 
and friends before you decide to take part in this research study. The nature of the study, 
risks, inconveniences, discomforts, and other important information about the study are 
listed below. 
 
WHO IS DOING THIS RESEARCH? 
This research will be conducted by experts in human and animal health from Tanzania and 
from the UK. Prof. John A. Crump and Dr. Moshi K. Ntabaye from the Kilimanjaro 
Christian Medical Centre in Tanzania and Prof. Sarah Cleaveland and Dr. Kathryn Allan 
from the University of Glasgow in UK will conduct the study, with others working on their 
behalf. The sponsors of this study, the Wellcome Trust, UK will pay for this research.  
 
WHO HAS REVIEWED THE STUDY? 
The KCMC ethics committee, National Institute of Medical Research and Tanzanian 
Wildlife Research Institute have reviewed this study in Tanzania. The study has also been 
reviewed by the University of Glasgow in the UK.  
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WHY IS THIS STUDY BEING DONE? 
The purpose of this study is to find out if the rodents in this area are carrying infections 
such as leptospirosis that may cause fever and illness in people. Illness with fever is very 
common in people seeking health care in this area. Leptospirosis has been identified in 
patients with fever at Kilimanjaro Christian Medical Centre (KCMC) and Mawenzi 
regional hospital in Moshi. It is important to learn more about the possible sources of this 
infection so that we can treat and prevent human disease more effectively.  
 
WHY HAVE I BEEN CHOSEN?  
This village has been selected at random from all the villages in the catchment area of 
KCMC. Your household is one of 20 households in this village that have also been 
randomly selected for study participation. Overall, around 600 households will be enrolled 
in this study over a 2-year period.  
 
DO I HAVE TO TAKE PART?  
It is up to you to decide whether or not to take part. If you do decide to take part, you will 
be given this information sheet to keep and will be asked to sign a consent form. If you 
decide to take part, you are still free to withdraw at any time and without giving a reason.  
 
HOW LONG WILL I BE IN THIS STUDY? 
Your participation will be required for one to two weeks. You can choose to stop 
participating at any time without penalty. 
 
WHAT IS INVOLVED IN THE STUDY? 
If you agree to participate in this study, you will first be asked to sign this consent form.  A 
study worker will ask then ask you some basic questions about you and the people that live 
in your household. We will also ask questions about the structure of your house and its 
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surroundings, the types of crops that you grown and the kind of animals that you come into 
contact with. 
Study personnel will then place traps for rodents in and around your household. Traps will 
be checked daily and any trapped rodents will be removed and humanely killed before 
being tested for infections such as leptospirosis.  
 
WHAT ARE THE POSSIBLE DISADVANTAGES AND RISKS OF TAKING PART IN 
THIS STUDY? 
There are minimal physical risks associated with this study.  For your safety, the traps 
placed within your household must not handled or moved by anyone other than project 
personnel.  Members of the household are asked not to move or handle the traps in any 
way, or to handle any rodents that they see in or around these traps within their 
households. Study personnel will require access to your household twice daily for one 
week to place and check rodent traps.  
 
ARE THERE BENEFITS TO TAKING PART IN THE STUDY? 
Participating households will experience immediate benefit through the removal of a small 
number of pest rodents from households. Study personnel can also help to advice on 
methods of rodent control if this is not already in place. On a wider scale, the results of this 
study will help to improve medical care and laboratory diagnostics of infection in 
Tanzania. In the future, we hope that information gathered in this study will help to prevent 
human and animal disease in this area. 
 
WHAT WILL HAPPEN TO THE RESULTS OF THE RESEARCH STUDY?  
After rodent samples are taken, a number of tests will be run to help us understand more 
about leptospirosis and other diseases carried by rodents in this area. Similar tests are also 
being run on samples collected from cows in local abattoirs. Animal samples will firstly be 
tested at the Kilimanjaro Clinical Research Institute in Moshi. After this, additional tests 
may be run at one of collaborating institutions including Glasgow University, the Royal 
Tropical Institute (KIT) in Holland and Sokoine University of Agriculture in Morogoro, 
Tanzania. Samples will be stored for a minimum of 10 years and may be used by other 
   243 
relevant research projects. Your name will not be on any of the samples taken from rodents 
so no one outside of the study team will be able to identify you from the samples. The 
results of these tests will then be analyzed alongside the data that we collect in the 
questionnaire survey to help us understand more these important infections. 
The results of this study will be communicated to Tanzanian healthcare workers, doctors, 
veterinarians and government officials to help improve human and animal health in this 
area. In addition, the results of this study may be published in national or international 
scientific journals or other publications. However, no personal details will be released 
outside the study collaboration and you and your household will not be identified in any 
report or publication.  
 
WILL MY INFORMATION BE KEPT CONFIDENTIAL? 
All information that is collected about you and your household during the course of the 
research will be kept strictly confidential. Except when required by law, you will not be 
identified in the study records disclosed outside of KCMC or University of Glasgow. If 
study results are made available to other researchers, you will be assigned a unique code 
number so that you cannot be recognized from these results. . 
 
HOW DO I WITHDRAW FROM THIS STUDY?  
You may choose not to be in the study or, if you agree to be in the study, you may 
withdraw from the study at any time. If you withdraw from the study, no new data about 
you will be collected for study purposes other than data needed to keep track of your 
withdrawal. Your decision not to participate or to withdraw from the study will not involve 
any penalty or loss of benefits to which you are entitled. If you do decide to withdraw, we 
ask that you contact Dr Kathryn Allan at KCMC (write to: Dr. Kathryn Allan c/o Francis 
Karia, KCMC/Duke Collaboration, CCFCC Building, KCMC, PO Box 3010, Moshi) in 
writing and let her know that you are withdrawing from the study. At that time we will ask 
your permission to continue using all information about you that has already been collected 
as part of the study prior to your withdrawal. 
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WHAT ARE THE COSTS AND COMPENSATION? 
There will be no additional costs to you as a result of being in this study and no 
compensation will be provided for your participation.  
 
WHOM DO I CALL IF I HAVE QUESTIONS OR PROBLEMS? 
For questions about the study or if you have complaints, concerns or suggestions about the 
research, contact [the project representative – to be named and phone number given once 
known]. For questions about your rights as a research participant, or to discuss problems, 
concerns or suggestions related to the research, or to obtain information or offer input 
about the research, contact the KCMC Ethics Committee at +255-27-275-3909. 
 
THANK YOU! 
On behalf of all the project investigators, we would like to thank you for agreeing to take 
part in this study. 
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Project Code Number: 57398/1 
Subject Identification Number for this trial: 
 
CONSENT FORM 
Title of Project: Leptospirosis in northern Tanzania: the role of rodents and cattle in 
a neglected public health problem 
Name of Researcher(s): Dr Moshi Ntabaye and Professor John Crump from the 
Kilimanjaro Christian Medical Centre, Tanzania; Professor Sarah Cleaveland and Dr 
Kathryn Allan from the University of Glasgow, UK.  
 
STATEMENT OF CONSENT 
"The purpose of this study, and the study procedures, risks and benefits have been 
explained to me. I have been allowed to ask questions, and my questions have been 
answered to my satisfaction. I have been told that I may contact the KCMC Ethics 
Committee at +255-27-275-3909 if I have questions about my rights as a research subject, 
to discuss problems, concerns, or suggestions related to the research, or to obtain 
information or offer input about the research. I confirm that I have read the information 
sheet dated 25
th
 February 2013 (version 1.2). I understand that my participation is 
voluntary and that I am free to withdraw at any time, without giving any reason and 
without my legal rights being affected. I agree to take part in this study.‖ 
 
           
Name of subject    Date   Signature 
 
    
Name of Person taking consent  Date   Signature 
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Witness (if applicable)   Date   Signature 
(1 copy for subject; 1 copy for researcher) 
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Appendix 4: Rodent study household questionnaire 
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RODENT PROJECT – HOUSEHOLD QUESTIONNAIRE 
SECTION 1 - Interview details 
Household ID:   LCR-[_][_][_] 
Interviewer ID (initials):   [_][_][_] 
1.3 Date of interview (dd/mm/yyyy) :  [_][_]/[_][_]/[_][_][_][_] 
1.4 Interview language:    Kiswahili  English  Maa 
 
Review details    
1.5 Reviewer ID:     [_][_][_] 
1.6 Date of review (dd/mm/yyyy) :  [_][_]/[_][_]/[_][_][_][_] 
 
 
SECTION 2 – Respondent details 
2.1 Sex:     Male  Female 
2.2 Age in years    [_][_][_]  
 
2.3 What is your tribe?   Chagga (Mchagga) 
Kabila lako?     Pare (Mpare) 
      Maasai (Mmaasai) 
      Sambaa (Msambaa) 
      Other Nyinginezo _________________ 
 
2.4 How long have you lived in this village? 
Ni muda gani umeishi katika kijiji hiki? 
 Units:   years (miaka)  months (miesi)  days (siku) 
 Number: [_][_][_] 
       
 
Household location 
3.1 District :  Moshi Urban 
   Moshi Rural 
3.2 Village : [_][_][_][_][_][_][_][_][_][_][_][_][_][_][_][_][_] 
3.3 Subvillage : [_][_][_][_][_][_][_][_][_][_][_][_][_][_][_][_][_] 
 
3.4 GPS location N/S Coord     [_][_] . [_][_][_][_][_] 
3.5 GPS location E/W Coord [_][_][_] . [_][_][_][_][_] 
 
3.6 GPS location Altitude (m) [_][_][_][_] 
 
3.7 Waypoint ID  [_][_][_] 
 
3.8 How long does it take to walk to the nearest stream/river? 
Inachukua muda gani kutembea mpaka kwenye mto/mfereji wa karibu zaidi? 
 Time _________________________ Hours Saa / Minutes Dakika 
 
3.9 How long does it take to walk to the nearest tarmac road? 
Inachukua muda gani kutembea mpaka barabara ya lami iliyo karibu zaidi? 
 Time _________________________ Hours Saa / Minutes Dakika 
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Compound and household description 
Please answer the following questions about the compound that you (the respondent) are 
part of. 
 
4.1 How many adults (≥ 18 years) live in this household? [_][_][_] 
Watu wangapi (≥ 18 miaka) wanaishi kaya hii? 
 
4.2 How many children (< 18 years) live in this household? [_][_][_] 
Watoto wangapi (< 18 miaka) wanaishi kaya hii? 
 
4.3 How many sleeping rooms are used by the members of your house? [_][_] 
Kuna vyumba vingapi katika nyumba yako? 
 
4.4 Do you have any electricity at your house?   Yes   No 
Una umeme wowote katika nyumba yako? 
 
4.5 If yes, what kind? Kama ndiyo, aina gani? 
 Grid (Gridi)   Solar (Solar)   Generator (Jenerata) 
 Other  Nyinginezo ____________________________________________ 
 
4.6 What is the primary energy source used for cooking at this household? (choose one 
only) 
Aina gani kuu (ya msingi) ya nishati inatumika kwa kupikia katika kaya hii? (chagua moja 
tu) 
 Electricity (Umeme) 
 Gas (Gesi) 
 Kerosene (Mafuta taa) 
 Cow dung (Kinyesi cha ng’ombe) 
 Firewood (Kuni) 
 Charcoal (Mkaa) 
 Other Nyinginezo ____________________________________ 
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4.7 What is the source of drinking water for members of this household? 
Nini chanzo kikuu cha majo ya kunywa katika kaya hii? 
Please indicate the primary water source used in the dry season and wet seasons (choose only one 
primary source in each season) and also indicate any other sources that are normally used during 
the dry and wet seasons. 
Water source 
Chanzo cha maji 
1° Dry season 
Kiangazi  
1° Wet season 
Mvua 
2° any season 
Wakati 
wowote 
Piped water into the home 
Yanayosukumwa kwa bomba mpaka 
ndani nyumbani 
1°  1°    
Public/communal well or standpipe 
Kisima au pampu ya jumuia 
 1°   1°    
River or stream (moving water) 
directly 
Moja kwa moja kutoka mto au 
mfereji (majo yanatotembea) 
 1°  1°   
Lake, pond, dam (standing water) 
directly 
Moja kwa moja kutoka Ziwa, 
dimbwi, bwawa (maji yaliyosimama) 
1°  1°   
Private well or pump 
Kisima au pampu ya binafsi 
 1°  1°   
From a spring 
Kutoka katika chemchem 
 1°  1°   
Rainwater 
Maji ya mvua 
 1°  1°   
Tanker truck 
Tanki la gari 
 1°  1°   
Cart of wheelbarrow with small tank 
or drum 
Mkokoteni na tanki dogo au 
madumu/pipa 
 1°  1°   
Bottled water 
Maji ya chupa 
 1°  1°   
Other 
Nyinginezo___________________ 
 1°  1°   
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4.8 Is the drinking water at this household treated (by filtering, boiling, chlorination, 
straining etc)? 
Je maji ya kunywa katika kaya hii yanafanywa salama (kwa kuchuja, kuchemshwa, kuweka 
dawa ya shabu/klorine, kuchuja kwa nguo n.k.?)  
  Always   Often   Infrequently   Never   
 
 
4.9 If Yes: how is it treated? (choose all that apply) 
Kama ndiyo: unayafanya salama/takasa namna gani? (Chagua vote yanayohusika) 
 Boiling (Kuchemsha)  
 Strain it through a cloth (Kuchujwa kwa nguo)    
 Adding disinfectant, such as chlorine or bleach (Kuweka dawa kama 
shabu/klorine)  
 Sedimentation and decant (Kuacha kwa muda yatwae/uchafu uende chini)  
  Filtering (Kuchuiwa) 
  Solar disinfection (Kufanya salama kwa jua)     
  Other Nyinginezo________________________________________ 
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4.10 What is the primary source of bathing water in this household? Nini chanzo kikuu cha 
maji ya kuoga katika kaya hii? 
Please indicate the primary water source used in the dry season and wet seasons (choose only one 
primary source in each case) and also indicate any other sources that are normally used during the 
dry and wet seasons. 
Water source 
Chanzo cha maji 
1° Dry season 
Kiangazi  
1° Wet season 
Mvua 
2° any season 
Wakati 
wowote 
Piped water into the home 
Yanayosukumwa kwa bomba mpaka 
ndani nyumbani 
1°  1°    
Public/communal well or standpipe 
Kisima au pampu ya jumuia 
 1°   1°    
River or stream (moving water) 
directly 
Moja kwa moja kutoka mto au 
mfereji (majo yanatotembea) 
 1°  1°   
Lake, pond, dam (standing water) 
directly 
Moja kwa moja kutoka Ziwa, 
dimbwi, bwawa (maji yaliyosimama) 
1°  1°   
Private well or pump 
Kisima au pampu ya binafsi 
 1°  1°   
From a spring 
Kutoka katika chemchem 
 1°  1°   
Rainwater 
Maji ya mvua 
 1°  1°   
Tanker truck 
Tanki la gari 
 1°  1°   
Cart or wheelbarrow with small tank 
or drum 
Mkokoteni na tanki dogo au 
madumu/pipa 
 1°  1°   
Bottled water 
Maji ya chupa 
 1°  1°   
Other 
Nyinginezo___________________ 
 1°  1°   
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4.11 What is the primary source of cleaning water (e.g. clothes/dishes) in this household? 
Nini chanzo kikuu cha maji kufulia na kuoshea katika kaya hii? 
Please indicate the primary water source used in the dry season and wet seasons (choose only one 
primary source in each case) and also indicate any other sources that are normally used during the 
dry and wet seasons.  
Water source 
Chanzo cha maji 
1° Dry season 
Kiangazi  
1° Wet season 
Mvua 
2° any season 
Wakati wowote 
Piped water into the home 
Yanayosukumwa kwa bomba 
mpaka ndani nyumbani 
1°  1°    
Public/communal well or 
standpipe 
Kisima au pampu ya jumuia 
 1°   1°    
River or stream (moving water) 
directly 
Moja kwa moja kutoka mto au 
mfereji (majo yanatotembea) 
 1°  1°   
Lake, pond, dam (standing water) 
directly 
Moja kwa moja kutoka Ziwa, 
dimbwi, bwawa (maji 
yaliyosimama) 
1°  1°   
Private well or pump 
Kisima au pampu ya binafsi 
 1°  1°   
From a spring 
Kutoka katika chemchem 
 1°  1°   
Rainwater 
Maji ya mvua 
 1°  1°   
Tanker truck 
Tanki la gari 
 1°  1°   
Cart of wheelbarrow with small 
tank or drum 
Mkokoteni na tanki dogo au 
madumu/pipa 
 1°  1°   
Bottled water 
Maji ya chupa 
 1°  1°   
Other 
Nyinginezo__________________ 
 1°  1°   
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4.12 What is the primary type of toilet system used by members of this household? (choose 
only one). Aina gani ya mfumo wa choo ambao unatumika na wakazi wa kaya yako? 
(chagua moja tu) 
 Flush or pour toilet with septic tank, including squat toilet  
Choo kwa kuvuta au cha kumwaga maji cha kuchuchumaa na mfumo wa shimo la 
maji taka 
 Flush or pour toilet connected to sewer pipe, including squat toilet 
Choo cha maji kilichounganishwa na bomba la maji taka, pamoja na choo cha 
kuchuchumaa  
 Pit latrine with covering slab 
Choo cha shimo kilichosakafiwa 
 Pit latrine without covering slab 
Choo cha shimo bila kusakafiwa 
 Ventilated improved pit latrine (VIP) 
Choo cha shimo bora chenya bomba la kutoa hewa chafu (VIP) 
 Bucket or plastic bags  
Ndoo au mifuko ya plastiki/Rambo 
 No facilities or field or bush 
Hakuna choo, kwenda porini 
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4.13 In the past 1 year (12 months), has there been standing water/flooding within this 
compound?  
Katika mwaka uliopita, kumekuwa na maji yaliyosimama/mafuriko katika eneo la kaya hii? 
  Yes      No  
 
4.14 What is the roof of your house made of? (choose only one option) 
Nyumba yako imeezekwa na paa la aina gani? (Chagua jibu moja tu) 
 Metal  Bati 
 Thatch  Nyasi 
 Wood  Mbao 
 Tiles  Vigae 
 Cement  Saruji 
 Other  Nyinginezo ________________________________ 
 
4.15 What is the floor of your house made of? (choose one option only) 
Sakafu ya nyuma yako imetengenezwa na nini? (Chagua jibu moja tu) 
  Dirt or mud  Vumbi/tope    
  Dung  Kinyesi cha mifugo    
  Brick  Matofali    
  Cement  Saruji   
  Tile or linoleum Vigae/sakafu ya mpira  
  Wood or planks Mbao  
  Other   Nyinginezo __________________________ 
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4.16 What are the walls of your house made of? (indicate all that apply) 
Ukuta wa nyumba yako umetengenezwa na nini? (chagua yote yanayohusika) 
  Mud or manure Tope au kinyesi cha mifugo  
   Burnt brick Tofali zilizochomwa 
   Mud bricks Tofali za matope 
   Cement  Saruji 
   Wood or planks Mbao 
   Stone  Mawe   
   Thatch  Nyasi  
   Other   Nyinginezo __________________________ 
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4.17 Do you have any of the following items in your household? (choose all that apply)  
Kuna chochote kati ya hivi katika nyumba yako? (chagua vote yanayohusika)  
If yes for any items, please enter the number of working items that are owned. 
Please enter 00 in the Number of units field for items that are not owned at this household. 
Asset 
Chombo/kifaa 
Number of working units 
Namba 
Ox plough Jembe la n’gombe/Plau [_][_] 
Ox cart Mkokoteni wa n’gombe [_][_] 
Bicycle Baisikeli [_][_] 
Motorbike Piki piki [_][_] 
Car Gari [_][_] 
Tractor Trekta [_][_] 
Mobile phone Simu ya mkononi [_][_] 
Radio Redio [_][_] 
Television Luninga [_][_] 
Sofa Makochi [_][_] 
Bed net Chandarau [_][_] 
Refrigerator Jokofu (friji) [_][_] 
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Land and crops 
5.1 What crops are grown around this compound (within 10 metres)? Choose all that apply. 
Karibu kaya yako (katika metre 10), mimea gani inalima? Chagua yote yanayohusika  
  Rice  Mpunga     Millet  Mtama   
  Sorghum Mtama     Maize  Mahindi 
  Sesame Ufuta     Cassava Muhugo 
  Sweet potato Viazi vitamu   Beans Maharage  
  Cabbage Kabeji     Lettuce Saladi  
  Tomato Nyanya    Banana Ndizi  
  Cotton Pamba     Coffee  Kahawa  
  Potato Viazi     Avocado Parachichi 
  Spinach Mchicha    Sugarcane Miwa  
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Household livestock ownership and herd management 
 
6.1 Are any animals of the following species kept within this compound?  
Je kuna yeyote wa wanyama wafuatao wanatunzwa/fugwa katika eneo hili? 
If Yes (for a given species), please record the total number of adult and juvenile animals that are 
currently kept at this compound (irrespective of who owns these animals).  
For mammals:  (Adult = > 1yr, Juvenile = 0-1 yr) 
For birds:  (Adult = adult plumage, Juvenile = non-adult plumage) 




Cattle Ng’ombe  Y  N [_][_][_] [_][_][_] 
Sheep Kondoo  Y  N [_][_][_] [_][_][_] 
Goats Mbuzi  Y  N [_][_][_] [_][_][_] 
Pigs Nguruwe  Y  N [_][_][_] [_][_][_] 
Horses Farasi  Y  N [_][_][_] [_][_][_] 
Donkeys Punda  Y  N [_][_][_] [_][_][_] 
Camels Ngamia  Y  N [_][_][_] [_][_][_] 
Cats Paka  Y  N [_][_][_] [_][_][_] 
Dogs Mbwa   Y  N [_][_][_] [_][_][_] 
Chickens Kuku  Y  N [_][_][_] [_][_][_] 
Ducks Bata  Y  N [_][_][_] [_][_][_] 
Rabbits Sungura  Y  N [_][_][_] [_][_][_] 
Pigeons Ngiwa  Y  N [_][_][_] [_][_][_] 
Other Nyinginezo 
______________________ 
 Y  N [_][_][_] [_][_][_] 
       
 
6.2 How do you graze your livestock during the day in the dry and wet seasons? (choose one option for each species and season) 
Unachunga/lisha namna gani mifugo yako mchana wakati wa kiangazi na wakati wa mvua? (chagua jibu moja kwa kila aina ya msimu)  
 

































































Free-ranging (no herdsman) 
(Wanajichunga wenyewe hakuna mchunji) 
        
Herded 
(Wanachungwa) 
        
Tethered 
(Wanaofungwa) 
        
Not grazed 
Wanakatiwa majani 
        
Other Nyinginezo 
______________ 
        
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6.3 Where are your adult livestock normally kept during the night in the dry and wet seasons? (choose one option for each species and season) 









































































Hawako sehemu moja 
        
Confined at the compound (<10 m from house) 
Wanawekwa kwenya eneo kaya (< 10 m kwa nyumba) 
        
Confined at the compound (> 10m from house) 
Wanawekwa kwenya eneo kaya (> 10 m kwa nyumba) 
        
Confined elsewhere (oustide the compound) 
Wanawekwa sehemu nyingine 
        
Other Nyinginezo 
___________________ 
        
       
 
 
Rodents around the compound 
7.1 Have you seen rodents in your house in the past month? Please indicate the frequency 
of sightings 
Je umewahi kuona panya katika nyumba yako katika mwezi uliopita? Tafadhali onyesha 
umewaona mara ngapi. 
  Every day     Kila siku 
  More than once a week   Zaidi ya mara moja katika wiki 
  Less than once a week   Pungufu ya mara moja kwa wiki 
  Never     Haijatokea 
 
7.2 Have you seen evidence of rodents (e.g. faeces, urine, noises, rodent tracks, rodent 
damage) in your house in the past month? (Please indicate the frequency of sightings). 
Je umewahi kuona panya au ushahidi wa panya (kama choo, mkojo, sauti, nija yake) 
katika nyumba yako katika mwezi uliopita? (Tafadhali onyesha umewaona mara ngapi). 
  Every day     Kila siku 
  More than once a week   Zaidi ya mara moja katika wiki 
  Less than once a week   Pungufu ya mara moja kwa wiki 
  Never     Haijatokea 
 
7.3 Have you seen evidence of rodents (e.g. faeces, urine, noises, rodent tracks, rodent 
damage) in your kitchen or stored food in the past month? (Please indicate the frequency of 
sightings) 
Je umewahi kuona panya au ushahidi wa panya (kama choo, mkojo, sauti, nija yake, vitu 
vilivyoharibiwa na panya) katika jiko lako au chakula kilichohifadhiwa katika mwezi 
uliopita? (Tafadhali onyesha umewaona mara ngapi) 
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  Every day     Kila siku  
  More than once a week   Zaidi ya mara moja katika wiki 
  Less than once a week   Pungufu ya mara moja kwa wiki 
  Never     Haijatokea 
 
7.4 Have you seen evidence of rodents (e.g. faeces, urine, noises, rodent tracks, rodent 
damage) in your compound in the past month? (Please indicate the frequency of sightings) 
Je umewahi kuona ushahidi wa panya (kama choo, mkojo, sauti, njia yake, vitu 
vilivyoharibiwa na panya?) katika eneo lako katika mwezi uliopita? (Tafadhali onyesha 
umewaona mara ngapi) 
  Every day     Kila siku  
  More than once a week   Zaidi ya mara moja katika wiki 
  Less than once a week   Pungufu ya mara moja kwa wiki 
  Never     Haijatokea 
 
7.5 Have you seen evidence of rodents (e.g. faeces, urine, noises, rodent tracks, rodent 
damage) in the fields around your compound in the past month? (Please indicate the 
frequency of sightings) 
Je umewahi kuona ushahidi wa panya (kama choo, mkojo, sauti, nija yake vitu 
vilivyoharibiwa na panya?) katika shamba lako katika mwezi uliopita? (Tafadhali onyesha 
umewaona mara ngapi) 
  Every day     Kila siku  
  More than once a week   Zaidi ya mara moja katika wiki 
  Less than once a week   Pungufu ya mara moja kwa wiki 
  Never     Haijatokea 
  Don‘t have fields    Hakuna shamba 
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7.6 Do any members of this household do anything to control rodents? 
Je, yeyote wa wakazi wa kaya hii anafanya chochote kuzuia hawa panya? 
   Yes  Ndiyo   No Hapana 
 
7.7 If yes, what type of rodent control do you use? (choose all that apply) 
Kama ndiyo, njia gani huwa unatumia? (onyesha zote ziinazohusika) 
 Mechanical (e.g. traps)  Kuwatega, kuwapiga (mfano: mitego) 
 Chemical (e.g. poisons) Kutumia dawa/kemikali (mfano: sumu) 
 Biological (e.g. keeping predators) Kutumia njia za kibiologia (mfano: kufuga paka) 
 Other Nyinginezo________________________________________ 
 
7.8 If yes for Chemical control; What is the name or brand of the poison that you use? 





7.9 How do you dispose of the carcasses of the rodents that you kill? (choose all that 
apply) Unapata/unafanya nini mizoga ya panya ambao unawaua (onyesha yote 
yanayohusika) 
 Leave them where they die   Nawaacha walipokufa 
 Throw them into the bush   Kuwatupa porini 
 Burn    Choma moto    
 Bury    Kuwafukia 
 Feed to other animals  Kulishia wanyama wengine 
 Consume    Kuwala 
 Other  Nyinginezo__________________________________ 
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7.10 How many rodents do you see in the different seasons of the year?   
Unawaona panya wangapi katika misimu tofauti ya mwaka? 
Please tick one box (Many, Few, None or Don’t know) for each season to indicate the numbers of 
rodents that you see in each season. 
 
 Long rain 
Mvua za muda 
mrefu 
Short rain 
Mvua za muda mfupi 
Dry 
Kiangazi 
Many Wengi    
Few Wachache    
None Hakuna    
Don‘t know Hajui    
 
 
END OF QUESTIONNAIRE 
 
 






The dilution of a known quantity of pathogen DNA below which 
the assay fails to detected 95% of replicates.  
Analytical 
specificity 
The ability of an assay to detect a particular organism (rather than 
other organisms) in a sample. 
Commensal 
rodent species 
Rodents including Rattus norvegicus, Rattus rattus and Mus 
musculus that live in close proximity and dependence on people. 
Compound A discrete area often but not always marked by a boundary hedge 
that includes the buildings and open space used by one (or more) 
family who share cooking facilities. 
Diagnostic 
sensitivity  
A measure of the proportion of true positives within a population 
that are correctly identified by a diagnostic test.  
Diagnostic 
specificity 
A measure of the proportion of true negatives within a population 
that are correctly identified by a diagnostic test. 
Household A permanent structure where one or more inhabitants who share the 
same cooking facilities sleep over night. 
Incidental host A mammalian host that becomes incidentally infected with a 
Leptospira serovar that is not normally maintained by that particular 
species or population (Ko et al., 2009, Levett, 2001) 
Maintenance host 
 
A host that is able to maintain infection without re-introduction 





The serogroup with the single highest titre demonstrated by the 




One or more epidemiologically connected populations or 
environments in which a pathogen can be permanently maintained 
and from which infection is transmitted to the target population 
(Haydon et al., 2002)  
Serogroup Broadest classification of Leptospira bacteria, grouped on the basis 
of antigenic characteristics. Serogroups frequently encompass 
Leptospira serovars belonging to different species with similar 
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serological reaction profiles (Levett, 2015).  
Serovar High-resolution taxonomic classification of Leptospira that now 
encompasses both genetic and serological characteristics of the 
bacterial sub-type (Levett, 2015).  
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